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Abstract 
Syntheses of 2,3-dihydrobenzofurans and 3,4-dihydrobenzopyrans normally involve several 
stages, therefore efficient syntheses of these compounds are desirable. 
A number of 3,4-dihydrobenzopyrans derivatives were prepared in one pot syntheses. The 
reaction is thought to proceed through cation intermediates, involving allylic cations generated by 
the reaction of allyl alcohols, 1,3-dienes, or diols in the presence of acids such as trifluoroacetic 
acid (TFA), or in a solution of glacial acetic and a metal catalyst or glacial acetic acid and 
sulphuric acid, followed by reaction with nucleophiles such as phenols or hydroquinones. This 
leads to the formation of allyl aryl ethers which rearrange via a [3,3]-sigmatropic reanangement 
and acid-catalysed intramolecular cyclisation, to give the conesponding 3,4-dihydrobenzopyrans. 
5-Formyl-2,3-dihydrobenzofuran and 6-formylamino-3,4-dihydrobenzopyran were synthesized 
by several routes and the isolated products exhibited cis-trans isomerism. 
It was found that the introduction of an alkyl substituent at carbon-4 in the model benzopyran 
locks the 2,3,4-alkyl substituents into axial and equatorial orientations. This may influence the 
peroxyl-radical scavenging activity of these compounds by altering the extent of orbital overlap 
between the 2p-type lone pair on the pyran oxygen and the aromatic 1t-electron system. 
2,3-Dihydrobenzofurans such as 5-hydroxy-2,3-dihydrobenzofuran have been shown to have 
better antioxidant activity than alpha-tocopherol due to the influence of the smaller, more strained 
ring, which allows better overlap of the oxygen lone pair and the 1t-electrons in the aromatic 
system. 
5-Hydroxy-2,3-dihydrobenzofuran was efficiently synthesised in an improvement on the yields 
previously reported in the literature. 
A series of substituted 2,3-dihydrobenzofurans were synthesised by the reaction of phenols with 
allylic alcohols or aldehydes in the presence of trifluoroacetic acid or catalytic amounts of 
sulphmic acid, which also promoted the acid-catalysed intramolecular cyclisation. 
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Introduction 
1.00 INTRODUCTION 
1.01 Vitamin E 
Vitamin E (1) which has a molecular formula C29HS002, is a naturally occurring 
antioxidant with various other biological functions l -8. It is a fat soluble vitamin9.10 and 
is implicated in defending unsaturated lipid molecules in cell membranes from 
degradation by autoxidation. This can occur either from normal dioxygen metabolism or 
various pathological and infectious disease states. 
R5 
H H 
Rs 
1 
a-T R5, R7, R8= CH.3 
~-T R5. Rs = CH.3, R7 = H 
y-T R5 = H, R7, R8 = CH3 
o-T R5, R7 = H, R8 = CH3 
Therefore, vitamin E is an essential molecule in maintaining life (and is also essential for 
fertility and reproduction in rats I I ). The word 'vitamin' comes from 'vital amine' -
although not all vitamins are amines as originally thought. Vitamin E is a member of a 
group of four structurally related compounds called the tocopherols of which a-
tocopherol (vitamin E) is considered the most potentl2. 
Included in this group are tocotrienols (2), which are very similar in structure but have 
an unsaturated lipophilic tail (a polyenic tail). However, tocotrienols have very little 
biological activity in mammals under high oxygen tension situationsl3. 
Rs 
2 
a-T R5, R7, R8= CH.3 
~-T R5, Rg = CH.3, R7 = H 
y-T R5 = H, R7. R8 = CH3 
o-T R5, R7 = H, R8 = CH3 
The richest natural sources of a-tocopherol are wheat-germ oil, various vegetable oils 
and green leafed vegetables such as lettuce8. Rubber latex from Hevea brasiliensis has 
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recently been discovered to be a rich source of free and esterified tocotrienols which can 
be extracted using non-polar, lipophilic solvents such as diethylether, or petroleum ether. 
1.02 A Brief History of Vitamin E 
Vitamin E (1) was first discovered in 1922 by Evans and Bishop14 and isolated as a 
crystalline allophanate in 1936. It is a viscous yellow oil, with a boiling point of 1400 (at 
reduced pressure)15,has a melting point of 2.5-3.50, and can be recrystallised from 
methanol at -35°16. The first chemical synthesis17 of tocopherol was carried out in 1938 
and since then many analogues have been made and many different syntheses have been 
reported. As well as an antioxidant, vitamin E has also been used to promote fertility 15. 
Synthetic analogues of vitamin E are used as preservatives18 and to treat various medical 
conditions such as trauma and diabetes. Vitamin E has also been used in the treatment of 
peripheral vascular disease19 and to improve the action of insulin in diabetes (diabetes 
may be associated with lipid metabolism20). It also acts as a diuretic, and has been used 
as an antipollutant 11 (where it has been claimed that a-tocopherol protects the lungs from 
damage caused by air pollutants such as ozone and nitrogen dioxide). It has been 
reported to increase the ability of white blood cells to resist infection21 , and claims have 
been made that it can slow down the ageing process. 
It has been proposed that the membrane damage caused by autoxidation in lipids is 
associated with the ageing process22. Theoretically, it would therefore be possible to 
slow down this process using vitamin E. This may be partly true as vitamin E has been 
shown to increase the life span of mice23. 
Benzofuran analogues of a-tocopherol have been shown to protect mice from 
autoxidation24. It is known that antioxidants tend to decrease in concentration with age 
so that the amount of oxidation products and cell oxidation in the body increases25. 
Recent studies have shown that the antioxidant vitamins (A,C & E) can lower coronary 
heart disease risk and mortality. It was found that low blood vitamin E levels served as 
strong predictors of heart disease mortality26. Free radical lipid peroxidation contributes 
to abnormal metabolism and ventricular function that is frequently seen after cardiac 
operations. Antioxidants, such as vitamin E, have been shown to improve the metabolic 
recovery in patients after cardiac by-pass treatment27,28. 
Vitamin E is present in vitamin supplements as dl-a-tocopheryl acetate or the d-a-
tocopheryl succinate. The recommended daily allowance (RDA) of vitamin E is IOmg21 , 
but this figure is an understatement since increased consumption of unsaturated fats can 
increase the RDA for normal health. 
Under IUPAC nomenclature vitamin E is 3,4-dihydro-2,5,7 ,8-tetramethyl-2-( 4,8,12-
trimethyltridecyl)-2H-I-benzopyran-6-0115 although it has been given other names such 
as 5,7,8-trimethyltocoI29. Difficulties with the stereochemical nomenclature of 
2 
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tocopherols and related molecules have been reported3o. There were no problems 
concerning the nomenclature of natural vitamin E but there had been considerable 
difficulties in naming the synthetic products with vitamin E activity. 
In a-tocopherols, there are three chiral centres, at position 2, 4', and 8'. In natural a-
tocopherol the configuration was assigned as 2R, 4'R, 8'R and it had been called d-a-
tocopherol. 
1 
Natural a-tocopherol (2R, 4'R, 8'R) 
Whereas, the a-tocopherol obtained from natural phytol or phytylbromide, respectively, 
was not a racemic mixture but a mixture of two enantiomers of a-tocopherols with the 
configurations 2R, 4'R, 8'R and 2S, 4'S, 8'S (referred as dl-a-tocopherol). However, 
the a-tocopherol obtained from synthetic phytol and isophytol, respectively, had also 
been referred to as dl-a-tocopherol. This material is a mixture of of all eight possible 
stereoisomers of a-tocopherol. Considering the fact a) the symbols d and dl were not in 
accord with IUP AC rules of stereochemistry and b) the old system did not provide 
distinguishing names for the two, chemically different, syntheic materials having the 
structures of a-tocopherol. Hoffman3o proposed a system for designation of these 
products. It was suggested that: 
a) Natural a-tocopherol should be called RRR-a-tocopheroi. 
b) The diastereoisomer of RRR-a-tocopherol being its epimer at C-2, thus having 
the configuration 2S, 4'R, 81R should be called 2-epi-a-tocopherol. 
c) The mixture of RRR-a-tocopherol and 2-epi-a-tocopherol, obtained by synthesis 
using natural phytol or phytyl bromide, respectively, should be called 2-ambo-a-
tocopherol. 
d) The totally synthetic products, obtained by synthesis from synthetic phytol or 
isophytol should be called all-rac-a-tocopherol. 
Selenium and vitamin E are closely related physiologically31. Therefore, it is difficult to 
induce vitamin E deficiency since selenium can partially substitute for a-tocopherol. 
Antioxidants are usually highly subsituted phenols, aromatic amines, or, less commonly, 
sulphur compounds (thiols). They can act either as electron or hydrogen atom donors. 
These antioxidants can be added to food to slow down the rate of oxidation by removing 
peroxyl and alkyl radicals. They are also added to rubbers and plastics to slow 
autoxidation and photochemical degradation32. The chemical properties of tocopherol are 
due to the free phenolic hydroxy group which can be acylated, etherified or 
3 
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phosphorylated3o. This results in loss of antioxidant activity, and such derivatives 
become essentially prodrugs. 
1.03 Vitamin E as an Antioxidant 
Vitamin E is distributed around the body by the blood in which it is bound by the plasma-
proteins33. The main site of action of Vitamin E is in the membranes of biological cells. 
The cellular membranes consist of two layers that surround the cell and are about 7 -1 Onm 
thick34,35. They are composed of lipids or fats in which proteins are located. Such 
membrane bilayers act as selectively permeable ban·iers for molecules and ions that need 
to pass in and out of the cell. The bilayer is a prime site of oxygen radical damage since 
it contains polyunsaturated fats with autoxidation-prone allylic sites in the form of 
phospholipids and glycolipids as well as cholesterol. 
The highest concentration of oxygen is found in the erythrocytes and this makes them 
susceptible to oxidation and damage by free radicals. In the case of mature human 
erythrocyte, there is no synthesis of new material so that damaged molecules and 
structures cannot be replaced or repaired. 
Metabolism in the human erythrocyte defends the cell against oxygen toxicity. Defective 
enzymes lead to the breakdown of this protection and cause haemolytic anaemia. 
Glutathione, in its reduced state, protects the cell membrane by rapidly destroying any 
peroxide in a reaction which is catalysed by the enzyme glutathione peroxidase (GP)36. 
Various organelles (subcellular structures) are also thought to be susceptible to radical 
damage, such as the endoplasmic reticulum and lysosomes. The products of lipid 
peroxidation and lipid peroxides are known to inactivate enzymes and proteins in the celL 
Lipid peroxides are formed by several mechanisms: namely autoxidation; chemical 
catalysis with haematin; and enzymic catalysis with lipoxidase2o. 
In any biological cell where dioxygen is used during metabolism, free radicals are 
formed, both as by-products and as useful intermediates. These free radicals need to be 
removed by the cell otherwise they will cause damage to the cell by destructive 
oxidation18,25. The reactive oxygen species (ROS) produced25 are:-
Superoxide anion radical 02 - . 
Hydrogen Peroxide H202 
Hydroxyl radical HO· 
To eliminate these destructive radicals which initiate cell peroxidation, the cell's defence 
system uses biological preventive antioxidants which function by converting 
hydroperoxides to molecular products that are not potential sources of free radicals. 
Glutathione peroxidase reduces lipid hydro peroxides to the corresponding alcohols (5) 
and it can also reduce hydrogen peroxide to water. 
4 
ROOH 
Introduction 
[2H] 
.. ROH + H20 Glutathione 
peroxidase 
(5) 
The enzyme superoxide dismutase (SOD)37 catalyses the reaction in (6) and the resulting 
hydrogen peroxide is decomposed by catalase to water. 
20~· + 2H+ SOD. H20 2 + O2 ! Catalase 
H20 
(6) 
The second defensive mechanism consists of a lipid soluble chain-breaking antioxidant, 
namely a-tocopherol. These antioxidant properties inhibit the autoxidation of:-
1) Vitamin A 
2) Unsaturated fatty acids e.g. linolenic acid 
3) Phospholipids 
Vitamin E can stop these free radicals at the propagation step and thus stops destructive 
oxidation. 
H 
-------) 
Phytyl moiety 
The major role of the phytyl moiety of the tocopherols seems to be to increase the 
solubility of the hydroxychroman moiety in those non-polar, lipophilic regions of 
biological systems (such as biomembranes) which require protection against 
autoxidation38. In fact the phytyl side chain has been shown to penetrate monolayers of 
phospholipid molecules. The autoxidation of micelles and model membranes has been 
studied and quantitative kinetic measurements made using water or lipid soluble initiators 
and water and lipid soluble antioxidants39. 
As well as scavenging active free radicals such as hydroxyl (HO·) and peroxyl (ROO·), 
tocopherols can also act as efficient scavengers of singlet oxygen (102) (the structure-
activity 
relationship in the quenching reaction of singlet oxygen with Vitamin E has been 
investigated by Mukai40) . 
Autoxidation is promoted by the following41 :-
1) Heat 
2) Light 
3) Metals such as Fe2+ 
5 
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4) Radical producing species 
Peroxides are known to affect proteins by initiating the formation of free radicals that 
result in polymerisation reactions which in tum leads to protein denaturation. Another 
consequence of peroxide formation is membrane damage leading to increased 
permeability which in the case of lysosomes (cellular bags of enzymes) would release 
destructive enzymes causing further cellular damage2o. 
1.04 Mechanism of Action of Tocopherol 
The autoxidation of most organic substrates in homogenous solution is a free radical 
chain process. It can generally be represented by the reaction sequence given as 
equations (a_d)42-50. 
1) Initiation: 
Production of 
R- + e.g. 
Initiator trace 
R-H 
Substrate 
R' or ROO' 
------- Ra-H + H-abstraction 
(a) 
The first step for each chain involves the production of a radical from some molecular 
precursor. Such chain initiation may be non enzymic, being caused by heat, or light, or 
by single electron transfer (SET) from a reducing agent such as Fe2+ to an acceptor such 
as the hydroperoxide, ROOH, or it may be an enzyme - catalysed SET reaction (or 102 in 
an Alder-ene reaction with a lipid double bond). 
2) Propagation: 
-R + 
RH 
-------!.~ ROO 
---.~ ROOH + R -
(b) 
(c) 
The radical R' reacts extremely rapidly with oxygen to form the peroxyl radical ROO, 
(b) which, in a subsequent much slower step, abstracts a hydrogen from the substrate 
RH to form ROOH and a new radical R· (c) (or possibly adds to a double bond). The 
new carbon centered radical proceeds through the propagation stage to yield another 
peroxyl radical. Thus a chain reaction is set in motion that proceeds through the 
propagation reactions (b), (c), until the propagation sequence is eventually broken when 
any two of the chain-carrying radicals (peroxyl radical ROO- or R·) react together to 
fOlm non radical products (R' to R-R or R-O-O-R ). 
~) Telmination: 
ROO 
• + ROO -------I.~ non radical products (d) 
6 
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In the presence of chain breaking phenolic antioxidants, ArOH. the oxidation chains are 
shortened and chain termination by (d) is suppressed and termination occurs via reaction 
e. 
ROO· ROOH 
'---../f 
RO·~ROH 
(e) 
The tocopheroxyl radical then reverts to its most stable form x by delocalisation of the 
free radical as shown in (C). 
.. .. (f) 
x 
This resonance stabilised tocopheroxyl radical is relatively um·eactive towards RH and 02 
and therefore it does not continue the chain, hence the term "chain breaking". It can be 
trapped by a second peroxyl radical to form a nonradical product. 
In model systems phenolic antioxidants, including vitamin E, have been shown to trap 
two peroxyl radicals. The first is terminated via reaction (e) which yields a molecule of 
lipid hydroperoxide (ROOH), and an a-tocopheroxyl radical. The second chain is 
terminated by the fast coupling of an ROO· radical with the a-tocpheroxyl radical x (g). 
ROO • (g) 
x 
If the mechanism stops at step (e), vitamin E can be regenerated from the a-
tocopheroxyl radical by reaction with a hydrophilic reducing agent such as the ascorbate 
anion. AH-, (vitamin C51 ). 
. -. ArO + AH .. ArOH + A (h) 
Vitamin C (ascorbic acid) quenches free radicals in the aqueous environment52 and is 
then transformed through this process into semi-dehydroascorbic acid. Uric acid may 
perform the same function in vivo. 
The effectiveness of a chain breaking antioxidant depends on a number of factors, 
including its reactivity towards peroxyl radicals. That is if a chain breaking antioxidant is 
to be effective, a relatively small quantity must protect a much greater quantity of the 
7 
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organic substrate (RH). The rate constant for reaction (e) must therefore be much greater 
than that for reaction (C)12 i.e. ks »k3. 
• k3 • ROO + RH ~ ROOH + R (c) 
ROO· + ArOH ks • ROOH + ArO· (e) 
Ingold et al 12 have compared the different chain-breaking antioxidants by measuring 
their k5 (e) values under similar conditions (Table 1), which shows that the 
benzofuran analogue of a-tocopherol (6) has a higher k5 value than other antioxidants 
and therefore, is the superior antioxidant. 
8 
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Phenol Dihedral angle (8 ') 
3 39 89 0 
4 250 
5 380 
6 570 
7 130 
OMe 
1 320 
R' = C16H33 (phytyl) 
Table 1 
* The dihedral angle for (1) cannot be determined by x-ray diffraction, studies as it is an oil at room 
temperature. 
They showed that a-tocopherol (1) and the structurally related model compound, 
pentamethylhydroxychroman (6) were very much better antioxidants than the major 
phenolic antioxidants used in commerce, such as 2,6-di-tert-butyl-4-methoxyphenol 
9 
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(BHA) (7). They attributed the increase in antioxidant activity to stereoelectronic factors 
because 4-methoxytetramethylpenol (3) had only about 10% of the reactivity of a-
tocopherol (1). This was due to the methoxy group in (3) being found to be 
perpendicular to the plane of the aromatic ring (9=90°). In this position, the p-type lone 
pair on the ethereal oxygen is in the plane of the aromatic ring (w.r.t the hydroxyl 
oxygen) and so can not stabilize the corresponding phenoxy1 radical. 
OMe Me 0 ,o~o, 
H 0 __ >===<-? 0 1 Me 
Me Me 
3 
Lone pair orbital of the I-oxygen is not held in the plane of the aromatic ring 
The extent of overlap will depend on the dihedral angle 9' between the p-type orbital on 
the oxane ring oxygen, and the perpendicular to the aromatic plane (see Figure 1), and 
this angle should be equal to the dihedral angle 9' between the 01-C2 bond and the 
aromatic plane. Stabilisation (by delocalisation) will be maximised when 9'=0° and will 
be at a minimium when 9'=90°. 
(aromatic plane) 
Figure 1 
However, in a-tocopherol (1) the saturated oxane ring adopts a half-chair conformation 
and holds the ethereal oxygen (01) in such a position (9=170 ) that the lone pair orbital 
can therefore overlap with the singly-occupied molecular orbital (SOMO) containing the 
radical. Hence stabilization of the phenoxyl radical by conjugative electron 
delocalisation, A to B is as shown in Scheme 1. 
-------------------------~--~-----~--
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~- R ...... 1IIIII(f---.~ 0 
A B 
Scheme 1 
X-ray values of 8' for various phenols are also shown in Table 1 (page 9), and the data 
supported this stereoelectronic explanation for the high reactivity of a-tocopherol. The 
dihedral angle (8') decreases along the series 6,5,4,3, the compound (6) (benzofuran 
analogue of a-tocopherol) being the most active simple phenolic antioxidant. Also, the 
O-H bond in a-tocopherol (1) is weak which will therefore, result in the hydrogen atom 
being cleaved more readily by an attacking peroxyl radical (ROO·), i.e. the more 
effective it will be as an antioxidant53. 
The synthesis, and kinetic studies of antioxidant activity, for new tocopherol related 
compounds have been reported by other researcher54. The chain breaking abilities of 
naphtholic antioxidants, such as polyalkylbenzochromanol, have been compared to those 
of vitamin E and were found to have higher activity than vitamin E itself55. Burton et 
a156-58 have measured the second rate constants (k5) (equation (e), page 8) for the 
reactions of a-,~-, 'Y-, and 8-tocopherol and other related phenols with poly 
(styrylperoxyl) peroxyl radicals by the inhibition of styrene. They concluded that a-
tocopherol (1) and a-tocopherol model compound such as (5) were the best phenolic 
antioxidants known. Furthermore, they found that a better tocopherol compound (6), 
which had a five membered heterocyclic ring instead of the six-membered one in 5, 
reported that the rate of reaction of (6) was 1.8 times higher than that of a-tocopherol 
(1) (see Table 1, page 9). 
OH OH 
8 9 
10 11 
1 1 
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Also, Mukai et al59 found that vitamin K l- chromanol (8) and K l- chromenol (9) were 
6.9 amd 4.5 times more active than a-tocopherol (1). Also, two new tocopherol 
derivatives (10) and (11) were found to be 1.8 and 1.1 times more active than (1). 
Barclay et al60 has also reported compounds which have higher activity than vitamin E. 
CH3 
H 
12, X=S 
13, X=N 
The antioxidant activities of I-thia-a-tocopherol (12) and l-aza-a-tocopherol (13) and 
their related compounds have also been reported5l but were found to be less than that of 
a-tocopherol. In an in-vitro study of all-rac-l-thio-a-tocopherols they were found to be 
less effective antioxidants than a-tocopherol. The number of peroxyl radicals trapped 
per molecule of these thio compounds was between 1.0 and 1.8 for 12 and13 whereas it 
it was 2.0 for a-tocopherol. 
1.05 Oxidised Forms of Vitamin E 
One of the mysteries surrounding vitamin E is its metabolic fate ll . Various reports have 
indicated that not all of the vitamin E that was shown to be absorbed in vivo is actually 
oxidised irreversiblyll,63,64. The major in vivo oxidation products which have been 
unequivocally identified are the Simon metabolites (14 and its "I-lactone 15)65,66. 
o 
These two metabolites have been found in the urine of rabbits65, humans66,67,68 and rats 
in which they are mainly present as glucuronic acid conjugates. Also vitamin E has been 
shown to be regenerated from a-tocopheryl quinone (18)69. It has been shown that a-
tocopheryl quinone is a potent anticoagulant that may be responsible for the beneficial 
effects of a-tocopherol in preventing heart attacks and strokes 70. a-Tocopherylquinonc 
(18) and trace amounts of the spiro-dimer of (17) (which can be formed from quinone 
methide (16) reacting with another molecule of 16 via a hetero Diels-Alders reaction) are 
both natural metabolites of a-tocopheroFl. a-Tocopherylquinone (18) is considered to 
1 2 
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be one of the first oxidative products of a-tocopherol in the human body. This quinone 
has been shown to cure nutritional muscular dystrophy in animals11 . 
(Hetero-
Diels-Alders) 
C16H33 .. 
I (Reaction with water 
, and rearrangement) 
CH3 
18 
17 
The reactions of various benzoquinone methides with phenols have been investigated73 , 
in order to identify the by-products that are formed during the oxidation of tocopherols. 
Two oxidation products of a-tocopherol are a-tocopurple (20)73 and tocored (19)74. 
The iodine oxidation of a-tocopherol in alkaline methanol was also shown to give 
quinones75 . 
o 
1.06 Other fat and water soluble Vitamins 
o 
20 
There are three other fat soluble vitamins - A, D, and K76 all have different functions 
compared to a-tocopherol. Vitamin D is required for the optimal intestinal absorption of 
dietary calcium 77. It also elicits effects elsewhere in the body. Vitamin K is important in 
blood coagulation and electron transport. (It has been studied by E.S.R.78) and Vitamin 
A which plays an essential role in the function of the retina and is required for growth of 
bone, reproduction and embryonic development79, such as ~-Carotenc (22) which 
quenches singlet oxygen53 and may prevent the onset of carcinogenesis80-81 . 
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102 + ~-carotene ---- 302 + ~-carotene + heat (i) 
There are also water soluble antioxidants such as Vitamin B complex, Ascorbic acid 
(Vitamin C) and uric acid (21). 
OH 
N~N tautomerism Jl .. J- ~OH « • 
HO N N ~ 
~-Carotene 
22 
Uric acid 
21 
Other synthetic chain breaking antioxidants include BHT (23) (butylated hydroxy 
toluene), BHA (24) (butylated hydroxyanisole) TBHQ (t-butylhydroquinone) and 
propyl gallate which are common food additives. 
BHT 
23 
BHA 
24 
Fat soluble vitamins tend to accumulate in membranes and lipid cells and can prove toxic 
if high levels are reached83 . However, the toxic effects of vitamin E are unproven 
although it may cause hypelvitaminosis syndrome when taken in large doses84. 
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1.07 Syntheses of racemic tocopherol 
The first recorded synthesis of dl-a-tocopherol was carried out by Karrer et all? in which 
trimethylhydroquinone was condensed with phytyl bromide in the presence of anhydrous 
zinc chloride in petroleum ether to give the product in almost quantitative yield. A second 
synthesis of dl-a-tocopherol was achieved by Bergal et al 85 who used phytol, 
trimethylhydroquinone and zinc chloride and modified the synthesis by adding decalin 
(b. pt.189-191 0) as the solvent. Smith and U ngnade86-88 found that better results were 
obtained by conducting the condensation in the absence of any catalyst or solvent. Under 
these circumstances, excellent yields of fairly pure product were obtained which could be 
further purified by high vacuum distillation. 
Racemic a-tocopherol can also be synthesised in excellent yield by reacting racemic 
isophytol with trimethylhydroquione in the presence of Lewis acids catalysts such as BF3-
diethyl etherate at 85-950C89. 
Other reported approaches have involved the coupling of chromans and side chain moietes90-
92, or involving the preformed chroman units, such as in the addition of Grignard reagent 
(25) to ketone (26) in ether followed by protonolysis to give the alcohol (27) as shown in 
Scheme 2. Addition of HBr ·afforded a-tocopherol itself by removing the methoxy 
protecting groups, and facilitating the formation of the oxane ring. 
+ 
25 26 
1 
HBr H3
C 
Tocopherol .. 
1 
27 
Scheme 2 
Another synthetic approach included the Wittig reaction between the homologues chroman 
aldehyde (32) and the side chain synthons (33)93-96 as shown in Scheme 3, such as the 
acid-catalysed reaction of trimethylhydroquinone (28) with the allylic alcohol (29) affording 
the chroman (30). Acetylation of this chroman (30), followed by ozonolysis led to the 
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desired aldehyde (31). Wittig coupling of the phosphonium salt (32) with the aldehyde 
(31) gives tocotrienol (33). Catalytic hydrogenation then afforded the a-tocopheryl acetate 
(34 )97. 
HO 
+ 
OH 
28 29 ~etherate 
... 
31 30 
+ 
C H3 O· Na + 
33 
1 H2! Pd. 
34 
Scheme 3 
Recently, Bienayme et al98 have proposed a highly convergent and atom-economical 
synthesis of dl-a-tocopherol (1) by using Rhodium(1)-catalysed arylation of ~-springene 
(38) with trimethylhydroquinone (28) as outlined in Scheme 4. The ene-type chlorination 
of myrcene (35) resulted in chloro-3-myrcene 36, whereas, its hydrochlorination in the 
presence of copper (1) chloride gave geranyl chloride (37). Reductive coupling of 37 with 
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36 was achieved by reaction with Grignard reagent followed by copper (I) chloride to afford 
diene 38. ~-Springene 38 was condensed with trimethylhydroquinone (28) under Rhodium 
(I) catalysis to afford 39. This was converted into the tocotrienol (2) by acid catalysis 
which was hydrogenated and acetylated to form vitamin E acetate (34). 
H 
2 
a 
b 
CI 
Vitamin E 
acetate 
34 
36 CI 
c 
+ 
37 
H 
OH 
28 
39 
a) Cl2 (g), pentene, reflux; b) CuCI, HCI (g), CH2CI2, oOc; c) MgO, THF, -20°C then CuCI ; d) [RhCI(COD)12, 
dppb , K2C03, toluene, 110°C; e) MeAICl2 or pTSA, hexane, 100°C: 0 H2, Pd/C, EtOH then AC20, Et3N, 2S°C. 
Scheme 4 
Vitamin E has been the synthetic objective of numerous studies directed towards the 
synthesis of the natural occurring form (2R, 4'R, 8'R)-a-tocopherol. The renewed interest 
in this vitamin is due to the development of new syntheses of the chiral centres in the side 
chain and chroman pOltions of the molecule. 
1.08 Syntheses of (2R, 4'R, S'R) a-Tocopherol 
The first formal total synthesis of natural (2R,4'R,8'R)-a-tocopherol (1) was reported by 
Mayer and Isler in 196399. 
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This group utilised a convergent approach in which the molecule was assembled via Wittig 
coupling between the chroman-2-carboxaldehyde (40) and the carbon-15 phosphonium salt 
(41). 
eRG 
40 
A related scheme described by Scott et al 96 involved coupling of the homologous units, 
chroman-2-acetaldehyde and the carbon-14 phosphonium salt. In both these approaches the 
chain intermediates were derived from naturally occurring (7R,11R)-phytopoo. d-a-
Tocopherol is the naturally occurring form of vitamin E. As wheat germ oil contains a 
relatively large amount of racemic a-tocopherol (0.02 to 0.20%) the latter can be obtained by 
saponification. Alternatively, hot ethanol extraction of the wheat germ followed by the 
removal of the solvent gives the required vitamin E. However, analysis shows the presence 
of a,f3,y, and 't-tocopherol. Therefore, the stereoslective synthesis of the (2R,4'R,8'R)-
isomer of a-tocopherol is desirable. 
Coffen et allOl have synthesized natural vitamin E (2R,4'R,8'R)-a-tocopherol based on (S)-
(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl) methyl keto ester (42) and allylic carbonate 
( 43). 
43 
The carbonate (43) was synthesized by the reaction of (R)-citronellal (44) and acetone (45) 
under basic conditions to afford the allylic ketone (46). Reduction of this ketone gave the 
corresponding allylic alcohol (47) which on esterification afforded the diastereomeric ester 
(48). The impOltant reaction in this scheme was the hydrolase-catalyzed kinetic resolution 
of the diasteromeric ester into the single isomer (49). Finally, acetylation of the allylic 
alcohol (49) afforded the corresponding carbonate (43) as outlined in Scheme 5. 
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o CH~+ A 
44 
t n-ButliiO-COOM, 
OH 
49 
45 
... (hydrolase) 
Lipase 
ex P. 
fluorescens 
Scheme 5 
o 
O~ 
46 
* (i-P,o), AlIi-P>-OH 
47 
~ 0 0 ~o~ DMAP (cat.) 
48 
The methyl keto ester (42) was prepared from chromanylacetic acid (50) as shown in 
Scheme 6. The conversion of chromanylacetic acid (50) into the O-benzyl chloride (51) 
had been followed according to the method of Cohen et a1102. The Meldlum's acid adduct of 
the acid chloride103 (52) refluxed in methanol afforded the methyl keto ester (42). 
50 
42 
i) MeOH I H+, 
ii) C7H70IK2C03 CO H ~ 
2 iii) NaOHIMeOH 
iv) Oxalyl chloride 
MeOHlHeat 
... 
Scheme 6 
51 
I Meldrum's acid 
~ pyridine/CH2 C12 
COCI 
The methyl keto ester (42) was coupled with allylic carbonate (43) using palladium which 
led to the formation of the coupling product (53) as shown in Scheme 7. Borohydride 
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reduction of 53 afforded the hydroxy methyl ester (54). Hydrolysis of (54) afforded the 
~-hydroxy acid (55). Removal of the carboxylic acid in 55 afforded the tocotrienol (56). 
Catalytic hydrogenation of the tocotrienol (56) and deprotection of the benzyl group 
afforded vitamin E, (d)-a-tocopherol (1) in 84% yield. 
-
o .0-
+ d 43 
o OCH3 
42 
54 
55 C02H 
-
56 
1 
Scheme 7 
1.09 Acid - Catalysed Syntheses of Vitamin E 
NaH, 
Pd[P(C6Hsh1 4, THF 
_78°C to R.T. 
~ (NaOH) 
OBut ~ Me2N--{ OBut 
I i) HfPt-CI EtOAc fi) H~lPd-C/EtOH 
The condensation of an hydroquinone or a phenol with an allylic alcohol is an impOltant step 
in the synthesis of dl-a-tocopherol and its related compounds. The rate of reaction is 
20 
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significantly accelerated in the presence of Lewis acids .such as zinc chloride85, aluminium 
chloride 104, boron trifluoroetherate89 , formic acid, acetic acid, rare earth metal (III) 
trifluoromethanesulfonates (triflates)105,106, sulphuric acids, or combinations of strong 
Bronsted acids. 
Recently, a number of researchers have utilised heterogeneous catalysis such as metal ion-
exchanged montmorillonites107 , Nafion NR 50108 , for the condensation reaction of 
hydro quinone 28 with the allylic alcohol 57 to give (58) which on deprotonation afforded 
a-racemic tocopherol 1 as shown in Scheme 8. 
+ 
OH OH 
28 57 
.. 
1 
Scheme 8 
Natural phytol and isophytol (57) have both been used in the synthesis of tocopherols. 
Tocotrienols have been synthesised in a similar way but using trans-geranyllinalool (59) 
instead of isophytol99. 
OH 
59 
Tocol and the lower homologues of a-tocopherol can also be synthesised by the route 109 
outlined in Scheme 8. 
a-Tocopherol is an oil, therefore its conversion into a solid analogue retaining its high 
biological activity would offer many advantages. The amino analogue of a-tocopherol (60) 
which is a solid that can be prepared by condensation of 2,3,5-trimethyl-4-aminophenol 
with phytol. This is known to possess high biological activity 1 10. 
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R = 3,7,Il-trimethyldodecyl 
If the phenolic hydroxy group in a-tocopherol is absent or is masked as an ether or as the 
allophanate, complete inactivity results. However, many carboxylic esters of a-tocopherol 
are active due to their metabolic hydrolysis to give the free phenol group. Some simple 
esters of a-tocopherol have been synthesised which show biological activity but are 
liquids65 . 
22 
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1.10 The 3,3·Sigmatropic Claisen Rearrangement 
The 3,3-sigmatropic rearrangment of allyl aryl ethers provides an efficient and selective 
method for constructing carbon-carbon bonds and has increasingly been employed in 
the syntheses of Vitamin E and sub-units which are present in vitamin E, namely 2,3-
dihydrobenzofurans and 3,4-dihydrobenzopyrans 111-114. 
A sigmatropic rearrangement is a concerted reaction in which an atom e.g. H or a group 
e.g. CH3 or a sigma bond migrates from one site to another. An example is the 
intramolecular c1aisen rearrangement of allylic aryl ethers (61) via intermediate (62) to 
give the o-allylphenols (63) 115-123 (Scheme 9). The order of a sigmatropic 
rearrangment is expressed by two numbers set in brackets:[i.j]. These numbers can be 
determined by counting the atoms over which each end of the s-bond has moved. Each 
termini is given the number 1. 
(J bond 
that 
formally 
"migrates" 
J I 
0 2 O,.{"R a o I',R I ~,,----~ -:/'" If( tautom ... ~ 3 yC~C 2' ~ C ..... C2'" 
Y H Y 
61 62 
Scheme 9 
1 
((
20H 
~ I 3' 2' I' 
3 C-C=C-R 
63 ~Fin~l 
position of 
'migrating' 
(J bond 
Thus in the example shown in Scheme 9, each terminus of the <i-bond has migrated 
from C-l' and 0-1 to C-3 and C-3', so the order is [3,3] hence, [3,3]-sigmatropic 
rearrangement. If both the ortho positions are blocked, the allylic group migrates to the 
para position by a further Claisen rearrangement. The [3,3]-sigmatropic Claisen 
rearrangement process has a condsiderable potential in the synthesis of optically active 
substances. 
The synthesis of (2RA'R,8'R)-a-tocopheryl acetate utilises a stereoselective (3,3)-
sigmatropic Claisen rearrangement of allylic alcohols 124. Treatment of the (S-) 
chromanylacetaldehyde (64) with Grignard reagent gave the acetylenic carbinol 65. 
Crystallisation of 65 gave the two diastereomeric acetylenic carbinols 66a and 66b, 
respectively, which on reduction afforded 67a and 67b, respectively. Orthoester 
Claisen rearrangement of allylic alcohols 67a and 67b, respectively, yielded the same 
unsaturated ester (68). Reduction of ester (68) resulted in the formation of the 
corresponding saturated ester (69). Further reduction of the saturated ester (69) gave 
the chromanyl alcohol (70) which was converted into tosylate (71). Coupling of (71) 
with Grignard reagent (72) 
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furnished the benzyl ether (73) which on hydrogenation and acetylation afforded the 
acetate 34 as shown in Scheme 10. 
cont'd overleaf 
I bis(2-methoxyethoxy) 
+ aluminium hydride 
~ Lindlar catalyst 
67a 67b 
~ i) CI-I:3C(Oc;HshIC2HscqH ./ 
~ii) [3,3] rearrangement / 
! H2• Raney Nid",1 
69 
Scheme 10 
24 
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i) bis(2-methoxyethoxy)Aluminium Hydride 
ii) H+, H20 
70 
71 
J
BrMg ........... %~/ ~ ~2 T 
Ether, H+ 
73 ! 5% PdIC, (CH,CO),O 
34 
Scheme 10 
OH 
Thioalkyl groups have been introduced regioslectively into the artha position of 
phenols (74) via [2,3] sigmatropic rearrangement of isopropylphenoxysulphonium 
alkylides (75) as shown in Scheme 11, producing an efficient synthesis of precursors 
for chromans, chromenes, coumarins and d-a-tocopheroI125• 
2 QI 3 y- HR [2,3] , lS+ 
...... , 2 9"" CHMe2 
74 initial position of 
(J bond 
Ylide 
Scheme 11 
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A different synthesis of racemic a-tocopherol has been described by Olson 126 where 
hexahydrofamesylacetone 76 was converted to the epoxide (77). The aromatic ring of 
the chroman was constructed by the addition of the dianion of 2,4-pentanedione to I, 2-
epoxy-2,6,IO,14-tetramethylpentadecane (77) to afford the hydroxy diketone (78). This 
diketone upon condensation with dimethyl acetonedicarboxylate affords the phenolic 
diester (79a) and upon reduction affords the trimethylphenol (79b). The phenol (79b) 
on oxidation with Fremy's salt gives tocopherylquinone (18) , a known precursor of a-
tocopherol (1) as shown in Scheme 12. 
77 
78 
R 
R 
79b (R=CH~ 
76 
1
1. (CH3hSCl 
2. Sod amide, Liq. NH3 
I Sodio lithio dianion 
,of 2,4-pentanedione 
I CH3C02CH2COCH2C02CH3 
+ (NaOCHyMeOH) 
! i) Sodium dihydro-bis(2-methoxyethoxy) aluminate ii)Reflux, Xylene. 1.5hr 
I Fremy's salt + t · ON[SO-;- N CH3(caprylylhh 
Scheme 12 
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1.11 The Nomenclature of Benzofurans and Benzopyrans 
The benzopyrans mentioned in this thesis are known as l-benzopyrans. The naming of 
these heterocyclic compounds will be followed by the rules adopted by the IUPAC. 
1. In numbering the polycyclic compound, an oxygen hetero atom is given the lowest 
number consistent with rule 4, as shown in the examples below127-129. 
2. Partially reduced ring compounds are often referred to as the dihydro derivatives of 
the parent unsaturated compound. Saturation is also indicated by attaching the symbol 
H together with the number denoting the position of saturation to the name of the parent 
unsaturated compound. Since the pyran ring system does not have a double bond at the 
3,4-position, is referred to as 3,4-dihydro-2H-benzopyran. The number 1 in the 
dihydro-1-benzopyrans denotes the position of attachment of the hetero atom to the 
benzene ring, so the full name is 3,4-dihydro-2H-l-benzopyran. Whereas, in the furan 
ring systems the double bond is not present at the 2,3 positions and therefore, will be 
referred to as 2,3-dihydrobenzofurans. 
5M2 6V--cf 6M3 7~O)2 H 
7 1 8 1 
2H -Benzofuran 3,4-2H -1-Benzopyran Vitamin E 
The polycyclic rings (indicated below) are named by the following rules: 
3. The name of the hetero ring is chosen as the parent compound and the fused ring is 
attached as a prefix. Therefore, the parent compound is the pyran and the fused ring is 
naphthalene and hence, is named as dihydronaphthopyran. 
Dihydronaphtho[ 1 ,2-b ]pyran Dihydronaphtho[2, l-b ]pyran 
4. It is also neccessary to indicate in the name the position of the ring junction. This is 
done by numbering the parent ring, in this case naphthalene and the sides of the parent 
ring system. The following breakdown of the structure with the appropriate numbering 
and the lettering will serve to illustrate how this is done. 
The pyran ring y is joined to the naphthalene x at the 1, 2-bond and fused to bond b. 
This is written as [1, 2-b], as indicated below. 
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CO· 8 a
l 
7 ~ ~ 2 ilk c 
~ ~ 6 g fed 3 
5 4 
x 
Dihydronaphtho[ 1 ,2-b ]pyran 
4 50 3 
6 0 2 
1 
y 
Whereas, in the other structure, the pyran y is joined to the naphthalene x at the 2, 1-
bond and fused to bond b. This is written as [2,1-b], as indicated below. 
x 
Dihydronaphtho[2, I-b ]pyran 
1.12 Synthesis of Benzofurans and Benzopyrans 
4 50 3 
6 0 2 
1 
y 
2,2-Dimethy1chromans are a type of benzopyrans which rarely occur in plants: they are 
however, obtained as degradative products during the structural elucidation of many 
naturally-occurring phenolic products bearing isoprenoid units. The Lewis acid 
mediated reactions of phenols with a variety of allylic alcohols130-13l , aldehydes132-133 , 
and dienes 104, 134, 135 have been studied within the context of developing new synthetic 
routes to benzopyrans (chromans) and benzofurans. Celtain of the latter have utility as 
antioxidants and have skeletal features that are also present in many naturally occurring 
benzocyc1ic ethers, such as coumarans, coumarins, flavones, rotenones, pterocarpans, 
hematoxylins and so on. 
1.13 Acid-catalysed syntheses of Benzofurans and Benzopyrans 
Dihydro-2H-benzopyran (82) was first synthesized by Claisen l36 ,137 in 1921 from 
phenol (80) and 2-methylbutadiene (81) in the presence of an acidic catalyst (Scheme 
13). 
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~_A_C_id_c_a_ta_l_y_st--J.~ A reflux 
(81) 
Scheme 13 
(82) 
Its structure was confirmed by its synthesis from ethyl coumarate (83). This was 
reduced to the dihydro derivative (84) by hydrogen using a palladium chloride catalyst, 
and was then converted into 1-(2-hydroxyphenyl)-2-methylpropan-2-01 (85) by 
Grignard reaction with methyl magnesium iodide. Cyclisation of the alcohol 85 in the 
presence of sulphuric acid afforded dihydrobenzo-2H-benzopyran (82) as shown in 
Scheme 14. 
~OH 
~COEt 2 (83) 
(82) (85) 
Scheme 14 
Dihydro-2H-benzopyran (82) and dihydro-2H-benzochromanone (87) can both be 
produced from chroman-4-ones. These latter ketones can be prepared by Friedel-Crafts 
reaction of phenols and the appropriate acrylic acids to afford (86) which cyclise to the 
desired Chromanone (87)138-140. Alternatively, Michael addition of phenols to 
acrylates leads to (88) which can also be cyclised by polyphosphoric acid (PPA) to 
chromanone (87)141-142, as shown in Scheme 15. 
86 87 
o 
Scheme 15 
Acylation of phenol 89 with acid chlOlide 90 affords a mixture of (91) and (92). 
Isolation of chromanone (92) followed by Clemmensen reduction affords the chroman 
(93)143-144, whereas lithium aluminium hydride reduction of (67) to the alcohol (94), 
followed by dehydration affords the chromene145 (95) as outlined in Scheme 16. 
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Me0)CroH I + ~ I AICl 3 
MeO ~ CI~ in ether 
MeG 
89 90 
MeO 
MeO 
MeO 
95 
Scheme 16 
91 o 
.. 
Oehyd . 
MeO 
+ 
MeO 
MeO 
93 
1 Zn-Hg HCI 
92 0 
94 OH 
The phenol (96) when reacted with propargyl alcohol (97) yields the 2,2-
dimethylchromene 98 directly, as in the Spath synthesis of seslin146 (73), (Scheme 17). 
o ~ o 
+ OH 
96 97 98 
Scheme 17 
Direct condensation of phenol (80) with propargyl alcohol (99) yields the 
corresponding aryl propargyl ether 100, which undergoes a 3,3-sigmatropic shift in the 
presence of Mexican bentonite clay in toluene to afford the dimethyl-2H-benzopyran 
(101) in good yield147 (Scheme 18). 
OH 
6 ~ Clay [3,3] + .. PhMe I~ OH 
,0 
80 99 100 101 
Scheme 18 
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However, in situ generation of the related allyl aryl ethers from hydroquinone (28) and 
(Z)-2-butene-l,4-diol (102) heated in toluene at 700C in the presence of p-
toluenesulphonic acid resulted in a mixture of the dihydrobenzofurans148 105 and 107, 
respectively. The reaction is temperature dependant. At 50°C 105 was the major 
product, resulting from a 1, 3-shift in ether (103) to the hydroquinone (104) which on 
acid-catalysis afforded (105), whereas in boiling toluene (112°C) the 3,3-shift is 
favoured with the hydroquinone 106 being formed, which on acid-catalysis afforded 
107 as shown in Scheme 19. 
+ 
HO~OH 
OH (z- isomer) 
28 102 
OH 
~f' 
H OH 
104 
H 
105 107 
Scheme 19 
1.14 Metal and Base-catalysed Syntheses of Benzofurans and Benzopyrans 
A tin (IV) chloride assisted iodo-cyclisation of 2-allylphenol (108) gave the 2-
iodomethyl-2,3-dihydrobenzofuran (109). A similar cyc1isation of 2-crotylphenol (110) 
gave 3_iodo-2-methyl-3.4-dihydrobenzo-2H-benzopyran 149 (111), (Scheme 20). 
31 
~I ~O QR 
I 
H 
(108) R=H 
(110) R=CH3 
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Scheme 20 
(109) 
~I ~O)·"R 
(111) 
I 
Recently, Yadav et a1150-151 have synthesized 2,4-dimethoxy-2-methylbenzopyran 112 
by reacting o-hydroxybenzaldehyde 113 with 2,3-dimethoxypropane 114 using a 
catalytic amount of scandium triflate, as shown in Scheme 21. 
Q:0H I + ~ CHO 
113 114 
Sc(OTfh 
112 
Scheme 21 
OMe 
OMe 
Me 
A known precursor in the preparation of tebufelone 115 a nonsteriodal 
antiinflammatory and an analgesic agent has been prepared by Janusz et al152 as shown 
in Scheme 22. 
115 
The di-tert-butylphenol 116 was initially brominated to give the corresponding 
dibromophenol (117). Alkylation of this phenol (117) in the presence of a base 
(potassium carbonate/acetone) affords the bromo ethers (118) or (119). The bromo 
ether ring was cyc1ised by lithium-halogen exchange to give the dihydrobenzofuran 
(120) or dihydrobenzopyran (121) (Parham cyc1oalkyation) as shown in Scheme 22. 
116 
Br 
120 n=l 
121 n=2 
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Br Br 
Br2/ MeOII. 
100% 
1. n-BuLi 
THF I Hex. 
-95°C to -80°C 
2. NH40 
K2C03 / acetone 
reflux 
Scheme 22 
117 
Br 
118 n=l 
119 n=2 
Palladium-catalyzed cross coupling reactions of Ar-X (where X=I, Br, and OTf) with 
carbon nuc1eophiles (R-MgX) have found wide application in the syntheses of complex 
organic molecules, due in part, to the mild reaction conditions and high functional 
group compatibility. Buchwald et al153 have utilised this methodology for effecting the 
intramolecular Pd-catalysed ipso substitution of aryl halides (122) and (123) in the 
presences of potassium carbonate and a ligand (Tol-BINAP) to afford 2,2-
dimethylbenzofuran (124), or using sodium tert -butoxide and a ligand (DPPF) to 
afford 2,2-dimethylbenzopyran (82) in moderate to good yields (Scheme 23). 
(YX0H 
~D~I Br 
122 
123 
Pd(OAch, Ligand (Y°v ~Base, Solvent, 80°-100°C 
124 
Pd(OAch, Ligand 
Base, Solvent, 80° -100°C 
82 
Scheme 23 
The alkali-metal ammonia reduction of aromatic systems (the Birch reduction) is a well 
known method in synthetic chemistry for the preparation of non-conjugated 
cyc10hexadiene derivatives such as prococenes (125, 126 and 127) 154. 
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125 126 127 
As well as producing the above prococene analogues, the Birch reduction of 2, 2-
dimethyl-2H-chromene (128) with sodium or lithium in liquid ammonia in the presence 
of alcohol as the proton donor, can also afford the chroman (129) albeit in low yields 
(Scheme 24). 
128 
(1-18%) 
Scheme 24 
Recently, a new approach to the synthesis of dihydrobenzofurans or 
dihydrobenzopyrans has been established by Knight et aI155-156. They utilised 1-
aminobenzotriazoles containing a 7-hydroxy alkyl substituents which were converted 
into the corresponding benzyne using N-bromosuccinimide (NBS). Intramolecular 
trapping by the hydroxyl group lead to the formation of dihydrobenzofuran or 
dihydrobenzopyrans (Scheme 25). 
N02 
NH2 
130 
Br 
140 n=1 
141 n=2 
(5 Steps) .. 
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Scheme 25 
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The l-aminobenzotriazole (133) was obtained in five steps from nitroaniline (130) by a 
modification of the Campbell and Rees method157-159, and the amino group in 131 was 
then protected (132). Lateral deprotonation of (132) gave the dianion (133). This can 
react with an electrophile (generated from aldehydes, ketones or epoxides) to produce 
the substrate (134) or (135). Deprotection of the amino group in 134 and 135 afforded 
(136) and (137), respectively. Treatment of 136 and 137 with N-bromosuccinimde 
afforded the dihydrobenzofuran (140) and dihydrobenzopyran (141) respectively via the 
benzyne intermediates (138) and (139). 
1.15 Carbocations as intermediate in routes to Benzopyrans / furans 
The formation of deep yellow colours in the solutions of triphenyl methyl halides in 
certain solvents was reported in 1902 by Gomberg and Norris160-161, among other 
workers. They attributed these reversible changes to what would today be called ion 
dissociation, the ion being intensely coloured. The name carbocation was applied to 
these species by Von Baeyer162. The electron - deficient carbon of the carbocation is 
sp2-hybridised and therefore has a trigonal planar geometry: (the 1t-orbital on this 
carbon contains no electrons). 
'+' 0 ,\\\\\\\ 
-_\!I~ C···· 
0" 
Carbocations are highly reactive intermediates and only have a short lifetime in 
solution, and are quickly converted into more stable molecules. The stability of the 
saturated alkyl carbocation varies depending on the groups attached to the electron 
deficient carbon. Themore alkyl groups that are attached, the more stable the cation 
Introduction 
formed. The stability, and hence the life time, of the carbocation increases from 
primary to tertiary. The tertiary system is the most stable because the positive charge is 
spread over a several centres due to C-H a-bond orbital - p-orbital interactions 
(hyperconjugation) and due to the Inductive effect - (+1 for alkyl groups)163. 
1.16 Allylic Carbocations 
Allyl cations (142) can be generated from suitable precursors such allylic halides and 
alcohols130-131, and 1,3_dienes104,134,135 and are relatively stable compared to the 
corresponding saturated alkyl cations. This is due to the resonance stabilisation 164 of 
the charge species i.e. the +M mesomeric effect, as shown in Scheme 25. 
Scheme 25 
The formation of an allyl cation depends on the nature of the leaving group Y present 
on the original molecule. The rate at which Y leaves depends on : the strength of the R-
Y bond, the polarisability of the R-Y bond and the stability of Y- species (de localised 
anion of strong acid). 
Mesylates (143) are example of good leaving groups as shown in Scheme 26. This is 
due to the fact that the C-O bond is much weaker than the S-O bond, and to the 
resonance stabilisation of the mesylate anion formed. 
M o II O-S- CH3 II 
o 
143 
Scheme 26 
o e II 
+ O-~-CH3 
o 
An example of a poor leaving group (requiring protonation to break the C-O bond) is 
given in Scheme 27. 
SNI ~. 
+ ~OH 
Scheme 27 
Other good leaving leaving groups include halide anions and triflates165. 
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1.17 Generation of Carbocations using Superacids in the Syntheses of 
Benzofurans and Benzopyrans. 
Over 60 years ago, J.B. Conant166 pioneered the use of the name 'superacid' by calling 
attention to acid systems more acidic than the conventional mineral acids. 
Subsequently, R.J. Gillespie167 introduced an arbitrary but widespread definition 
according to which superacids are systems whose acidity, as characterised by Hammett 
acidity function (Ho) exceeds that of 100% sulphuric acid (Ho= -12). Significant 
progress in developing new superacid systems and studying their chemistry has been 
made by Olah et al168. 
Bronsted/Lewis acid mixtures of HF-SbF5, HF-HS03F, HS03F-SbF5, etc, with 
superacidties up to 1015_1018 (Ho<-30) times stronger than 100% H2S04 have been 
developed. 
Carbocations can be generated from electrophilic reactions since Meerwein's pioneering 
studies have been carried outl69 , especially, superacids can be used to generate 
carbocations from allylic alcohols or halides and dienes. The fast and efficient 
syntheses of carbocations from superacids could be used in the syntheses of 2,3-
dihydrobenzofurans and 2H-l-benzopyrans. 
In this study, trifluoroacetic acid which possesses 'near superacidity', sulphuric acid or a 
mixture of acids (sulphuric and glacial acetic acid) and metallic acid catalyst such as 
zinc chloride will be used in the reactions of phenols and allylic alcohols or 1,3-dienes 
as acid catalysts in the context of developing one-pot syntheses of 2,3-
dihydrobenzofurans and 2H-1-benzopyrans. 
1.18 Aim and Objectives 
• Syntheses of 2,3-dihydrobenzofurans and 2H-l-benzopyrans in general involves 
several steps and often give low yields. Therefore an efficient syntheses of 
these compounds were achieved by condensing phenols and the appropriate 
dienes, allylic alcohols, aldehydes and diols using a number of different acid 
catalyst systems. These compounds were synthesised in a one-pot syntheses. 
• Exploration of side reactions and mechanistic aspects of these compounds. 
• An industrially viable process for the production of a-tocopherol on a multi-
kilogram scale. 
• Syntheses of antioxidants superior to that of a-tocopherol: 
i) Benzofuran model compound of a-tocopherol. 
ii) By substituting the benzopyran at the 4-position with an alkyl group to give a 
conformationally locked system. 
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2.01 Synthesis of 2,2-Dimethyl-3,4-dihydrobenzopyrans (82) 
2,2-Dimethyl-3,4-dihydrobenzopyrans are usually prepared by multistep syntheses with not 
very satisfactory yieldsl70. Direct syntheses based on the reactions of suitability substituted 
phenols with isoprene, catalysed acidic species or aluminium phenoxide give poor to 
moderate yields 171. Better yields are obtained by reacting the sodium or potassium 
phenoxide salt with isoprene in the presence of a Lewis acid (AlCI3, FeCI3, or SnC4)104,172. 
Since these methods still give only low to moderate yields of 3,4-dihydrobenzopyrans, 
attempts to improve the yields using the method of Smith9 were investigated. Also, 
previously unreported spectral properties of 2,2-dimethyl-3,4-dihydrobenzopyrans and 
proposed mechanisms of reactions will be discussed. 
The methodology of Smith86,88, was extended to other substituted phenols. Phenols (28a-
£), isoprene (81), and zinc chloride were heated under reflux in glacial acetic acid to afford 
the 2,2-dimethyl-3,4-dimethylbenzopyrans (82a-f) in greater than 30% yield as the main 
products. However, the 2,2-dimethyl-3,4-dimethylbenzopyrans 28b, 28c, and 28f reacted 
further with isoprene (81) to afford the 4-isopentenyl-2,2-dimethyl-3,4-
dimethylbenzopyrans (144b, 144c, 144£) respectively, as by-products, while 2,2-
dimethyl-3,4-dimethylbenzopyran 82e similarly afforded the dichroman 145e as shown in 
Scheme 25. The reaction was modified by adding the isoprene dropwise using a 
hypodermic needle which was positioned at the base of the flask, to the reaction mixture and 
performed by efficiently stirring the heterogeneous mixture at 1000C for 4 hours in an 
atmosphere of argon. 
ZnC12 ~ __ +_A_c_O_H __ ~~ 
A IOO°C,4hr 
81 
28a,82a Rl> R3, R4= CH3, R2 = OH 
28b,82b Rl, R3, ~ = CH3, R2= H 
28c, 82c Rl, R30 R4 = H, R2 = Cl 
28d,82d Rb R3, ~ = H, R2 = OH 
28e,82e R1, R2 = H, R3, R. = OH 
28f,82f R1, ~ = H, Rz-R3 = CH=CH-CH=CH 
144b Rl, R3, ~ = CH3, R2 = CH2CH=C(CH3h 
144c RI=H, R2 = Cl, ~ = CH2CH=C(CH:V2 
R4 
82, 144 and 145 
144f Rl= H, R2 - R3 = CH=CH-CH=CH, ~ = CH~HC(CH3h 
145e Rl = II, R2 - R3 = CH2CH2(CH3}zCO, R4 =OH 
Scheme 25 
38 
Discussion 
The results are summarized in Table 2 . 
M.pt Yield Lit. M.pt 
Cpd. Rl R2 R3 
[OC] (%) [OC] 
R4 
82a CH3 OH CH3 CH3 92-94 37 92-9488 ,173 
82b CH3 H CH3 CH3 39-40 42 40-41 88 
144b CH3 CH2CHC CH3 CH3 Oil <2 N/R 
(CH3h 
82c H CI H H Oil 34 83-85 172 
144c H Cl H CH2CHC Not <1 N/R 
isolated 
(CH3h 
82d H OH H H Oil 11 77-80 173,174 
82e H H OH OH Oil 47 N/R 
14Se OH CH2CH20C(CH3h H Oil Trace 120-121 175 
82f H CH=CH-CH=CH H Oil 52 Gum 134 
144f H CH=CH-CH=CH CH2CHC Oil 5 N/R 
(CH3h 
Table 2: N/R = not reported in the literature, therefore novel compounds. 
It was found that the benzopyrans 82a and 82b were formed in moderate yields, whereas, 
benzopyrans 82c, 82d, and 82f were obtained in low yields. This can be attributed to the 
fact that the reaction appears to be favoured by the presence of electron-donating substituents 
CRt, R2, R3, Rt in Table 2) on the benzene ring which increased the rate of cyclization, and 
hence gave higher yields of benzopyran, while the electron-withdrawing substituents 
decreased the rate of cyclisation. Hydroquinone (28d) was found to be slightly inactive 
towards isoprene (81) and resulted in a low yield of 82d. The inactivity may be due the 
partial insolubility of the hydroquinone (28d) in acetic acid. The benzopyrans 82b, 82c 
and 82f reacted further with isoprene (81) to afford isopentenyl-2,2-dimethyl<~A­
dihydrobenzopyrans 144b, 144c, and 144f respectively. In one case, 28e led to the 
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formation of double chroman 145 e. In all cases, the 2,2-dimethy 1- 3,4-
dihydromethylbenzopyrans were accompanied by the corresponding phenols 28a-f. These 
were removed by treatment of the crude product with Claisens alkali 176, which was prepared 
by dissolving potassium hydroxide (35g) in water (25ml) and methanol (1 OOml). The 
spectral evidence in support of the structures proposed for the 3,4-dihydrobenzopyrans (82a-
82f) is discussed below. 
2.02 Spectral Analysis of the 2,2-dimethyl-3,4-dihydrobenzopyrans 
The infra red absorptions of compounds 82a and 82b are shown in Table 3 and are 
consistent with their literature values and with the structures proposed. The various bands in 
the infra red spectra of 2,2-dimethyl-3,4-dihydrobenzopyrans and tocopherols have been 
reported by several researchers171 ,177. Rosenkrantz178 has assigned the band near 1587 cm-
1 (stretching) to the absorption of the conjugated C=C system in the benzene ring, the band 
near 1368 cm-1 (stretching) to the geminal dimethyl group and a band near 1250 cm-1 to the 
phenolic C-O (stretching) absorption, which is characteristic of the chroman moiety in 82a 
and 82b. The bands at 3000, 2950 and 2860 cm-1 are typical C-H stretching frequencies. 
The absorptions at 3640 and 3420 cm-1 (free and bonded OH stretching, respectively) are 
characteristic of 82a. 
Compound 
82a 
(3,4-Dihydro-6-hydroxy-2,2,5,7,8-
pentamethylbenzopyran) 
82b 
(3,4-Dihydro-2,2,5,7,8-
pentamethylbenzopyran) 
Absorption (cm-1) 
3251 (OH), 2981-2929 (C-H), 1366 
(gem-dimethyl), 1264 (C-O)179. 
2971-2910 (C-H), 1363 (gem-dimethyl), 
1219 (C-O). 
Table 3 
The proton shifts (in ppm) in the 1 H NMR spectra of the 3,4-dihydrobenzopyrans are listed 
in Table 4 (see Appendix for spectrum) and are consistent with their proposed structures. 
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5 
6 
7 
8 
82 
Structure Cpd C-2- C-3- C-4- H-5 H-6 H-7 H-8 
• (CH3h CH2 CH2 
CH3 (CH3) (CH3) HO 5 4 (OH) (CH3) 
I ~ 3 CH3 82a 1.28 1.81 2.61 2.10 4.22 2.10 2.15 
H3C 7 
.& 0 2 8 
CH3 
1 CH3 
CH3 (CH3) (CH3) (CH3) H (H) I~ CH3 82b 1.29 1.77 2.59 2.07 6.54 2.10 2.15 
H3 
~ 0 
CH3 
CH3 
H 
a (H) (H) (H) I~ CH3 82c 1.31 1.76 2.72 6.99 - 6.77 - 7.03 
H ~ 0 
H 
CH3 6.71 
H 
H (H) (H) (OH) (OH) I~ CH3 82d 1.34 1.75 2.69 6.50 6.52 5.64 5.64 
HO ~ 0 
OH 
CH3 
H 
HO 
(H) (OH) (H) (H) 
I~ CH3 82e 1.25 1.74 2.69 6.50 2.99 6.50 7.68 
H 
~ 0 
H 
CH3 
Table 4 
The geminal dimethyl protons C-2-(CH3h in 2,2-dimethyl-3,4-dihydrobenzopyrans 82a-
82e in Table 4 are found to be magnetically equivalent, and therefore come into resonance 
at the same frequency. The geminal dimethyl protons are increasingly deshielded in going 
from 82a-82d. This can be attributed to the increasing electron donating effect (+ M effect) 
of the groups present on the aromatic ring which are more likely to reach into the saturated 
part of the ring. However, the geminal dimethyl protons in 82e are deshielded in comparison 
to those in 82a-b, possibly due to the CH3 groups in 82a-b being more electronegative than 
the hydrogen atoms attached to the aromatic ling in the 82e. The benzylic methylene protons 
(C-4-CH2) are most affected by the deshielding of the circ1uating IT electrons and are found at 
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low field compared to the methylene protons on C-3 which resonate at higher field. The 
methylene protons C-3-CH2 and C-4-CH2 on the heterocyclic ring system in 82a-e appear 
as triplets (J = 6-7 Hz)173. The phenolic protons in 82a, 82d and 82e respectively, are 
exhanged in deuterium oxide (02°) to give the corresponding deuterated species. The 
phenolic proton can appear as a sharp singlet (due to rapid exchange, no coupling), or more 
usually as a broad singlet (slow exchange, coupled) that can resonate between 4-8 ppm. 
depending on the concentration, solvent and temperature. 
An extensive mass spectrometric study of aromatic ethers in which the oxygen forms part of a 
saturated 6-membered ring system was conducted by Williams, Thomas and Gautschi180. 
They reported and explained the fragmentation pathways for typical 3,4-dihydrobenzopyrans. 
The mass spectrometry results for compound 82a-e were consistent with their proposed 
structures. 
CH3 H3C CH3 HC CH3 H~CH2. Loss of '>= CH2 HO Loss of 2FC~ HO¢CH2 H3C H3C .. 
H~ ~ \t( 0+. (- 56) H~ (- 55) H~ ~ OH 
CH3 CH3 
mJz = 164 (100%) mJz = 220 (70%) mJz = 165 (95%) 
148 82a 146 
(- 28) ! -CO r 
CH3 
Ho=<P 
+ co 
H~ ~+ 
CH3 H~ OH 
149 147 
! +. 
CH3 CH3 I 
HO)~:::Z):H2 HO* a .. H~ :::,.. I CH3 
H~ CH3 
CH3 
150 151 
Scheme 26. Fragmentation pathway of 2. 2-dimethylbenzopyrans (Path A). 
Thus the fragmentation scheme for compound 82a (Scheme 26) shows that the molecular 
ion of, 82a could lose a 4-carbon fragment from the heterocyclic ring (a retro Diels-Ald~I"). 
This reaction may occur with or without hydrogen transfer and the peaks appear at t\.1-55 
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(146) and M-56 (148) respectively, (although Williams180 reported that the 3,4-
dihydrobenzopyrans always fragment with hydrogen transfer to fOlm the conjugated system 
146). Loss of CO from the quinone methide 148 via (149) and the rearrangement of 
(150) gave the phenol 151. Fragmentation of 146 could rearrange to form the stable 
tropylium ion (147), (Path A). Another possible fragmentation patttem of 82a (Path B) is 
outlined in Scheme 27. 
- (·CH3) 
H~ (M - 15) 
mJz = 220 (70%) 
82a 
CH3 
HO H 
.. a 
H~ 
CH3 
154 ! (H- shift) 
CH3 
HO 
- (C2H4) 
H~ 
(- 28) 
CH3 
155 
~ 
.. 
H~ CH3 
mJz = 205 (5%) 
HO 
H~ 
HO 
H~ 
152 
1 
CH3 
CH3 
153 
CH3 
CH3 
mlz = 177 (5%) 
156 
(- 28+ -CO) 
mlz = 149 (3%) 
157 
Scheme 27 : Fragmentation pathway of 2,2-dimethyl-3,4-dihydrobenzopyran (Path B). 
This involves the loss of one of the geminal methyl groups from the M+·to give 152, which 
has also been reported in related compounds by Nilsson 181 and Williams 180. It is proposed 
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that the oxonium ion 152 could be in resonance between the tertiary carbocation 153. 
Rearrangement of 153 affords the secondary carbocation 154. Further degradation of 154 
may occur by ring contraction involving the hydride shift to form the primary carbocation 
155 followed by loss of ethene to give 156. Nillson 181 found that this kind of 
fragmentation occurs in "(-tocotrienols. The oxonium ion (156) could further ring contract 
with the elimination of CO to form the stable tropylium ion (157). 
2.03 Oxidation of 2,2-dimethyl-3,4-dihydrobenzopyrans 
The 2,2-dimethyl-3,4-dihydrobenzopyrans can undergo atmospheric oxidation. The (CI) 
mass spectrum of the mother liquor of 60b showed the presence of a dimeric compound 163 
(mlz =407, M+ 1). 
Initially, compound 82b could be oxidised by atmospheric oxygen in the presence of light to 
give the benzylic radical 158. This radical is probably stabilised by resonance involving the 
canonical structures 159, 160, 161 and 162 (Scheme 28). 
H ~~H H • ~~Ul ( ~ CH2 <? CH2 
~ I .. • ~ I __ .. - ___ •
H 
oxid. 
• 
82b 158 159 160 
1 1 
H 
.. . 
162 161 
Scheme 28 
Formation of 163 is most likely to arise by the dimerisation of 159 (C-C radical coupling at 
the 5-position) as shown in Scheme 29. A similar reaction has also been observed by 
Nilsson et al in "(-tocopherols179. 
H ~ ~ 
6 CH') l { H~ 
7<? 1 5 .. 
~ 
8 4 
3 
H 
159 
radical • 
coupling 
Scheme 29 
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The benzylic radical 159 forms dimers only by coupling at the 5-position ilTespective of 
whether a methyl group is present at the 8-position, and regardless of whether the ortho-
position (7-position) is substituted or not, as observed in this study and also by other 
researchers 179. This is also found in the electrophilic substitution of 5-hydroxyindane182, 6-
hydroxytetralin 182, and bromination of a-tocopheroI183. The observation that electrophilic 
substitution only occurs at the 6-position (ar-~) of 5-hydroxyindane (164) and at the 5-
position (ar-a) of 6-hydroxytetralin (165) is interpreted to be the result of the directing effect 
of the cyclic ring system. 
ar-a 
HO~ 
.VJ ~ 
ar - ~ 164 165 
This phenomenon has been referred to as The Mills-Nixon effect184. According to Kekule, 
benzene exists as a resonance hybrid of the two canonical structures 166a and 166b. 
o ~ · 0 © 
166a 166b 
Mills and Nixon184 suggested that when 'strained' cyclic groups were attached to the benzene 
ring, in indane for example it lead to bond fixation in the ground state, such that, 167 would 
be the preferred canonical form for indane (where a single bond is common to the two rings), 
while for tetralin the preferred canonical form would be 168 (where a double bond is 
common to the two rings). 
OJ 
167 168 
However, Vaughan et al185 suggested that the ground states of 167 and 168 are the same for 
both positions of substitution, factors determining the product distribution are the relative 
distribution of the two transition states of 167 and 168 which are transition state 1 and 2 are 
shown in Scheme 30 below. 
----------------------------------------------------~ ----- --~----
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ar-~ substitution 
.. .. .. 
169 170 171 172 
Transition state 1 
ar-a substitution 
.. .. .. 
173 174 175 176 
Transition state 2 
Scheme 30 
Thus, in the canonical structures (169-172) of the transition state for ar-J3 substitution, three 
of the four forms have a single bond between the carbons common to the three rings. 
Therefore, going from the ground state to the transition state would involve lengthening of the 
common bond, this would result in decrease in strain when the fused ring is a five-membered 
and an ar-J3 intermediate would therefore be favoured. In the canonical structures (173-
176) for ar-(X substitution, three of the four resonance forms have double bonds between the 
carbons common to the three rings. Therefore, this bond would decrease on going from the 
ground state to the transition state, and strain if present in the adjacent ring should be reduced, 
resulting in enhancement of reactivity at the ar-(X position 186. Meir187 indicated that the 
condensation of small saturated rings (6-membered or smaller) to the benzene molecule 
always causes a distortion of the aromatic ring and thus induces a certain strain into the 
system. This may favour reaction at one position over another, and hence, account for this 
effect. Today, the Mills-Nixon effect184,188-193 is known as the effect causing an aromatic 
moiety to localize its bonds (e.g. alternating arrangement of single and double bonds instead 
of the usual symmetric arrangement) due to the strain imposed by small annelated ring(s) and 
hence, to change the systems structure and reactivity. Some chemists claim that the effect is 
reaP94-199 whereas others suggest that it is an artifact of theoretical approximations, and 
higher level calculations show that the effect is not real200-202. However, the debate on the 
Mills-Nixon effect is still under study today. 
In summary, this study has shown that 2,2-dimethyl-3,4-dihydrobenzopyrans can be 
synthesised by condensing both phenols and hydroquinones with carbocations generating 
from butadiene in the presence of glacial acetic acid. An overview of the mechanistic pathway 
of these 2,2-dimethyl-3,4-dihydrobenzopyrans is proposed together with the analysis of the 
spectral data. 
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2.04 Synthesis of 2,2-dimethyl-3,4-dihydro-4-isopropyl-benzopyran (178) 
82a R=CH3 
1 R = C16H33 
R 
It is well established that a-tocopherol (1) is one of the two best chain-breaking, phenolic 
antioxidants known56 (the other being 82a). That is a-tocopherol (1) and the structurally 
related model compound 82a react more rapidly with peroxyl radicals (j) than any of the 
numerous other phenols investigated by Ingold et a156. 
ROO· 
Peroxyl radical 
+ ArOH __ k.....,.!l_ .... ROOH 
82a or 1 
+ ArO • (j) 
Phenoxyl radical 
Ingold56 has compared the rate constant value (k l ) for the trapping of the peroxyl radical 
(ROO,) by a-tocopherol! (or 82a) (as shown inj), with those found for structurally related 
phenols that lacked the fused 6-membered heterocyclic ring and has shown that this ring is 
largely responsible for the high reactivity of a-tocopherol. This ring exerts a stereoelectronic 
effect by constraining the ring oxygen in such a manner that the p-type lone pair is well 
orientated to stabilize the developing phenoxyl radical. With this in mind, it was decided to 
introduce an isopropyl grouping in the C-4 postion of 82a to form compound 178, since the 
isopropyl group in 178 may constrain the ring oxygen even further, and thus make it 
potentially better antioxidant than a-tocopherol. 
This was achieved by using the method of Smith86-88 . Phenol 28a was reacted this time 
with 2,5-dimethylhexa-2,4-diene (177) to form the 2,2-dimethyl-3,4-dihydrobenzopyran 
178 as shown in Scheme 31. 
OH 
+ 
28a 177 
ZnC1 2 
+ AcOH 
lOO°C,4hr 
Scheme 31 
.. 
178 
Compound 178 showed some interesting features in its 1 H NMR spectrum, and the chemical 
shift values are compared with those of compound 82a in Table 4 (see Appendix for 
spectrum). 
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m 
d 
82a 178 
Cpd. C-2- C-3- H-4 C-4a-H C-4b- C-4c- C-5- C-6- C-7- C-8-
(CH3)2 CH2 CH3 CH3 CH3 OH CH3 CH3 
82a 1.28 1.81 (CH2) - - - 2.10 4.22 2.10 2.15 
2.61 
(CH3) 1.63(ax) (CH) 0.89- 0.77- 0.83-
178 1.05 2.02 (eq) 2.84 0.98 0.80(ax) 0.86(eq) 2.11 4.35 2.15 2.15 
(CH3) 
1.48 
Table 4 
The gem -dimethyl groups on C-2 were chemically equivalent in 82a. However, in 178 they 
were found to be non-equivalent, one methyl group adopting an axial conformation, the other 
an equatorial conformation, and resonating at 1.05ppm and 1.48 ppm respectively. The 
methylene protons on C-3 in 178 were also observed to be chemically non-equivalent 
compared to those in 82a, and they too adopted either an axial or an equatorial confOlmation. 
Due to the adjacent vicinal proton on (C-4), which further couples with each of the axial- and 
equatorial - orientated doublets protons on C-3 into two doublets resonating at 1.63ppm and 
2.02ppm (approx. 6-7 Hz), respectively. Chemical shift non-equivalence of the methyl 
groups of the isopropyl group on the chiral centre (C-4) formed an A6X system (as is 
frequently observed203). The methine proton on the chiral centre (C-4) was split by the 
adjacent methylene protons (C-3) and equally by the vicinal methine proton (C-4a) into a 
quartet which resonated at 2.84 ppm. The methine proton (C-4a) itself was split by the 
methine proton at C-4 and equally by the two methyl groups (C-4b and C-4c) into a multiplet 
which resonated between 0.89-0.98 ppm. The equivalent methyl protons (C-4b) and (C-.:k:) 
were split by the methine proton at C-4a into two doublets which were shielded and resonated 
at 0.78 ppm and 0.84 ppm, each having coupling constant of approximately 7 Hz. 
The introduction of the isopropyl grouping at C-4 has confOlmationally locked the protons on 
C-2, C-3, and C-4 which suggested that the compound 178 adopts a more rigid 
conformation than that formed in 82a. This phenomenom has been seen in 4-substituted 
flavans204 and will be further discussed in Chapter 4. 
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2.05 Proposed Mechanism for the Formation of substituted 2,2-dimethyl-
3,4-Dihydrobenzopyran 
Using the method of Smith86,88,173 the moderate yields (30%) obtained, could be accounted 
for by the fact that initially, zinc chloride could hydrolyse to form zinc hydroxide as shown 
below (k). 
+ Zn(OHh + 2HCI (k) 
In situ generation of HCI could lead to the transformation of isoprene (81) into 1-chloro-3-
methyl-2-butene (179). This in fact, is the commercial process for producing such 
compounds43. It was found that addition of excess isoprene lead to polyisoprenylation of the 
phenol and therefore failed to increase the yield of the mono-isoprenylated 2,2-dimethyl-3,4-
dihydrobenzopyrans. Therefore, the availability of HCI could be the limiting factor in 
benzopyran formation in converting the isoprene to 1-chloro-3-methyl-2-butene and not the 
quantity of isoprene. 
Alternatively, Olah206 has shown that H+ AICI4- and H+BF 4- similarly act as superacid 
catalysts (Ho = -15 to -16) and by analogy, H+ZnCI3- which could be generated from zinc 
chloride and hydrogen chloride (I) may act as a catalyst in this reaction. 
+ HCI .. (I) .. 
This could form a complex with the isopentenyl cation as shown in Scheme 32. 
:r r 
[ ally lie + 
HCl ~ ~ ?( ~reoonane; ;r (addn) (- Cl) 
+ 1° Allylic 3° Allylic 
Cl 
81 179 
1 ZnC12 
ZnC13-
allylic ~ resonance ~ 
1° + 
_ .. -~ Q;0 
ZnC13-
182 183 
isoprene - zinc chloride complex 
180 181 
Scheme 32 : Mechanistic pathway for the generation of isopentenyl cation 
] 
Smith88 observed that conc. hydrochloric acid alone can promote the coupling of isoprene 
with trimethylhydroquinone to form the allyl ether. However, cyclisation of the ether to the 
chroman was not observed. presumably as the value of Ho for HCI is below-3.0207 . 
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Concerning the mechanistic pathway, there is no guarantee that all phenol allylation reactions 
proceed in the same manner. However, in many instances it has been shown that the reaction 
involves previous formation of allyl aryl ethers followed by [1,3] or [3,3] sigmatropic 
rearrangement208 . It is proposed that the isopentenyl cation 181 attacks the more 
nucleophilic part of the phenol 28a to form the allyl aryl ether 186 via 185, which then 
proceeds via [3,3] sigmatropic rearrangement to form 187 which tautomerises to 188 
(driven by aromatisation). Protonation of the double bond in 188 leads to the formation of 
the tertiary carbocation 189. With subsequent cyclisation and deprotonation, this leads to the 
formation of the 2,2-dimethyl-3,4-dihydrobenzopyran 82a. It is possible that zinc chloride 
could form complex (184) with trimethylhydroquinone 28a as shown in Scheme 33. 
+ ~ ZnCl2 ~ OH 
28a 181 
! ZnCI2 
.. 
82a 
I} 
~O 
H 
185 
H 
189 
(- H+) 
~ I~ 
186 
1[3.3] 
Keto - Enol 11 
Tautomerism 
Scheme 33: The mechanism of fonnation of a 2,2-dimetbyl-3,4-dihydrobenzopyran 
A second possible mechanistic scheme is outlined in Scheme 34. The phenol 28a could 
react with the primary carbocation 180 to form the the allyl aryl ether 190 which then 
undergoes a [3,3] - sigmatropic rearrangement to form 191, which in turn tautomerise to 
give 192. Protonation of 192 leads to the formation of the secondary carbocation 193 or 
the plimary carbocation 195. Subsequent cyclisation and deprotonation of each leads to the 
formation of the benzofuran (194) and the benzopyran (196), Since neither of these two 
products were obtained, the former route involving the more stable tertiary carbocation 
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appears to prevail (as would be expected, based on the relative stabilities of the allylic 
carbocations involved). 
+ 
OH 
180 28a 190 
1 
Keto - Enol Tautomerism 
.. 
192 191 
194 196 
Scheme 34 
Bigi 174 suggested that isopentenyl cation (181 in Scheme 33) reacts with phenols in the 
presence of strong acid zeolite HSZ-360 catalysts to form the ether 197. This subsequently 
rearranges via [1,3] sigmatropic shift to form 198 which then under acid promoted 
cyclisation forms 82 as outlined in Scheme 34. 
5 I 
o~ 
6 [1,3] rearrangement 
197 
Discussion 
198 
Scheme 34 
82 
Casnati et aI209 , have condensed isoprene with a 1: 1 mixture of phenol/potassium phenoxide 
salt in the presence of aluminium chloride in a solvent such as benzene. They did not present 
any mechanistic evidence. It is probable that H+ AICI4- is the superacid responsible for 
promoting the condensation and subsequent cyclisation of the allyl phenylether to form the 
benzopyran (82). 
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2.06 Improved syntheses of 2,2-dimethyl-3,4-dihydrobenzopyrans 
Generally, 2,2-dimethyl-3,4-dihydrobenzopyrans are prepared in two step syntheses with not 
very satisfactory yields170, so the method of Ismail et a[210 was used in an attempt to 
improve these yields. 2,2-Dimethyl-3,4-dihydrobenzopyrans (82a-82j) can be synthesized 
in one-pot syntheses, in the presence of a solvent and an acid211 or in the presence of an acid 
such as trifluoroacetic acid which acts as both the solvent and promotes the acid-catalysed 
cyclisation of the allyl aryl ether to the 2,2-dimethyl-3,4-dihydrobenzopyrans. The advantage 
of using trifluoroacetic acid as a solvent is that its physical properties provide benefits over 
alternative acids212. 
Using the method of Ismail et a121O, various phenols (28a-28j) and allyl alcohol 199 were 
heated under reflux in trifluoroacetic acid to afford 2,2-dimethyl-3,4-dihydrobenzopyrans 
(82a-82j) in moderate yields. However, the 2,2-dimethyl-3,4-dihydrobenzopyrans 82g 
and 82h reacted further with the alcohol to afford the corresponding 4-isobutenyl-2,2-
dimethyl-3,4-dihydrobenzopyrans 144g and 144h, respectively_ Without isolation, 144g 
and 144h by acid-catalysis, further cyc1ised to afford 200g and 200h, respectively, as 
outlined in Scheme 36. 
R2 
R3 
OR j TFA + IOOoe,4hr 
OR 
R4 
28 199 
283,823 Rh R3, R4= CH3, R2 = OH 
28b,82b Rl, R3, ~ = CH3, R2= H 
28g,82g Rl> R2 = H, R3, ~ = CH3 
28h, 82h Rb ~ = CHJ, R2, R3 = H 
28i,82i Rh R3 = CH3, R2, ~ = H 
28j,82j Rl, ~ = H, R2 = CI, R3= CH3 
.. 
R2 + 199, H+ R2 
.. 
R3 
~ 
82/144 
144b Rb R3, ~ = CH3, R2 = CH2CHC(CH3h 
144g R., R3, R4 = CH3, R2 = CH:CHC(CH3h 
144h Rl = H, R2 = CH2CHC(CH3h, R3, Rt = CH3 
144i R1, ~ = CH3, R3 = CH3, R2 = CH2CHC(CH3h 
200g Rl- R2 = C(CH3h CH2CH2, R3, ~= CH3 
200h Rb R2 = CH3, R3 - ~=CH2 CH2>C(CH3h 
Scheme 36 
The phenols 28a, 28b and 28j gave good yields of the corresponding 2,2-dimethyl-3,4-
dihydrobenzopyrans 82a, 82b and 82j, respectively as shown in Table 36. Compounds 
144b, 144g, 144h, and 144i were not isolated and on further acid-catalysed cyc1isation 
of the isopentenyl grouping in these molecules lead to the formation of 200g-200h. These 
were easily identified by their respective 1 H NMR spectra, which showed the complete 
absence of any aromatic protons. Any unreacted phenols (28a-28j) were removed by 
treatment with Claisen's alkali 176. 
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B.pt [OC Yield Lit. 
Cpd. Rl R2 R3 R4 1 torr] (%) B.pt [OC 
1 torr] 
82a CH3 OH CH3 CH3 90-92 57 92-9488,173 
(M.pt) (M.pt) 
82b CH3 H CH3 CH3 128-132/2 51 40-41 88 
(M.pt) 
82g H H CH3 CH3 148-152/3 5 N/C 
82h CH3 H H CH3 108-11211 4 N/C 
82i CH3 H CH3 H 108-110/1 trace N/C 
82j H C1 CH3 H 54-56 73 N/C 
(M.pt) 
Table 6: N/C = novel compound, therefore not reported. 
The 1 H NMR spectra of compounds 82a-82j were consistent with their proposed structures 
and are summarized in Table 7. One of the interesting features observed was that the peak 
heights of the C-4 methylene proton and the aromatic methyls in 82a-82j were found to fall 
relative to the peak heights of the C-3 methylene protons and some broadening of the signals 
was observed but the multiplicities and the shift in band positions were not affected. This 
effect can be attributed to the presence of traces of trifluoroacetic acid present in the sample. 
It is thought that the effect is produced by the aromatic nucleus of the benzopyrans that is very 
easily oxidisable by the presence of acid or oxidising agents to the cation radical state (m)213. 
H+ +. [Phenol] • [Phenol] (m) 
Similar affects have been observed by Dean213, who noticed that small traces of acid present 
in deuterated solvents such as d-chloroform induced line broadening of the C-4 methylene 
protons of 3,4-dihydrobenzopyrans, especially tocopherol and its related compounds. 
Structure No. C-2- C-3- C-4- H-5 H-6 H-7 H-8 
(CH3h CH2 CH2 
CH3 4 (OH) 
HO 6 5 
7 1 
~ 3 82a 1.28 1.80 2.61 2.03 4.23 2.03 2.07 CH3 
H3C 
# 0 2 8 CH3 CH3 
CH3 
H I~ CH3 82b 1.30 1.78 2.59 2.04 6.54 2.09 2.15 
H3 
# 0 
CH3 
CH3 
S4 
Discussion 
H 
H I~ CH3 82g 1.31 1.76 2.73 6.03 6.80 2.09 2.21 
H3 
b 0 
CH3 
CH3 
CH3 
H ~ 
I CH3 82h 1.30 1.79 2.60 2.13 6.60 6.87 2.18 
H b a 
CH3 
CH3 
CH3 
H I~ CH3 82i 1.30 1.80 2.57 2.17 6.49 2.22 6.54 
H3 
b 0 
H 
CH3 
H 
a I~ CH3 82j 1.30 1.77 2.70 6.64 - 2.26 7.01 
H3 
b 
CH3 H 
Table 7 
The mass spectra of 82a-82j were consistent with their structures. The fragmentation 
patterns are similar to the ones shown in Scheme 26-27 (p.42-43). 
The formation of the novel oxacyc1opentanaphthalene 200g as outlined in Scheme 37 
(p.56) can be accounted for the fact that the isopentenyl grouping in 144g under these more 
strongly acidic condition leads to the formation of the tertiary carbocation (201) which on 
cyc1isation and deprotonation leads to the formation of 200g (provided that the ortho-
position to the isopentenyl group is unsubstituted) in low yields as shown in Table 8 (see 
A ppenrlix for spectrum). This can be also account for by the formation of the novel 
oxacyc1opentanaphthalene (200h) from 144h. 
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144g 
(Aromatisation) 
200g 
200h Rb R2 = CH3, R3, R4 = CH2CH2C(CH3h 
Scheme 37 
B.pt [OC 
Cpd. Rl R2 R3 R4 / torr] 
200h h CH3 CH3 126-132/3 
200g CH3 CH3 h 148-152/3 
Table 8: N/C= novel compounds 
3° carbocation 
+ 
201 
1 
Yield Lit. 
(%) B.pt [OC 
I torr] 
16 N/C 
25 N/C 
The 1 H NMR spectra of 200g-200h showed signals for six methyl groups resonating at 
1.29-1.39 ppm, and signals for four methylene groups resonating around 1.71-1.89ppm 
respectively, and a complete absence of any aromatic protons, hence, confirming the 
presence of oxacyclopentanaphthalenes ( as far as we are aware) 200g-200h. 
Their mass spectra also showed the required molecular ion peaks for 200g and 200h. 
Thus condensation reaction of an allyl alcohol with a suitable hydroquinone is an important 
process in the synthesis of benzopyran heterocycles. For example, although there are 
numerous reports in the literature concerning the synthesis of rac-a-tocopherol 1214, the 
development of a more effective and practical system is still being sought. On this basis, the 
methology of Ismail ef a[2l0 was employed to seek a more effective and practical acid catalyst 
for the synthesis of a-tocopherol (1), as outlined in Scheme 38. 
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Trimethylhydroquinone (28a) was reacted with isophytol (36) in the presence of 
trifluoroacetic acid to afford a - tocopherol 1, 83% yield. 
+ 1 TFA el~33 • OH OiF16H33 (1000e,4hr) 
28a 36 1 
Scheme 38 
The 1 H NMR spectrum of the product was consistent with the proposed structure. A possible 
mass spectral fragmentation of a-tocopherol 1 is shown in Scheme 39. 
+ 
• 
(M - 225) 
.. .. 
+ 
1 153 152 
(mlz = 430, 100%) (mlz = 205, 10% ) 
Loss of (M - 265) 
o 
I HO~ ~C~J; 1-'oH 
203 147 
(mlz = 165,90%) 
Scheme 39 
The molecular ion 1, loses the phytyl side chain (M-225) to afford the tertiary carboaction 
153, which is resonance stabilised. Alternatively, the molecular ion lk (via a retro-Diels-
Alder reaction) can lose the phytyl chain to afford 203 which forms the more stable tropylium 
ion (147). 
Recently, Yamamoto et al2I5 have used rare earth metals trifluoromethanesulfonate (triflates) 
to catalyse the reactions. In paIticular, Scandium (III) trifluoromethanesulphonate (Sc(OTf)3) 
was found to be the most effective catalyst for the condensation of trimethylhydroquinone 
with phytol to afford a-tocopherol in good yield (88%), together with the minor impurities of 
the diastereomers of the dihydrobenzofuran 204, in contrast to the 83o/r yield of the pure a-
tocopherol obtained in this work. 
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204 
Ha1l207,216 found that the threshold of acidity (Ho) required for pyran formation was 
approximately -3.0, and observed that no reaction occurred with hydrogen chloride, formic 
acid (Ho = 2.2)217, formic-hydrochloric acid, or 50:50 (v/v) formic-trifluoroacetic acid 
mixtures. Trifluoroacetic acid (TFA; Ho = _3.0207,216) fulfills the aforementioned criterion 
and has been used to synthesise efficiently a variety of racemic benzopyrans as well as 0,-
tocopherol, as shown in this study. Swanholm and Parker218 have studied the ortho-Claisen 
rearrangement of allyl ethers where trifluoroacetic acid has been used to synthesize ortho-
cresol from allyl-p-tolyl ether, and they have shown that trace quantities of water (up to 
10%), which are not tolerated by other condensation procedures, actually enhance the rate of 
cyc1isation and condensation by (approximately) twenty fold. This observation could be due 
to the fact that TFA is a strong acid in aqueous solution (pKa = +0.3)198, and a weak acid in 
the pure state199 and the presence of water might allow the possibility of catalysis by H30+. 
Therefore, it is thought that a combination of various acids might induce this "acidity jump 
phenomenon" (near Superacid mediated catalysis by TFA). Superacids have been used by 
Olah to generate carbocations206. 
The advantage of using trifluoroacetic acid is that it avoids the use of catalysts such as FeCI3, 
SnCl4 or AlCl3 because these catalysts can introduce metallic impurities into the reactions. 
Trifluoroacetic acid acts as both the solvent and the catalyst for the rearrangement and 
subsequent condensation of phenols and allylic alcohols in the formation of benzopyrans. In 
similar work, phenols and propargyl alcohols when heated together can directly yield 2,2-
dimethylchromenes, as in the Spath synthesis of the natural product seselin 146. 
In summary, this study has shown that 2,2-dimethyl-3,4-dihydrobenzopyrans can be 
efficiently synthesised by reacting both phenols and substituted hydroquinones with 
carbocations generated from the appropriate allylic alcohol in trifluoroacetic acid under an 
atmosphere of argon in a one pot synthesis. 
2,2-Dimethyl-3,4-dihydrobenzopyrans have been synthesised in low to average yield (5-
54%) by using Smith's methods86, 173. The method undertaken in this study using 
trifluoroacetic acid also gave low-average yields together with novel compounds whose 
spectral data have not been reported in the literature before. 
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2.07 Synthesis of 2,2-dimethyl-2,3-Dihydrobenzofurans (124a-r) 
2,2-Dimethyl-2,3-dihydrobenzofurans are important intermediates in natural product 
chemistry219-221, and they have been shown to exhibit a range of different bioactivity222. 
The 5-hydroxy-2,3-dihydrobenzofurans and 5-h ydroxy-2,3-dihydronaptho [1,2-b] furans 
have been shown to be extremely effective antioxidants in a variety of systems60,223,224. 
In particular, they were found to be even more efficient than a-tocopherol, the major 
lipid-soluble chain-breaking antioxidant in human blood225. In addition, 5-hydroxy-2,3-
dihydrobenzofurans have proved to be effective free radical scavengers in biological 
systems working, for example, as lipoperoxidation inhibitors220 or as inhibitors of 
leukotriene biosynthesis226. Therefore, the synthesis of 2,3-dihydrobenzofurans are of 
interest. 
[3,3] Sigmatropic rearrangements of allyl aryl ethers (the Claisen rearrangement) provide 
an efficient method for constructing carbon-carbon bonds and have been increasingly 
employed in synthesisll1-114. Though there are some reports of 2,3-
dihydrobenzofurans (124) being obtained as minor products during Claisen 
rearrangements227-232, they are generally synthesized in two steps from allyl aryl ethers 
(205) utilising the [3,3] sigmatropic reaction followed by cyclisation of the resulting 2-
allylphenols (206) in the presence of strong acid catalysts233-237 as outlined in Scheme 
40. 
~ V-of\ 
205 124 
Scheme 40 
These procedures resulted in low yields and required vigorous conditions during all the 
steps133,238. A [3,3] sigmatropic reaction has been reported involving heating 2-methyl 
allyl p-tolyl ether at 1400 C for 9hrs in the presence of zinc chloride239 but with poor 
yields of the product 124. The reaction conditions, however, were still unsatisfactory 
(longer reaction times) with comparatively low yields. Saidi240 has reported that the 
rearrangement of allyl naphthyl ethers promoted by titanium tetrachloride produced 2,3-
dihydronaphthofurans in average to good yields, while recently, Ryu241 , synthesised 
2,2-dimethyl-2,3-dihydrobenzofurans from aryl methyl allyl ethers using aluminium 
chlOlide in the presence of potassium carbonate and mixed solvent systems (acetone / 
DMF, 5: 1) to generate the methyl allyl ethers followed by a [3.3] sigmatropic 
realTangement and cyclisation of the ethers using aluminium chloride as the catalyst, to 
afford the corresponding 2,2-dimethyl-2.3-dihydrobenzofurans. They stated that the 
best results were achieved by using aluminium chloride as the catalyst. 
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In this study242, however a campaign was undertaken to improve the yields and carry out 
a one-pot syntheses, where various phenol derivatives (2S) and allylic alcohol (207) 
were heated under reflux using trifluoroacetic acid, which acts as both the catalyst and the 
solvent (see Scheme 41) to afford 2,3-dihydrobenzofurans (124) in poor to moderate 
yields. The 2,3-dihydro-isopropenyl-benzofurans (209) were obtained in less than 2% 
yield, while 2,3-isopropyl-dihydrobenzofurans (210) in poor to moderate yields, were 
also obtained as side products (Route A). The results are summarized in Table 9 
(where the various % figures are given). 
::*OH+ HO~ 
R4 
28 
+ 
207 
h o 
20S 
TFA ~ 
lOOoe,4hrs R3 
[Route A] ~ 
124 
100°C, 4hrs, Toluene 
[Route B] 
Scheme 41 
Also, mechanistic pathways will be proposed, compared to other workers and spectral 
data of 2,2-dimethyl-2,3-dihydrobenzofurans will be discussed. 
The methodology of Martini133 (Scheme 41, Route B) was also extended to other 
phenols and compared with that of the method outlined in Scheme 40, Route A. The 
appropriate phenol 2Sa-r was dissolved in a solvent such as toluene and heated under 
reflux with isobutyraldehyde (20S) in the presence of catalytic amount of concentrated 
sulphuric acid to afford the 2,3-dihydrobenzofurans 2Sa-r (in Table 9). The 
isopropenyl-2,3-dihydrobenzofurans (209) (trace amounts), and isopropyl-2,3-
dihydrobenzofuran 210 were obtained as side-products, (Route B) as shown in 
Scheme 41. 
In comparison of the results obtained in Table 9, it can be seen generally that the yields 
of the 2,3-dihydrobenzofurans synthesised using both Routes A and B as outlined in 
Scheme 41, increase as the aromatic ring is increasingly substituted by the electron 
donating weakly (+1) methyl groups. The best results were obtained in the case of the 
most hindered phenols 2Sa-2Sb. The presence of electron withdrawing (-I) groups 
such as CI, OCH3 and Br in the aromatic ring gave comparatively low yields as in 124c. 
124p, and 124q. respectively. The presence of ortho substituents (2Sm). led to low 
yields of the conesponding dihydrobenzofuran (124m) probably as a consequence of a 
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steric hinderance. The unsubstituted phenol 28r gave also very poor yield of the 
corresponding dihydrobenzofuran (124r). 
B.pta Yielda B.ptb Yieldb B.pt. lit 
124 Rl R2 R3 R4 [OC/ (%) [OC / (%) / [OC/mm 
mmHg] mmHg] Hg] 
a CH3 OH CH3 CH3 118-120 37 oil 22 122-
(M. Pt.) 123130 
(m.pt) 
b CH3 H CH3 CH3 43-45 35 46-47 83 47241 
(M. Pt.) (m.pt) 
c H Cl H H 82-84 / 6 60-62/ 6 117238 
0.18 0.13 (1 Torr) 
f H H CH=CH- 58-60 I 6 64-66/ 46 Gum240 CH=CH 
0.20 0.22 
g H H CH3 CH3 82-86/ 26 N/C N/C 45/0.0 
0.11 5241 
h CH3 H H CH3 92-96 I 11 58-64 I 15 48/0.03 
0.06 0.04 241 
• CH3 H CH3 H 84-86 I 27 50-56 I 38 88-89 I I 
0.10 0.08 0.01 243 
. H Cl CH3 H 72-78 I 31 62-66 I 12 N/R J 
0.12 0.09 
I H CH3 CH3 H 52-60 I 13 64-66 I 46 50-65244 
0.1 0.12 (1 Torr) 
m H H H CH3 80-82 I 3 42-48/ 8 32 I 
0.25 0.15 0.1241 
n H H CH3 H 80-82 I 32 42-44/ 32 131 133 
0.28 0.16 (m.pt) 
0 H CH3 H H 68-72 I 10 48-50/ 10 32 I 
0.22 0.15 0.1241 
P H OCH3 H H 62-66 I 4 N/C N/C NMR 
0.13 evidence 
245 
q H Br H H 82-84 I 3 62-64 I 2 NMR 
0.09 0.07 evidence 
246 
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52-54/ 
0.17 
1 56-62/ 
0.19 
3 31/ 
0.1241 
Table 9: [a] in this study, [b] by Martini's method, N/C=not carried out, NIR = not reported. 
The yields of 2,2-dimethyl-2,3-dihydrobenzofuran 124a and 124j obtained in this study 
(Route A) were better than those obtained by the Martini et a[l33 (Route B). The 2,2-
dimethyl-2,3-dihydrobenzofurans 124c, 1240, 124q, and 124r were obtained in 
similar yields, by both routes. However, the rest were obtained in lower yields 
compared to those of Martini et al133. 
In this study242, however, it has been shown that the 2,3-dihydrobenzofurans can be 
synthesized in a one-pot reaction by reacting phenols with an allylic alcohol in the 
presence of TFA which acted as both the catalyst and the solvent. The 2,2-dimethyl-2,3-
dihydrobenzofurans synthesized by the Martini et al133 (Route B) where toluene was 
used as the solvent and concentrated sulphuric acid as the catalyst (two different species). 
However, both Routes A and B gave comparatively low to moderate yields together 
with side products. 
The ir spectra of the 2,3-dihydro-2,2-dimethylbenzofurans were consistent with the 
proposed structures. The absorption bands at around 2967 and 2852 cm -1 present in all 
the spectra of all the benzofurans, this was attributed to the C-H stretching vibrations of 
the CH3 and CH2 groups. The bands appearing at around 1370 cm-1 were attributed to 
the 2,2-dimethyl groupings present in the benzofurans. The other bands observed 
between 1500 and 1600 cm-1 were mainly from the aromatic moiety. The bands at 
around 1270-1215 cm-1 attributed to the C-O-C (ether C-O stretch) grouping present in 
the benzofuran ring system. The ir spectrum of compound 124a showed the expected 
O-H stretching vibrations at 3446 cm-1 (broadened due to the intermolecular H-bonding). 
:6:)<; 
7 1 
124 
The proton nmr spectra were also consistent with the structures proposed for all the 2,2-
dimethyl-2,3-dihydro-2,2-dimethylbenzofurans (124) and the chemical shifts of the 
various protons are listed in Table 10. 
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124 (CH3h CH2 Ar-H Ar-H Ar-H Ar-H 
(C2) (C3) (C4) (C5) (C6) (C7) 
a 1.44 2.89 [CH3] [OH] [CH3] [CH3] 
2.09 4.27 2.09 2.09 
b 1.41 2.90 [CH3] [H] [CH3] [CH3] 
2.07 6.47 2.10 2.14 
c 1.46 2.98 [H] [Cl] [H] [H] 
7.02-7.03 - 7.05-7.09 6.61-6.64 
g 1.46 2.97 [H] [H] [CH3] [CH3] 
6.61-6.64 7.24 2.11 2.22 
h 1.49 2.92 [CH3] 2 x [H] [CH3] 
2.18 6.53-6.87 2.19 
. 1.49 2.87 [CH3] [CH3] I [H] [H] 
2.13 6.40 2.21 7.19 
. 1.44 2.93 [H] [Cl] [CH3] J [H] 
7.06 - 2.28 6.58 
I 1.44 2.93 [H] 2 x [CH3] [H] 
6.54 2.15-2.17 6.89 
m 1.45 2.97 3 x [H] [CH3] 
6.68-6.95 2.18 
n 1.45 2.94 [H] [H] [CH3] [H] 
6.97-7.00 6.60-6.63 2.28 6.55 
0 1.44 2.95 [H] [CH3] [H] [H] 
6.94 2.26 6.87-6.90 6.60-6.63 
p 1.45 2.96 [H] [OCH3] [H] [H] 
7.06-7.04 3.71 6.60 6.59 
q 1.44 2.96 [H] [Br] [H] [H] 
7.15-7.14 - 7.24-7.17 6.59-6.56 
r 1.49 3.02 4 x [H] 
6.73-7.16 
Table 10 
The protons of the geminal methyl present on C-2 appeared as a singlet and resonated in 
the region 1.41-1.49 ppm. The methylene protons present on C-3 showed a singlet, and 
resonated around 2.87-3.02 ppm, respectively in IH nmr spectra. The signal for the OH 
group in 124a which is exchangeable by deuterium oxide, resonated around 4.77 ppm. 
Two regioisomeric products are possible from the reactions of the allylic alcohol (207) 
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with both the phenols 281 and 28n. Thus, the phenol 28n could produce 2,2,6-
trimethylbenzofuran 124n or 2,2,4-trimethylbenzofuran 124s while the phenol 281 
could produce 2,2,5,6-tetramethylbenzofuran (1241) or 2,2,6,7 -tetramethylbenzofuran 
(124t) as outlined in Scheme 42. 
s V
OH
+ HO~ 124n 
28n 207 
124s 
s 
s 'l(;+~ ~ HO 
OH 
1241 
281 207 
124t 
Scheme 42 
The 1 H nmr spectrum of the product from 28n showed a doublet resonating at 6.97-
7.00 ppm (lH), a second doublet resonating at 6.60-6.63 ppm (lH), and finally, a 
singlet at 6.55 ppm (lH) which nearly superimposed on one peak of the latter doublet. 
Such a pattern indicated that the 2,3-dihydrobenzofuran obtained from phenol 28n was 
2,2,6-trimethylbenzofuran (124n) and not the 2,2,4-trimethyl isomer (124s) which 
would have been expected to show a doublet (meta-coupled), a doublet of doublets 
(ortho-coupled), and another doublet (meta-coupled) in the aromatic region of 1 H nmr 
spectrum. 
The 2,3-dihydrobenzofuran obtained from phenol 281 was 2,2,5,6-
tetramethylbenzofuran (1241) and not 2,2,6,7-tetramethylbenzofuran (124t). This 
was confirmed by the 1 H nmr spectrum of the product which showed two singlets 
resonating at 6.89 ppm and 6.54 ppm, respectively each integrating for one proton. 
Compound 124t would have been expected to show two doublets ortho-coupled to each 
other. From a steric point of view a moderate regiosc1ectivc control fa\'ours the 
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formation of the less hindered 2,3-dihydrobenzofurans 124n over the alternative 124s, 
and 1241 over 124t. 
The carbon-13 spectra of the 2,2-dimethyl-2,3-dihydrobenzofurans and 2,2-dimethyl-
2,3-dihydrobenzonaphthofuran (124f) were consistent with their proposed structures 
and are summarised in Table 11. 
R7 
124 
The chemical shift of the carbon at C-2 in 2,2-dimethyl-2,3-dihydrobenzofurans 124a-r 
is relatively deshielded from the geminal methyl groups present at C-2 and the carbon at 
C-3. The carbon at C-2 in 124c, 124j, 124q and 124p is relatively deshielded in 
comparison to the other carbons at C-2 present in dihydrobenzofurans. This is possibly 
due to the electronic nature of polar groups (CI and Br are weak Tt-donor, a-acceptor 
whereas OCH3 is a strong Tt-donor, a-acceptor) present on the aromatic part of the 
system. The carbon at C-2 in the dihydrobenzonaphtofuran (124f) is also deshielded 
·bl d h f£ f th h hal )OSSI h ue to t e anIsotropIc e ect 0 e napJ t ene nng. 
124 R4 R5 Rti R7 C-2 C-2- C-3-CH2 
(CH3h 
a CH3 OH CH3 CH3 85.08 28.45 42.84 
b CH3 H CH3 CH3 85.83 28.62 42.83 
c H Cl H H 87.46 28.07 42.75 
f H H CH=CH-CH=CH 87.53 28.63 43.86 
2 H H CH3 CH3 85.97 28.36 43.29 
h CH3 H H CH3 85.76 28.60 42.27 
. CH3 H CH3 H 86.38 28.45 41.69 I 
.i H CI CH3 H 87.36 28.05 42.55 
I H CH3 CH3 H 86.39 28.25 42.86 
m H H H CH3 85.80 28.31 43.29 
n H H CH3 H 86.61 28.19 42.61 
0 H CH3 H H 86.31 28.16 42.96 
p H OCH3 H H 86.49 28.12 43.34 
q H Br H H 87.35 27.49 42.64 
r H H H H 86.48 28.23 42.89 
Table 11 
65 
Discussion 
2.08 Mechanism of Formation of the 2,2-dimethyl-2,3-
dihydrobenzofuran (124a-r) 
Protonation of the allyl a1cohol207 by the TFA to afford 211 followed by eliminaion of 
water leads to the formation of the symmetrical carbocation 212a which undergoes 
allylic resonance resonates with 212b as shown in Scheme 43. 
)l W .. ~+ (-H2O).. ~ ~ ... ---.. A 
OH C,..OH2 + U U + 
207 211 212a 212b 
Scheme 43 
Nucleophilic attack by the phenol 28 (OH) on the carbocation 212a-212b (Scheme 
44) leads to the formation of the aryl allyl ether 20S which could rearrange by a [3,3]-
sigmatropic shift to form the ketone 214. Ketone 214 would tautomerise to the enol 
206 (to restore aromaticity). 
0.~~ ~o + .- Q;Y ( - H+) .-~7 
I I 
H H 
28 213 205 ! (3,3) 
H 
Keto - Enol .. 
" Tautomerism 
206 214 
1 
217 
124 
Scheme 44 
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Protonation of the double bond in 206 leads to the formation of either the 30 carbocation 
215 or the 10 carbocation 216. As the former would be energetically favoured, 
cyclisation by intramolecular nucleophilic attack on the more stable intermediate 
carbocation 215 and deprotonation affords the benzofuran 124. 
2.09 Mechanism of formation of the substitited 2,3-Dihydrobenzofuran. 
Martini et al133 , proposed that on acid-catalysis, the phenol (28) reacts with 
isobutraldehyde (208) to form the benzylic alcohol (218), as outlined in Scheme 45. 
Protonation of 2-hydroxybenzyl alcohol (218) with subsequent loss of water leads to 
the formation of the substituted styrene (221). Further protonation of the alkenyl phenol 
(221) leads to the intermediate 30 cation (222) which by intramolecular nucleophilic 
attack by the lone pair of the oxygen on this cation leads to the formation of the 2,3-
dihydrobenzofuran (124). 
OH 
o ~OH + h o 
28 208 218 219 
! 
« 
(H 
0 
(220) 
.. 
124 222 221 
Scheme 45 
Arduni et al238, on the other hand, has stated that the 2-hydroxybenzyl alcohols such as 
(218) can be thermally dehydrated via an ortho-quinonemethide (220) to give a 2-
alkenylphenol (221) by carrying out the reaction in hexane. The resulting 2-
alkenylphenol (221) on further protonation generates the cation (222) and 
intramolecular cyclisation to 2.3-dihydrobenzofuran (124) at room temperature using 
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catalytic amounts of polymer-supported sulphonic acid (Amberlyst 15). Further 
confirmation was afforded by Arduni et a[238, when the 2-hydroxybenzyl alcohol (218) 
was cyclised to give the 2,3-dihydrobenzofuran (124) in toluene at 80oC, also using 
amberlyst 15. 
OH OH 
+ HO~ H+ • 
OH 
28a 207 124a 
Scheme 46 
The reaction of trimethylhydroquinone (28a) with methallyl alcohol (207) has been 
investigated by both Lars et az247 and Ingold et aL57. They performed the reactions in 
anhydrous formic acid in the presence of catalytic amounts of concentrated sulphuric acid 
and isolated the benzofuran (124a) in yields of 29% and 12%, respectively (Scheme 
46). 
However, Novak et aL130 performed the reaction in the presence of toluene and p-toluene 
sulphonic acid as the catalyst and obtained benzofuran (124a) in yields of 11 %. 
In this study242, when the reaction was repeated using trifluoroacetic acid as the catalyst, 
with a reaction time of 4hrs, 124a was produced in 37% yields, together with 2-methyl 
propenyloxy- 2,3-dihydrobenzofuran (223) and the 5-phenoxyl-2,3-dihydrobenzofuran 
(224) with their respective molecular ion present in the mass spectra. 
Avo 
223 224 
Also, the reaction of 2,3,5-trimethylphenol (28b) with methallyl alcohol (207) in the 
presence of trifluoroacetic acid as a catalyst led to the formation of the expected 
dihydrobenzofuran (124b) in 35% yield, as shown in Scheme 47. 
~ II H+ • -? I 
+ HO~ ~ 
OH 
28b 207 
Scheme ~7 
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However, traces of the 1,3-dioxine (225) and an intermediate (226) were observed in 
the CI mass spectral analysis (mlz=263 and mlz=337, M+ 1, repectively). 
x 
225 226 
Novak et al130 have proposed a mechanistic route for the formation of compound 225, 
and 226 (Schemes 48 and 49). The acid-catalysed reaction between 28b and 207 
forms the allyl ether 227, which then undergoes a [3,3] sigmatropic rearrangement, 
tautomerism, protonation of the double bond in 228, and subsequent cyc1isation to 
produce 124b. 
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OH 
28b 
228 
!H+ 
OH 
229 
.~(+O A 
234 
x 
225 
+ 
H 
Discussion 
+ HO~ [3,3] .. 
207 227 
124b 
- (H+) H+ 
... .. 
OH 
230 231 
1 [207] 
X ~ 
233 232 
Scheme 48 
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The acid-catalysed shift of the double-bond in (228) into conjugation with the benzene 
ring (via carbocation 229) leads to the formation of 2-methylpropenyl phenol (230). 
Protonation of the double bond in 230 affords the 20 carbocation (231). Nucleophilic 
attack by the allylic alcohol (207) on this cation forms 232 which on further acid-
catalysed double bond migration gives 233. Protonation of the double bond in 233 
generates the 20 carbocation (234) and subsequently undergoes intramolecular 
cyclisation to give the 1,3-dioxine derivative (225). 
Novak et al130 also proposed that the styrene 230 on acid-catalysed addition of phenol 
(28b) via cation 231 could generate the phenoxylpropyl phenol 235. On [1,3]-
sigmatropic migration of the side chain in the phenoxylpropyl phenol (235) gives the 
intermediate 226 and subsequent elimination of water affords the xanthene 199, as 
outlined in Scheme 49. However, the xanthene (236) was not observed in this 
study_ 
OR 
230 
28b 
.. 
236 226 
Scheme 49 
Due to the acidic conditions used, an alternative mechanism for the formation of 
intermediate 236 could involve direct aromatic electrophilic substitution between 28b 
and 207 to afford 228. Acid catalysed double-bond migration in 228 gives 2-methyl-
isopropenyl phenol (230). Further acid catalysis affords the cation 231 and 
electrophilic substitution reaction between the intermediate 231 and the substituted 
phenol (28b) gives (226), as outlined in Scheme 50. 
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+ 
HO~ + {H~ • Y (- H2O) OH 
28b 207 28b (- H+)! 
(H~ i. (H+) 
... .. 
ii. (- H~ 
231 230 228 
! 
231 28b 226 
Scheme 50 
In summary, it is proposed that the mechanism of formation of the dioxine (225) 
(Scheme 48, p.70) and the intermediate 226 (Scheme 50) in this study, is identical 
with that proposed by Novak et a1130• 
2.10 Spectral analysis of substituted 2,3-Dihydrobenzofurans (124) 
The mass fragmentation patterns observed in the mass spectra of these compounds were 
consistent with their proposed structures. The benzofuran 124b could lose a methyl 
radical to form the oxonium ion 237 (which is resonance stabilised). From either 
canonical form, a fUlther loss of a methyl radical could afford 242 as shown in Scheme 
51. 
These characteristic fragmentation patterns were observed in all of the 2.3-
dihydrobenzofuran derivatives (124a-r). 
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124b 237 238 
(m/z = 190, 82%) (m/z = 175,100%) 
rCH3) 
239 241 
(mlz = 160, 12%) 
1 I 
240 242 
(m/z = 160, 12%) 
Scheme 51 
Besides the expected 2,3-dihydrobenzofuran (124a-r), the formation of ortho and para-
(2-methylpropenyl)-2,3-dihydrobenzofurans (209) was observed. The formation of 
these by-products depended on the substitution pattern in the initial phenol (Table 12). 
210 
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Compd. RI R2 R3 R4 
209b CH3 * CH3 CH3 
209c H CI H CHC(CH3h 
209f H * CH=CH-CH=CH 
209g H * CH3 CH3 
209h CH3 * H CH3 
209i+ CH3 * CH3 H 
209j CH3 CI CH3 CHC(CH3h 
2091 H CH3 CH3 CHC(CH3h 
209m H * H CH3 
2090++ H * CH3 H 
2090 H CH3 H CHC(CH3h 
209p H OCH3 H CHC(CH3h 
209q H Br H CHC(CH3h 
209r H * H H 
Table 12 : [*] CHC(CH3)2' [+] 243i exists as an isomer of 209i where R2=H, R4 = 
CHC(CH3)2' [++] 2450 exist as an isomer of 209n where R2= H, R4 = CHC(CH3)2 . 
For example, the allylic carbocation 212 can attack the 2,2-dimethyl-2,3-
dihydrobenzofuran (124i) at the 2-position or at the 4-position in the aromatic ring to 
afford the para-(2-methylpropenyl)-2,3-dihydrobenzofuran (243i) or the ortho-(2-
methylpropenyl)-2,3-dihydrobenzofuran (244i), respectively. The ortho- or the para-
(2-methylpropenyl)-2,3-dihydrobenzofurans (244i or 243i) on acid catalysis can afford 
the positional isomer 245i or 209i, respectively, as outlined in Scheme 52. 
C H3 
~2 ~ }-+ 18 
212~4 
124i 
-< 
243i 
CH3 
H3 C 
244i 
Scheme 52 
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The proton NMR spectra of the isopropenyl-2,3-dihydrobenzofuran derivatives (209i) 
were consistent with the proposed structures. These products were isolated by high 
vacuum distillation. 
1.56 ppm 1.89 ppm 
\ / 
243i 209i 
The IH NMR spectrum of isopropenyl-2,3-dihydrobenzofuran (209i) is typical of the 
isopropenyl-2,3-dihydrobenzofurans derivatives (209) showing the characteristic 
vinylic proton resonating at around 5.95 ppm, and the two methyl singlets resonating at 
1.56 ppm and 1.89 ppm, respectively. However, the other possible isomer of 209i, 
namely 243i, was not detected in the IH NMR spectrum as the two vinylic proton 
signals required for this isomer were absent. The GC-MS analysis showed the presence 
of a single peak confirming the presence of just one isomer. 
The ortho and para-isopropenyl-2,3-dihydrobenzofurans (2450, 2090) (Martini133 
Route B, p.60) reacted further (via carbocations 248 and 246, respectively) with the 
corresponding phenol (280) in an acid catalysed reaction to afford the 2-methyl-l-p-
tolyloxypropyl-2,3-dihydrobenzofurans (2470) and 2-methyl-l-o-tolyloxy-propyl-2,3-
dihydrobenzofurans (2490) as outlined in Scheme 53, respectively. 
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2090 2460 
para-Isomer 
2450 
ortho-Isomer 
r+ 
•• ~OH 
-V 2480 
280 
Scheme 53 
o 
2470 
(m/z = 324) 
2490 
(m/z = 324) 
This was further substantiated by the GC-MS analysis, which showed two peaks, having 
the retention time 27.59 min and 27.84 min, respectively, and both having the same mass 
(m/z=324) and could be attributed to 2470 or 2490. A further two peaks were 
observed with the retention time of 20.06 min and 29.01 min, again both having the 
same mass (m/z=378) which could possibly be attributed to 2500 or 2510. 
o 
~ 
2500 
(m/z = 378) 
~ ~o 
2510 
(m/z = 378) 
Similarly, the ortho-isopropenyl-2,3-dihydrobenzofuran (2090) reacted with the 
corresponding phenol (280) to afford the ortho-tolyloxypropyl-2,3-dihydrobenzofuran 
(2520). The ortho-isopropenyl-2,3-dihydrobenzofuran (2090) also reacted in an 
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acid-catalysed reaction with the phenol (2530) to afford 2540 as outlined in Scheme 
54. 
2090 
2540 
(mJz = 378) 
~ 
+ ~OH 
280 
Scheme 54 
2520 
(mJz = 324) 
The GC-MS analysis showed the presence of two peaks, having the retention time 25.53 
min and 27.39 min, respectively, and both having different mass (m/z=324 and 
m/z=378) and could possiblybe attributed to 2520 and 2540. 
2.11 Mechanism of formation of isopropenyl-2,3-dihydrobenzofuran 
(209b-r) 
There are two possibilities as to how the isopropenyl-2,3-dihydrobenzofuran 209 may 
be formed (Routes X and Y, in Scheme 55). Firstly, Route X (see Scheme 55 on 
p.78 for mechanism) shows the formation of benzofuran 124 which is further attacked 
by electrophilic aromatic substitution by the ally lie carbocation on C-5 position to form 
isopropenyl-2,3-dihydrobenzofuran (209). If this position is not available then the 
carbocation can attack by electrophilic aromatic substitution at the C-7 position. 
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207 
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Tautomerism 
restoration of 
aromaticity 
OH 
256 
Scheme 55 
7 
124 
Route X 
209 
1 
257 
Secondly, it is possible that the allylic carbocation derived from 207 electrophilically 
attacks the phenol (28) at the para-position to afford the para-alkylated ketone (255) 
which rearranges to form the para-alkylated phenol (256), followed by cyclisation to 
give 209 (Route V). Route X would be favoured over Route Y because it is 
possibly obtained by alkylation in a one step process from the 2,2-dimethyl-2,3-
dihydrobenzofuran (124) which is stable (retains aromaticity). However, if the reaction 
proceeds by Route Y then the alkylated ketone 255 could be trapped by means of a 
Diels-Alder reaction 248. 
Generally, in unsaturated systems double bonds can be reduced by catalytic 
hydrogenation where the catalyst can be a metal such as palladium (Pd), nickel (Ni), 
etc249 . 
Besides the expected 2,3-dihydrobenzofuran (124a- r), 0 rth 0 and pa ra - (2-
methylpropenyl)-2J-dihydrobenzofurans (209), the isopropyl-2.~-dihydrobenzofurans 
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(210) were also observed. The isopropyl-2,3-dihydrobenzofurans (210) could be 
formed by ionic hydrogenation of (209) via the cation (258) as shown in Scheme 56. 
H 
(Protonation) 
209 258 
Scheme 56 
(Hydride 
source H) 
.. 
210 
This is usually observed in reactions in which hydrosilanes function as a selective 
reducing agent250 such as in the conversion of alcohols to carbocations by acid-catalysis, 
followed by reduction of carbocation by means of a hydride donor, such as a 
hydrosilanes25o (though other reducing agents agents heve been used251-254). This 
process is known as 'Ionic Hydrogenation'. However, in this study it was difficult to 
state what the hydride source was. One possible source could be silicon grease which 
was used to seal the apparatus in the experiment led to the formation of 210. 
The presence of a number of isopropyl-2,3-dihydrobenzofurans (210) as listed in 
Table 13, formed by Routes A and B (see Scheme 41, p.60) were not isolated in 
some cases but detected mainly by GC-MS and in others by 1 H NMR spectroscopy. 
210 Rl R2 R3 R4 
b CH3 * CH3 CH3 
c H CI H CH2CH(CH3h 
i CH3 * CH3 H 
j H CI CH3 CH2CH(CH3h 
0 H CH3 H CH2CH(CH3h 
r H * H CH2CH(CH3h 
Table 13: * CH2CH(CH3)2 
However, the % figures of the isolated isopropyl-2,3-dihydrobenzofurans (210g-n) are 
shown in Table 14. 
210 
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B.pt [OCI Yield B.pt [OCI Yield 
210 RI R2 R3 R4 torr] a (%)a torr]b (9c )b 
g H * CH3 CH3 116-120 I 12 NIR NIR 
0.16 
h CH3 * H CH3 124-127 I 16 96-110 I 6 
0.1 0.06 
jC CH3 * CH3 H N/R Nil N/R NIl 
j H Cl CH3 CH2CH(CH3h N/R Nil N/R NIl 
I H CH3 CH3 CH2CH(CH3h 72-76 I 8 N/R NIl 
0.13 
m H * H CH3 60-64 I 36 60-64 I 2 
0.20 0.22 
od H * CH3 H 64-68 I 3 116-120 I 11 
0.20 0.43 
Table 14 : * CH2CH(CH3)2' [a] Obtained by Route A, [b] Obtained by Route B, [c] can exist as an 
isomer of 210i, where R2=H, R4=CH 2CH(CH3 )2' [d] 2100 can exist as an isomer where R2=H, 
R4=CH2CH(CH3)2' N/I=not isolated, NIR=not reported. 
As a typical isopropyl-2,3-dihydrobenzofuran spectrum, the IH nmr spectrum of 210g 
is summarized in Table 15. 
The proton on carbon-2' (C-2'-CID in 210g exhibits a typical pattern of an A6X system 
(CH(CH3h). The methylene protons on carbon-I' (C-1 '-CH2) showed a doublet at (9.0 
Hz) due to the splitting of the proton on carbon-2' (C-2'-CID. The methylene protons 
(C-3-CH2) in 210g showed a singlet and resonated at around 2.94 ppm. The geminal 
dimethyl groups on carbon-2 (C-2-CH3h) appeared as a singlet at around 1.46 ppm. 
2' 
210g 
Compd H-2 H-3 H-4 H-5 H-6 H-7 H-l' H-2' H-2' 
210g (CH3h (CH2) (Ar-H) Ar-C) (Ar- (Ar- (C-1 '- (CH3h (C-2'-
- CH3) CH3) CH2) CH) 
1.43 2.94 6.71 2.12 2.13 2.39- 0.88- 1.75-
2.42 0.92 1.78 
Table 15 
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The mass spectral analyses were consistent with the proposed structures of all the 
isopropyl-2,3-dihydrobenzofurans in the series. 
In summary, 2,2-dimethyl-2,3-dihydrobenzofurans were prepared by two synthetic 
routes. Firstly, by Route A, in a one-pot synthesis using trifluoroacetic acid (TFA), 
where it acts as both the solvent and as the catalyst242. This reaction is thought to 
proceed via 3,3-sigmatropic rearrangement and has the advantage of using simple 
reaction conditions. It is convenient and has produced low to moderate yields (4-32%). 
Secondly, by Route B, using the method of Martini133 where phenols were condensed 
with isobutyraldehyde in the presence of toluene and concentrated sulphuric acid to 
afford 2,3-dihydrobenzofurans in low to high yields (4-84%). Here the solvent and the 
catalyst were different compared to the former method. Nevertheless, the reaction is 
thought to proceed initially via ortho-alkylation of the phenol (regioslectively), only in 
selected phenols. However, in this study, some polyalkylation of the 2,3-
dihydrobenzofurans does seem to occur using the two methods (Routes A and B) 
stated in Scheme 41 (p.60). 
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2.12 Synthesis of substituted 5-Amino-2,3-dihydrobenzofurans and 
substituted 6-Amino-3,4-dihydrobenzopyrans 
Tocopherol (1), and the substitued 2,3-dihydro-2,2,5,7,8-pentamethylbenzofuran 
(124a) are known to be efficent inhibitors of lipid peroxidation in vivo58,255. Recently, 
these compounds have become the focus of attention for investigators in the treatment of 
traumatic and ischemic central nervous system (CNS) injury256-258. It is proposed that 
the reactive oxygen radicals which are commonly formed in normal cell metabolism and 
subsequent lipid peroxidation are a factor which contribute to CNS trauma and 
ischemia259. Under normal condition their production is localised by the body's natural 
defenses including antioxidants (A, C, and E), glutathione, superoxide dismutase (SOD), 
and catalase which protect against the damaged caused by oxygen radicals26o. However, 
under pathological conditions, these systems can be overwhelmed and the generation of 
these radicals enhanced261 . Lipid peroxidation initiated by these oxygen radicals results 
in membrane degradation and cell death. Therefore, the synthesis of these compounds 
which are capable of reducing post-traumatic tissue damage, and which enhance 
neurological recovery is of interest. Recently, Ohkawa et aL262 have shown that the 5-
amino-2,3-dihydrobenzofuran (260) was effective against the degradative processes 
mentioned above. 
1 
1 R = C16H33 
82a R=CH3 
259 
R 
124a 
260 
Introduction of the amino group (in place of the hydroxyl group) in the model (J.-
tocopherol compound 259, and in the 2,3-dihydrobenzofuran (260) would be expected 
to improve the hydrophilicity and the metabolic stability of the compounds. 
The 5-coumaranoxyl (263) and 6-chromanoxyl (261) radicals formed by reaction of 
(82a) and (124a) with peroxyl radicals are reported to be stabilised by the unpaired 
electron on the p-type lone pair of oxygen in position 1 and SOMO of the phenoxy 
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radical attached at position 6 by conjugative electron delocalisation56 to afford (264) and 
(262), as outlined in Scheme 57. 
.. 
82a 262 
• (ROO) 
• 
124a 263 264 
Scheme 57 
The same effect is expected in the case of the 5-coumaranaminyl radical (267) and 6-
chromanaminyl radical (265), generated in the same way from (259) and (260) by 
peroxyl radicals, as shown in Scheme 58, since the amino group like the hydroxyl 
group can also donate an electron, and hence stabilise the oxygen radical263. 
H 
I 
• 
• N (ROO) 
• .. 
259 265 266 
• (ROO ) .. .. 
260 267 268 
Scheme 58 
Electron-donating substituents such as methyl groups264 should also enhance the 
antioxidant activity due to the stabilization of the aminyl radical making methyl 
substituted 2,3-dihydrobenzofurans and 3,4-dihydrobenzopyrans potentially better lipid 
peroxidation inhibitors. 
Synthetic routes to the methyl substituted 5-aminobenzofuran (260) and 6-
aminobenzopyran (259) were investigated, with the intention of making them one pot 
syntheses. The 2,3,5-trimcthylphenol (28b) was converted into formylamino-2.3,5-
trimethylphenol (270) utilizing a slightly modified method of Smith ef af265 in which the 
phenol (28b) was dissolved in methanol, in the presence of excess NaOH prior to C-
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coupling using diazotised sulphanilic acid. The resultant azo-compound was reductively 
cleaved by the action of sodium hydrosulphite to produce the aminophenol (269). 
Smith et af265 found that this method of preparing the aminophenol (269) was superior 
to that of Claisen266, which involved nitrosation of the phenol (28b) and reduction of 
the nitrosophenol to the aminophenol (269). Formylation of 4-aminophenol (269) 
resulted in the formation of the N-formylaminophenol (270) as outlined in Scheme 
59. 
i-iii iv 
OH OH OH 
28b 269 270 
i) MeOH, NaOH, ii) Sulpbanilic acid, NaN02, HCl, DoC, iii) Na2S204, iv) HC02H, reflux. 
Scheme 59 
Previous syntheses of 5-aminocoumaran (260), by Cruickshank et al267 , involved the 
methallylation of the phenol (269) using methallyl chloride and potassium carbonate as 
the base, to give the corresponding ether. Claisen rearrangement of the ether in N,N-
diethylaniline or N,N-dimethylaniline afforded the C-methallylated compound. This was 
cyclised in methanol under acidic conditions or in the presence of magnesium chlOlide to 
afford (260). Deprotection of the formamide or acetamide group afforded the 
cOlTesponding 5-aminocoumaran267. 
Therefore, 5-formylamino-2,3-dihydro-2,2,4,6-7-pentamethylbenzofuran (271) was 
synthesized using three different methods all involving one pot syntheses, as outlined in 
Scheme 60. 
Using method A, (Martini et al133) the phenol (270) was reacted with isobutyraldehyde 
(208) in the presence of toluene and catalytic amounts of concentrated sulphuric acid to 
form the 5-formylamino-2,3-dihydro-2,2,4,6-7-pentamethylbenzofuran (271) in 
moderate yields (53%). The moderate yield can be accounted for by the limited solubility 
of the phenol (28b) in toluene: prolonged heating under reflux did not increase the 
yield. 
Using method B (Smith et all to), the 5-formylamino-2,3-dihydro-2,2,4,6-7-
pentamethylbenzofuran (271) was produced in high yield (87%), when anhydrous 
formic acid was used. However, longer reaction times 22hrs were required. Using 
TFA242 (Method C) the 5-formylamino-2,3-dihydro-2,2,4,6-7-pentamethylbenzofuran 
(271) was produced in excellent yields (73%). 
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lOH Method B (87%) 
207 
+ 
H H I I 
HyN 
+ h (Method A} .. HyN 0 (53%) 0 OH 0 
270 208 271 
+ I t:H (Method C) (73%) 
207 
Scheme 60 
The hydrolysis of the formyl group was accomplished by heating the formylamino 
compound (271) under reflux with methanol in acidic conditions262, (Scheme 61). 
35% ago HCI-MeOH (1:1, v/v) 
reflux, 2 hrs 
271 260 
Scheme 61 
Since a-tocopherol (1) is an oil, its conversion into a solid derivative of high biological 
activity would be of advantage. Solid derivatives of a-tocopherol (1) are limited in 
number, and the easiest of these to prepare are the allophanate and the 3,5-
dinitrophenylurethan which unfortunately are not suitable for biological purposes268 . 
The 6-amino-3,4-dihydrobenzopyran (259) an analogue of the model compound 82a 
should form a solid salt and hence might offer a highly effective radical-trapping agent 
which could retard the rate of oxidative degradation of organic materials of commercial 
and biological impOitance269 . 
Thus, several one-pot syntheses of the fOimyl protected 6-amino-3,4-dihydrobenzopyran 
(274) were attempted (Scheme 62). 
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The reaction of the formyl protected aminophenol (270) with various allylic alcohol 
(273 and 199) and the diene (81) under acidic conditions gave the corresponding 6-
formylamino-2,3-dihydrobenzopyran (274) in good yields (63, 69, and 74% 
respectively). 
The reaction between phenol (270) and isoprene (81) under acidic conditions afforded 
273 together with the deprotected amine (259) in low yields (17%) (Method D). It 
was thought that the amine (259) was susceptible to deprotection and on standing 
oxidised to the oxa-imine (272). It was therefore, converted to the more stable formyl 
derivative (273). 
H 
Oxidation 
... 
Reduction 
259 272 
This was also observed in Method E where the amine (259) was obtained in 35% 
yield. 
270 
:t 
OH 
273 
+~ 
OH 
81 
OH 
199 
(Method E) 
(Method D) 
(Method F) 
Scheme 62 
274 R=NHCHO 
259 R=NH2 
1 
However, the reaction of the formyl protected aminophenol (270) with the allylic 
alcohol (273) by heating under reflux in trifluoroacetic acid for 4 hours (Method F) 
afforded the desired compound (274). 
The i.r. spectra of the substitued 5-amino-2,3-dihydrobenzofurans and the substituted 6-
amino-3,4-dihydrobenzopyrans were consistent with the proposed structures. They 
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showed typical bands for N-H stretching at 3258 cm- I , a sharp doublets was observed 
between 1696 and 1660 cm- 1 corresponding to the amide C=O stretching and N-H 
bending, respectively. 
The proton NMR spectra of N-formyl groups have been extensively reported27o. The 
classical case is the proton NMR spectrum of dimethylformamide taken at various 
temperatures. At room temperature, it shows two sharp singlets at 2.84 ppm and 3.0 
ppm for the N-methyl protons. Whereas, at higher temperature the two sharp singlets 
broaden and coalesce. This is because Tt-bonding between the nitrogen atom and the 
carbonyl carbon atom slows the rotation about this bond as shown in Scheme 63. 
~, r. .,CH3 0 + ,CH3 
C---i... N ...... I------'.~ \ ., N 
'\ ;-==. , 
H CH3 H CH3 
275 276 
\----..... ,-----) Y 
0, CH3 
)
' I .---.~ 
H + CH3 
Scheme 63 
A similar effect can be observed in the proton nmr spectra of the N-monosubstituted 
formamide (271). Due to the restricted rotation about the C-N bond caused by the 
partial double bond character between the nitrogen atom and the carbonyl carbon atom in 
the resonance hybrid (277), the hydrogen on the carbon can either be cis to the NH 
proton (278b) or trans to the NH proton (278a), which in turn can result in the non-
equivalence of the two hydrogens on the C-N atoms, producing four deshielding 
hydro gens (doublets) in a different chemical environment, as shown in Scheme 64270. 
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Resonance hybrid 
H H 
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C=N 
... • -0 + 
Scheme 64 
278b 
cis to NH 
This has also been observed in amide grouping present in polypeptide 
macromolecules271 , where almost invariably the -C=O and -N-H bonds are parallel or 
nearly parallel and so, there is little twisting about the C-N bond. The atoms 0, C, N 
and H are reported to be nearly coplanar because the peptide bond has substantial fraction 
of double bond character. 
Alternatively, Potapov et al272 have shown that amides (including monosubstituted 
amides) can also exihibit tautomerism. For example, the N-monosubstituted amide 
(27tb) can undergo tautomerism to give its iminol form (279a) or (279b) which in 
turn can also result in the non-equivalence of the two hydrogens on the C-N atoms, 
producing four deshielding hydrogens (doublets) in a different chemical environment 
(Scheme 65). 
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27tb 279a 
or H 
279b 
Scheme 65 
From the proton NMR of (271) two sets of geminal dimethyl groups and methylene 
protons were observed around 1.46-148 ppm and 2.93-2.94 ppm, respectively. The N-
formyl group showed a very broad singlet resonating at around 6.83 ppm (N-H, D20 
exhangeable (no coupling observed), a broad doublet resonating at around 6.89-6.94 
ppm (N-H, 3JH_H=12.5 Hz, D20 ecxhangeable), a sharp doublet between 7.94-7.99 ppm 
(CHO, 3JH_H=12.5 Hz) and a very sharp doublet around 8.39-8.40 ppm (CHO, 3JH_ 
H=1.6 Hz). The latter two doublets, on the addition of deuterium oxide showed two 
singlets. This indicated that two compounds were present in the proton NMR spectrum, 
in the ratio of 1 : 1 (by evaluating the integral steps of the 1 H NMR spectrum). 
In N-monosubstituted amides, the trans conformer (280b) has been shown to be 
strongly preferred over the cis conformer (280a)273. It is noteworthy, however, that 
even the bulky phenyl group strongly prefers to be cis to the carbonyl group (280a) 
rather than to the much less sterically demanding hydrogen as in (280b), (Scheme 
66). 
Ha 
I 0yN 
Hb I 
280b 
(10%) 
3JH_H = 11.0 Hz 
oc 
Scheme 66 
280a 
(90%) 
3JH_H = 2.0 Hz 
The proton Hb has been quoted to resonate between 8.2 ppm and 8.7 ppm while the 
proton Ha can resonate between 7.5 ppm and 9.5 ppm274. 
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If the amide (271) was to exhibit tautomerism, from the proton nmr spectrum, the 
conjugated iminol form (279a or 279b) would be strongly favoured over the non-
conjugated form (271) to give a 2: 1 or 3: 1, or whatever, ratio but not 1: 1 ratio. So, it is 
unlikely that the amide-iminol tautomerism would be favoured in this case. The only 
other possibilty would be the cis and trans conformation (Scheme 67), even though the 
trans conformation (271a) as discussed earlier, would be favoured over the cis 
conformation (271b). It is possible that the bulky 2,3-dihydrobenzofuran substituent 
on the N-formyl group may force the cis conformer (271b) to exist in equilibrium with 
the trans conformer (271a), in 1: 1 ratio (see Appendix for spectrum). 
H H 
I I 
0yN .. .. HI(N 
H ° 
271a 271b 
(50%) (50%) 
3JH_H = 12.5 Hz 3JH_H = 1.6 Hz 
Scheme 67 
The 1 H nmr spectrum of 274 was consistent with the proposed structure and also 
showed the presence of the cis conformer (274a) and trans conformer (274b) in 1:1 
ratio (Scheme 68). 
H 
274a 
CIS 
H 
I 
... 0yN 
:::::;"';::=:=:=========~ H 
Scheme 68 
274b 
trans 
Mass spectral analysis of 5-formylamino-2,3-dihydrobenzofuran (271) was consistent 
with its proposed structure. The mass fragmentation pattern is proposed in Scheme 
69. Initially, eNO cleavage of the molecular ion (271) leads to the formation of 281 
which could be resonance stabilised (the oxonium ion, (282»). The loss of the 
fOlmylated amino group from (271) leads to the cation (283), which on rearrangement 
forms the stable tropylium ion (284). 
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271 281 282 
(m1z=233, 100%) (m1z=204, 54%) 
- NHCHO· o .. 
283 284 
(m1z= 188, 52%) 
Scheme 69 
The mass spectrum for compound 274 was consistent with its proposed structure. 
Several possible mass fragmentations are outlined in Schemes 70 and 71. 
Firstly, the mass fragmentation pattern for 274 shows that a loss of a formyl radical 
eCHO) could lead to the formation of cation (285) which could be resonance stabilised 
(the oxonium ion, 286). 
Secondly, direct loss of the N-formylated amino group from the molecular ion (274) 
could afford cation (287) which on rearrangement could give tropylium ion (288), as 
outlined in Scheme 70. 
H 
I :+. I 
(M-29) • 
• (- CHO) 
274 285 286 
(m/z=247. 100%) (m1z=218,8%) 
-NHCH~ 0 • 
287 288 
(m!z=202,350/(') 
Scheme 70 
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A third possiblity is the fragmentation shown in Scheme 71, could result from the loss 
of an alkene from the molecular ion (274) via a retro-Diels-Alder fragmentation (without 
hydrogen abstraction) to give the oxonium (289) which on rearrangement gives the 
tropylium ion (290). Expulsion of carbon monoxide results in the formation of 291. 
Fourthly, a retro Diels-Alder with H-abstraction could form the oxonium ion (292) 
which could on form the cation 293. Rearrangement of 293 leads to the formation of 
the tropylium ion (294). 
274 
(m1z=247, 100%) 
• 
289 
(m1z=191,47%) 
(M-55) (Loss of CH2=CCH2CH3) 
H 
I 
HyN 
o 
292 
(m1z= 192,68%) 
1 
H 
I 
HyN o 
o 
293 
Scheme 71 
o 
(M-28) (M-CO) 
291 
(m1z= 163, 14%) 
OH 
294 
The mass fragmentation pattern of amine 259 was consistent with its proposed structure 
and is outlined in Scheme 72. A retro-Diels-Alder fragmentaion of 259 (without H-
abstraction) leads to the formation of 295. Expulsion of carbon monoxide from 295 via 
296 leads to the stable aromatic ring containing ion (297). Alternatively, a retro-Diels-
Alder (with H-abstraction) leads to the cation (298) which on rearrangment forms the 
tropylium ion (299). 
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OR 
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Scheme 72 
(M-28) 
(- CO) 
Rearrangement 
296 
297 
In summary, the spectral data for the monosubstituted formamide (271), (274) and 
(259) is consistent with the proposed structures. 
2.13 Mechanism of formation of 6-Formylamino-3,4-dihydrobenzopyran 
(274) 
The tertiary carbocation (181) which could be resonance stabilised by the primary 
carbocation (180), was generated from the allylic alcohols (273and 199), under acidic 
conditions with the elimination of water or via protonation of the diene (81), as outlined 
in Scheme 73. 
~ 
OR 
273 
+ ~ .. Allylic ~ ~ 
" 
81 181 
3° 
+ 
Favoured 
199 0H 
Scheme 73 
93 
Discussion 
The reaction steps involved the initial formation of the corresponding methallyl ether 
(300), deprotonation of 300 affords 301. Claisen rearrangement to the ketone 302 
which tautomerises to its enol form (304) (a three step process 302·304), Protonation 
of the the alkenic double bond in (304) affords the tertiary cation (305) and finally 
cyclisation to the desired compound 274 via protonation of (306). Similar mechanisms 
(Scheme 74) are proposed to apply in all the related syntheses. 
0: ~--.~ 
.~ 
270 181 
302 
.. 
274 
H 
303 
Keto - enol Tautomerism 
306 
Scheme 74 
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.. 
I rearr. UK Claisen D. 
o 
301 
H 
304 
305 
In conclusion, 5-formylamino-2,3-dihydrobenzofurans have been synthesized using 
several different methods, in one pot syntheses. The method of Martini et al l33 gave 
moderate yields (53%) where toluene was used as the solvent and concentrated sulphuric 
acid was the acid catalyst. The method of Smith et all 10 provided good yields (879r) 
however, longer reaction times were required (22 hrs). The method involving TFA242 
also gave good yields (73%) with shorter reaction times (4hrs). The advantage of this 
method was that trifluoroacetic acid (TFA) acted as both the solvent and as the catalyst in 
the reaction. 
A similar methodology was employed in the syntheses of 6-formylamino-3A-
dihydrobenzopyrans using N-formylaminophenol which was condensed with the 
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appropriate allylic alcohols and diene using a number of acidic catalysts. All the 
methodologies used produced good yields of the desired compound. However, in some 
cases this resulted in the deprotection of the formyl grouping to yield the 6-amino-3,4-
dihydrobenzopyrans (35%). 
The 5-formylamino-2,3-dihydrobenzofurans and 6-formylamino-3,4-
dihydrobenzopyrans exhibited cis-trans isomerism. This was evident from the proton 
NMR spectra. 
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2.14 Syntheses of substituted 3,4-Dihydro-2,2,4-trimethylbenzopyrans 
(309) 
3,4-Dihydrobenzopyrans containing substituents at the C-4 position (of which 
chromakalin (307) is an example), along with many other analogues have been shown to 
be potassium channel activators or openers275-277. This class of compounds has attracted 
considerable attention because of the evidence for their potential in the treatment of those 
disorders in which smoothe muscles contraction is involved. Besides providing active 
antihypertensive agents, it has been established that potassium channel activators have 
potential for use in the treatment of bronchial asthma, and certain analogues have been 
shown to be potent relaxants of guinea pig trachealis in vitro278• Also, compounds like 
Robustadial A (308) which contain the 3,4-dihydrobenzopyran moiety have been shown 
to be effective in the treatment of malaria279. 
~o 
NC 
.,\\OH 
CH3 
CH3 
307 
HO 
CH3 
124a 
CH3 
CH3 
82a 
HO 
OHC 
CH3 
309a 
Secondly, 3,4-dihydrobenzopyran (82a) and 2,3-dihydrobenzofuran (124a) have been 
shown to be efficient inhibitors of lipid peroxidation in vivo57 . The latter (124a) is 
known to be a supelior antioxidant to 82a225 . With this in mind it was decided to 
investigate the further possibility of enhancing the antioxidant activity of 82a by 
introducing a methyl group at the 4-position. This should cause the ring to exert a 
stereoelectronic effect by constraining the ring oxygen in such a manner that its p-orbital 
lone pair is better able to stabilize the developing phenoxyl radical and hence, make it a 
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better antioxidant. Earlier syntheses by Bridge et al143 and later by Baker et af280 of 3,4-
dihydro-2, 2, 4-trimethylbenzopyrans involved the condensation of phenol (28r) with 
3,3-dimethylacryloyl chloride (310) to afford the chromanone (311). On reaction with 
Grignard reagents these afforded the alcohol (312), subsequent dehydration of which 
gave 223, which in tum gave the desired compound 309 (Scheme 75). The overall 
yields were inevitably low with five steps being involved. 
o 0 
O~ +Cl~ # OH CH3 CH3 
28r 310 
Nitrobenzene 
24 hrs, R.T. 
c. H2S04 I Dehydratio~ 
312 
Scheme 75 
Pd-charcoal I H ~ 
2 
Ether 
The 3,4-dihydro-2,2,4-trimethylbenzopyrans (309) were synthesised in a one-pot 
synthesis by reacting the appropriate phenol (28) with 2-methyl-2,4-pentanediol (314) 
in the presence of a 1:3 mixture of concentrated sulphuric and concentrated acetic acid at 
room temperature or at reflux temperature, using the method of Ryu et af241 , (Scheme 
76). The results are summarized in Table 16 (on p.97 and p.98). 
Rl 
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a CH3 
b CH3 
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e CH3 H CH3 H 39 
f H CI CH3 H 40 
g H H CH3 CH3 42 
. H H CH3 CH3 9 I 
j H CH3 H H 5 
k H OCH3 H H 18 
I H Br H H 7 
m OH H OH OH 4 
0 CH3 N02 CH3 CH3 74 
Table 16: [b] = observed in GC-MS analysis only. 
Compound 3090 was obtained by nitration of 309b using concentrated nitric acid in 
acetic acid at 0°C281. 
Compounds 309a, 309b and 309f gave moderate yields. On several occasions 309d, 
309g, 309h, and 309k were reacted further with 314 via acid promoted cyclisation to 
afford the novel 315d, 315g, 315h, and 315k, in moderate to good yield (see page 
95). The additional hydroxyl group available at the 6-position in 309m reacted further 
with 314 to afford the double chroman 316m. 
315h 
98 
315d 
OH 
316m 
315k 
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Their ir spectra were consistent with their proposed structures, showing several bands at 
2970-2840 cm-1 corresponding to the aliphatic C-H stretch, bands around 1600-1578cm-
1 corresponding to the C=C benzene ring stretching, and around 1250 cm- 1 
corresponding to the C-O stretch of the ether linkage. Their nmr spectra showed that the 
geminal methyls at C-2, and the geminal hydrogens at C-3 were magnetically non-
equivalent. This non-equivalence has also reported by Nowakowska et a[282 who stated 
that its was due to the heterocyclic ring in 309 being non-planar. The geminal coupling 
constants of approximately 13 Hz, and the 3J vicinal coupling constants of 6.6 Hz are 
entirely consistent with the structures for 309a-309m. Nowakowska et a1282 stated that 
in the unsubstituted compound 309 (where RI-R4=H) only one proton gave a doublet; 
coupling of the second proton was not observed. Both of the methylene protons on 
carbon-3 axial appeared as doublet of doublet for compounds 309a, b, d, e, g and m. 
The carbon at C-4 in 309a-m shows a doublet at around 26.4 ppm. The proton 
chemical shifts for compounds (309a-m) are documented in Table 17 below. 
A study performed by Milstein and Cohen283,284 on the rate of lactonization of 0-
hydroxyhydrocinnamic acid and its methyl derivatives have shown that the substitution of 
hydrogen by groups such as CH3 on the ring or the side chain of the 0-
hydroxyhydrocinnamic acid has conformationally restricted the molecule Ctrialkyllock') 
such that it promoted rapid lactonization. However, it is proposed that the groups on C-
2, C-3 and C-4 interlock in such a way that it conformationally restricts the molecules 
(trialkyllocks) such as in 309a-m (nmr evidence). As a result the methylene protons on 
C-3 and the methyl groups on C-2- (CH3h are chemically non-equivalent. 
309 
309 C-2-CH3 C-2-CH3eo C-3-H C-3-H C-4-CH3 C-4-H ax ax eQ 
a 1.15 1.41 1.67-1.75 1.95-2.03 1.24-1.27 2.97-3.11 
(s) (s) (dd) (dd) (d) (m) 
b 1.18 1.42 1.67-1.74 1.94-2.02 1.30-1.27 2.95-3.09 
(s) (s) (dd) (dd) (d) (m) 
c 1.22 1.38 1.47-1.56 1.76-1.84 1.28-1.31 2.80-2_95 
(s) (s) (t) (dd) (d) (m) 
d 1.33 1.42 1.58-1.65 1.90-2.00 1.22-1.25 3.16-3.20 
(s) (s) (dd) (dd) (d) (m) 
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e 1.22 1.39 1.67-1.75 1.92-2.04 1.29-1.31 2.92-3.06 
(s) (s) (dd) (dd) (dd) (m) 
f 1.21 1.39 1.43-1.53 1.77-1.85 1.28-1.30 2.80-2.96 
(s) (s) (t) (dd) (d) (m) 
g 1.22 1.38 1.63-1.72 1.95-2.03 1.28-1.31 2.92-3.06 
(s) (s) (dd) (dd) (d) (m) 
. 1.24 1.39 1.46-1.56 1.78-1.86 1.29-1.32 2.83-2.98 I 
(s) (s) (t) (dd) (d) (m) 
j 1.23 1.39 1.47-1.57 1.78-1.86 1.30-1.33 2.88-2.93 
(s) (s) (t) (dd) (d) (m) 
k 1.22 1.38 1.45-1.52 1.77-1.84 1.27 -1.31 2.82-2.97 
(s) (s) (t) (dd) (d) (m) 
I 1.22 1.39 1.50-1.56 1.77-1.87 1.29-1.32 2.83-2.99 
(s) (s) (t) (dd) (d) (m) 
m 1.18 1.43 1.70-1.78 1.96-2.01 1.26-1.29 2.99-3.12 
(s) (s) (dd) (dd) (d) (m) 
Table 17 
Equatorial and axial hydrogens on the same carbon (e.g. Carbon-3) of a conformationally 
locked six-membered ring constitute an AMX system, depending on the nature of the 
substituent on the adjacent carbon285. This is evident from columns 4 and 5 of Table 
17, where, typically, the equatorial His dehsielded relative to the axial H by about 0.1 -
0.7 ppm285 . In 309m and 3090 these protons are deshielded, relative to those in the 
other molecule, due to the presence of the strongly electron-withdrawing nitro group on 
the aromatic ring. 
The 13C spectra of 309a-309m are consistent with the proposed structures and are listed 
in Table 18. 
309 C-2 C-2-CH3(ax) C-2-CH3 (eq) C-3-CH2 C-4-CH3 C-4-H 
a 73.72 26.10 29.73 43.76 22.10 26.70 
b 73.95 26.73 29.57 43.43 21.71 26.33 
c 73.92 24.37 30.07 42.96 20.38 25.97 
d 73.68 29.34 29.81 51.82 10.94 35.41 
e 73.68 26.34 29.05 43.54 20.81 25.97 
f 74.55 24.37 29.94 42.38 20.21 26.08 
g 73.66 28.36 29.05 43.56 21.65 25.87 
. 74.32 29.74 30.11 42.89 19.17 26.06 I 
100 
Discussion 
j 74.28 24.40 30.05 42.83 20.31 26.29 
k 73.92 30.05 30.05 42.76 20.41 26.70 
I 74.65 24.40 29.87 42.20 18.46 26.35 
m 73.37 26.53 29.34 43.19 21.69 26.58 
Table 18 
The quaternary sp3 carbon (C-2) is bonded directly to oxygen, and hence is strongly 
deshielded, with a chemical shift of 73ppm. This has also been observed by 
Nowakowska et al282 in other chromans. The gem-dimethyl groups on C-2 are axial and 
equatorial, therefore magnetically non-equivalent, and therefore resonate at two different 
positions, as shown (24.37 to 30.05 ppm) in Table 18. The methyl carbon on C4 
resonates at around 20 ppm, while the carbon-4 resonates at around 26 ppm, 
respectively. 
It is possible to predict the conformations of chromans from the coupling constant of the 
C3 and C4 protons. Ekiel et al 286 have found that in a-tocopherol (1) and its model 
compound (82a) all four vicinal coupling constants for the protons on carbon 3 and 4 are 
similar. 
HO 
H~ 
CH3 
1, R=Phytyl 
82a, R=CH3 
They suggested that this would exclude the possibility of a single conformation (planar, 
half-chair or half-boat forms), since eclipsed or antiperiplanar protons would lead to high 
values for some of the coupling constants, while the coupling for the gauche protons 
would be low. Therefore, very similar values for the coupling constants as shown in 
Table 19 would indicate that approximately equal populations of two interconverting 
conformers are present. 
Compd Coupling Constant (1) Hz 
3Jac 3Jad 3Jbc 3Jbd 3Jcd 2Jab 
1 6.9 6.9 7.1 7.1 - -
82a 6.9 6.9 6.9 6.9 - -
309 6.89 - 7.65 - 6.98 13.67 
Table 19 
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This would imply that the two half-boat states interconvert or the two half-chairs 
interconvert. The latter would seem more probable since half-chair conformations have 
been found for (82a) in the solid state. Also, half-chair conformers have been found to 
be the most stable forms in cyclohexenes by Eliel et af287 , since cyclohexene has some 
resemblance to the structure of the chroman in (309). Therefore by analogy this would 
be observed in the 4-substitued chromans (309), since all the vicinal coupling constants 
have almost similar values (see Table 19). This has also been seen in 4-substituted 
flavans204. 
H~ 
CH3 
309 
Therefore the two half-chair conformers (A and B) are possible for the 4-methyl 
substitued chromans (309a-m) as shown below. 
A B 
where 5 and 6 are fused to benzene ring 
The formation of the products with the additional fused 5-membered rings (315d, 315h 
and 315k) was confirmed by nmr spectroscopic analysis. Compound 315h is used as a 
representative sample for this trio. 
{ 
HxJ6 
AMX system HM 
HA 7 
315h 
The proton nmr spectrum of 315h showed signals for the two sets of gem-dimethyl 
groups at 1.23 ppm and 1.27 ppm, and 1.31 ppm and 1.35 ppm. The protons on C-3 
and C-7 are chemically non-equivalent and with the protons on C4 and C6 formed two 
AMX systems, with two sets of doublets of doublets each. The methyl protons on C4 
and C6 gave rise two set of doublets for the methyl groups at 1.39 ppm and 1.41 ppm, 
respectively. The protons on C4 and C6 each appeared as sextets which resonated at 
2.85-2.95 ppm and 3.0 l-:t 11 ppm, respectively. The aromatic proton on C5 gave rise to 
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a singlet and resonated at 6.85 ppm. All of the assignments were consistent with the 
proposed structure (see Appendix for spectrum). 
Similar patterns were observed for 315d, 315h and 315k, again they were consistent 
with their proposed structures. 
The mass spectra of 309a-m were consistent with the proposed structures and a 
fragmentation pattern for 309a is outlined in Scheme 77 . 
309a 
(mJz=234, 75%) 
Retro-Diels 1 (M-55) 
Alder 
319 
(mJz=179,80%) 
• (M - CH3) 
(M - 15) 
-II' 
• 
317 
(mJz=219, 11 %)) 
+ 
320 
(m1z=178,100%) 
Scheme 77 
318 
Loss of a methyl radical from the molecular ion leads to the fonnation of the resonance 
stablised oxonium ion (317). 
Alternatively, a retro-Diels Alder fragmentation leads to the fonnation of the conjugated 
phenol (319) which upon loss of a hydrogen radical atom fonns the oxatropylium ion 
(320). 
2.15 Mechanism of Formation of 3,4-Dihydro-2,2,4-
trimethylbenzopyran (309) 
The stable carbocation 321 would attack the phenol (28) to form the oxy-cation 322 
which, with deprotonation, leads to the aryl ether 323. This is followed by [3,3]-
sigmatropic realTangement to afford the ketone 324 which rapidly tautomerises to give 
the phenol (325). On protonation of the alkenic double bond in the phenol (326) and 
subsequent intramolecular cyc1isation (327) and deprotonation of 328 gives rise to the 
desired 3.4_dihydro-2,2,4-trimethylbenzopyran (309). 
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Q + .. Q~ .. ~~ ~ + ~ 0 OH ~O 
28 321 322 H 323 
Claisen f 
Rearrangemen 
Keto-
Enol", 
.. 
Tauto-
326 325 rism 324 
327 328 309 
Scheme 78 
The secondary carbocation (329) could attack the phenol (28a) via the mechanistic path 
shown in Scheme 78 to afford the 3,4-dihydro-2,4,4-trimethylbenzopyran (330), as 
outlined in Scheme 79. 
H 
~ 
•• + 
OH 
28a 329 330 
Scheme 79 
However, there was no evidence in the proton nmr spectrum for the presence of 330. It 
would have been expected to show a sextet, and a doublet of doublets for the proton on 
C-2 and protons on C-3, respectively. The 13C nmr spectrum of 330 shows that the C-2 
quaternary sp3 carbon is bonded directly to the oxygen (8 75.8 ppm), as discussed 
earlier, while in 330 it would be attached to the aromatic ring and would be expected to 
resonate at around 30 ppm. 
The 13C nmr spectra of 309a-m confirms this, in that the carbon signal for C-4 appears 
as a doublet at 26.4 ppm , while the carbon spectrum of 330 would show signals 
resonating at 70 ppm and 31.5 ppm. The mass spectrum of 330 would be expected to 
show the charactetistic fission of the Ar-O bond while subsequent expulsion of a methyl 
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radical and ketene would lead to an abundant peak at m/z=l92. Instead observed, 
elimination of the C-4 fragment of the pyran ring gives rise to the base peak at m/z=178 
of 309a (Scheme 77, p.103). 
330 331 
Alternatively, 2,3-dihydro-2-isopropyl-3-methylbenzofuran (331) could be formed, 
since ring closure to form five-membered rings and six-membered ring is highly favoured 
over competing intermolecular reactions such as polymerisation and is favoured over 
formation of rings of other sizes. Ruzicka and others288-29o viewed this situation as the 
result of two competing factors: (i) an unfavourable strain energy that hinders formation 
of small rings, which strain becomes negligible for five- and six-membered rings, (ii) 
while the probability of ends meeting is most favourable for closing three-membered 
rings and progressively diminishes throughout the homologous series as the ring size 
becomes larger. However, in this case there was no evidence for the formation of the 
five membered ring system 331. 
This could be due to the stluctural factors which enhance the rate of cyclisation leading to 
the fOlmation of the more stable six-membered ring system 330. A well known example 
is the alkyl substituent effect 'the gem-dialkyl effect' or the well known Thorpe-Ingold 
effect287,291-296. In this the gem-dimethyl groups cause, by mutual repulsion, an 
increase in the angle ~ and a concomitant decrease in the angle a (323). 
0~ ~~ J~ 
323 
Kirby et al297 confirmed this effect by X-ray studies, for instance, for malonic acid and 
dimethylmalonic acid. If the bonds forming the angle a are within a six-membered ring, 
this would result in ring stabilization. Ashwood298, recently, stated that the geminal 
dimethyl groups at C-2 of the benzopyran moiety in the syntheses of chromakalins 
greatly enhanced the yields of the Claisen rearrangement. 
Halfenist et al299 stated that the gem dimethyl effect resulted in an increase in the rate of 
cyclisation in the thelmal rean·angement of aryl propargyl ethers to chromenes when the 
hydrogens at the C-2 of 332a were replaced by CH3 (332b). If one or both groups are 
hydrogen. the rotamer with that H nearer the benzene ring's ortho H would predominate 
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332a, and the ethenyl group would not be situated in a position to react, without 
overcoming a substantial energy ban'ier to rotation. 
332b 
However, in 332b where at C-2 there are two methyl groups, the rotamer would have 
the ethenyl group in a better position to react, since the methyl groups would be more 
bulky at least that the ground state ethenyl group and therefore would be away from the 
benzene ring. 
Engbert et a[3oo stated that the rate enhancement (gem-dimethyl effect) could not be due to 
the restrictions in rotamer population alone. Milstein et al 283,284 found that very high rate 
enhancements were observed in some systems upon alkyl substitution. This was 
demonstrated, for example, by the high efficiency of the 'trialkyl lock effect' in the 
lactonization of some 3-(2-hydroxyphenyl)propionic acids. Overall, these effects 
probably operate in the initial cyclisation step of the [3,3]-rearrangement (323 to 324) 
see Scheme 78, p.l 04). 
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3.00 Conclusion 
This study has shown that 2,2-dimethyl-3,4-dihydrobenzopyrans can be efficiently 
synthesised by reacting both phenols and substituted hydroquinones with carbocations 
generated from the appropriate 1,3-diene such as isoprene or allylic alcohol in the 
presence of zinc chloride and glacial acetic acid or trifluoroacetic acid under an 
atmosphere of argon in a one pot synthesis. 
2,2-Dimethyl-3,4-dihydrobenzopyrans have been synthesised in low to average yield (5-
54%) using Smith's methods86,173. The use of trifluoroacetic acid also gave low to 
average yields together with novel oxacyclopentanaphthalenes whose spectral data have 
not been reported in the literature. 
2,2-Dimethyl-2,3-dihydrobenzofurans were prepared by two synthetic routes. Firstly, in 
one-pot syntheses using trifluoroacetic acid (TFA), in which the acid acts both the 
solvent and as the catalyst242. This reaction is thought to proceed via [3,3]-sigmatropic 
rearrangement and has the advantage of using simple reaction conditions. It is 
convenient and has produced low to moderate yields (4-32%). 
Secondly, where phenols were condensed with isobutyraldehyde in the presence of 
toluene and concentrated sulphuric acid to afford 2,3-dihydrobenzofurans in low to high 
yields (4-84%). Here by contrast, concentrated sulphuric acid acts only as the catalyst. 
Nevertheless, the reaction is thought to proceed initially via an initiaL regioslective 
ortho-alkylation of the phenol in selected cases. However, some polyalkylation of the 
2,3-dihydrobenzofurans does seem to occur in both methods. 
5-Formylamino-2,3-dihydrobenzofurans have been synthesized in one pot syntheses 
using several different methods. 
Firstly, the method of Martini et az 133 gave moderate yields (53%) when toluene was 
used as the solvent and concentrated sulphuric acid was the acid catalyst. Secondly, the 
method of Smith et al110 provided good yields (87%); however longer reaction times 
were required (22 hrs). Finally, the method involving TFA242 also gave good yields 
(73%) and shorter reaction times (4hrs). The advantage of this method was that 
trifluoroacetic acid (TFA) acted as both the solvent and as the catalyst in the reaction. 
A similar methodology was employed in the syntheses of 6-formylamino-3,4-
dihydrobenzopyrans using N-formylaminophenol which was condensed with the 
appropriate allylic alcohols and diene using a number of acidic catalysts. All the 
methodologies used produced good yields of the desired compound. However, in some 
cases, deprotection of the formyl grouping to yield the 6-amino-3,4-dihydrobenzopyrans 
(35%) occurred. 
The 5_formylamino-2,3-dihydrobenzofurans and 6-formylamino-3.4-
dihydrobenzopyrans exhibited cis-trans isomelism. (As confirmed by their proton NMR 
spectra). 
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3,4-Dihydrobenzopyrans substituted with a methyl at the 4-position were synthesised in 
one pot syntheses by the reactions of phenols with 1,2-diols in the presence of a mixture 
of glacial acetic acid and concentrated sulphuric acid in low to high yields together with 
novel oxacyc1opentanaphthalenes in low to average yields. 
In summary, it has been shown that 3,4-dihydrobenzopyrans and 2,3-
dihydrobenzofurans can be efficiently synthesised in one pot syntheses: an improvement 
on all the previous multistage syntheses. 
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4.00 Future Work 
1. Confirmation of the proposed mechanisms by labelling studies - it has been shown in 
this study that TFA, glacial acetic and sulphuric acid mediated reaction of hindered 
phenols with the appropriate dienes, allyl alcohols, aldehydes and diols have afforded 
2,3-dihydrobenzofurans and 3,4-dihydrobenzopyrans. 
Due to the availability of time the deuteruim labelling studies were not carried out, in 
order to confirm the mechanisms which have been proposed in this thesis. For 
example, as shown in Scheme 79, the deuterium should be incorporated at the position 
C-3 in 188 If the proposed mechanism is correct, elimination of the proton from 
carbocation 333 should afford the deuterated model compound 334. 
+ 
CF3COOD ;: .. .. -(H 2O) 
OH 
OH ~) (273) (181) (28a) 
! 
Keto - Enol 
.. 
(189) 
.. 
Scheme 79 
Labelling studies should also be extended to the 5-membered ring analogue of the 
model compound 335 and the tri-alkyl locked compound 336 to verify that the 
deuterium is incorporated in the positions which we have proposed. 
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(335) (336) 
2. Improving the Antioxidant activity - a-tocopherol, the main component of vitamin 
E, the 6-hydroxychroman, the 6-aminochormans, as well as the corresponding ring 
contracted analogues-2,3-dihydrobenzofurans are some of the most active peroxyl 
radical trapping agents known 12,55,56,59,60,301,302. Ingold and co-workers have attributed 
the improved antixoxidant activity of these compounds to the stereo electronic effect57, 
involving the p-type lone pair orbital of the nonphenolic oxygen. Sulfur analogues 
should be considered to be more effective than oxygen at stabilising the neighbouring 
radical centre303 . However, they have been found to be slightly less reactive towards 
peroxyl radicals than their corresponding chroman derivatives61 ,304. 
I-Seleno-a-tocopherol (1) and I-telluro-a-tocopherol (124) derivatives have not yet 
been prepared. Organoselenium and organotellurium compounds have shown 
interesting antioxidant properties. As you go down the group six of the periodic table, 
the elements become less electronegative. 
la x=o 
bX=S 
cX=Se 
dX=Te 
(124) 
124a X=O 
tX=S 
uX=Se 
vX=Te 
Thus the electron transfer to the reactive alkoxyl and peroxyl radicals becomes more 
likely to occur. Also the selenium containing glutathione peroxidases305 have shown to 
catalyse the reduction of hydrogen peroxides, fatty acids hydro peroxides and organic 
peroxides using the tripeptide glutathione and other thiols as reducing agents. Other 
researchers have reported organo selenium and organotellurium compounds with chain 
breaking306,307 or thiol peroxidase activity308. 
3. Design and Construction of Natural product libraries based on the Benzopyran 
Moiety - the 2,2-dimethylbenzopyran moiety is present in more than 4000 compounds 
including natural products and design structures309. The relatively high incidence of 
this benzopyran unit and its del1vatives in natural products is partially attributable to the 
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numerous prenylation and cyclisation reactions In many polyketide biosynthesis 
pathways. 
Moreover, the derivatives of the benzopyran unit remain sufficiently lipophilic to cross 
cell membranes, a key features of any biologically relevant small molecule library31O. 
Furthermore, a topographical analysis of structure therapautics have identified the 
benzopyran moiety as a prefrential framework for drug design.311 
Therefore, further design and synthesis of the natural product libraries based on the 
benzopyran moiety would still be desirable. 
4. Coumarins such as calanolides A and B, have shown to be HIV -1 specific reverse 
transcriptase inhibitors.312 
Calanolide A 
Calanolide B 
R1=H, R2=OH 
R1=OH, R2=H 
These compounds are of special interest because they are active against AZT-resistant 
strains of HIV -1. The key structural feature, both synthetically and biologically, of the 
calanolides is the trisubstituted chroman ring. 313. Furthermore, chiral chromans are 
prevalent in other natural products, such as Vitamin E314. 
o rl 0 C(N"'~N)) I H H I 
.0 PPh3 Ph3P.o 
337 
Trost et a(315 has sought a general route to the enantioselective preparations of chroman 
in which the chirality has been introduced at the C-2 position, by the use of ligand such 
as 337 and in a catalytic reaction, as outlined in Scheme 80. 
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+ 
OH 
338 339 340 
341 
a) 1% Pd2dba3. b) 3% 4. c) Catecholborane. 2% (PPh3)3RhCl. then NaOH, H202 (88%), d) Tf20, 2,6-di-t-
butylpyridine. CH2C12 (78%). 
Scheme 80 
The palladium-catalysed reaction of phenol 338 with geranyl methyl carbonate (339) in 
the presence of ligand 337, afforded the tertiary ether 340. Cyclisation of the ether 340 
afforded the chiral chroman 341. 
Introduction of chirality at C-2 by the use of the catalyst and ligand stated above, could 
be explored in the syntheses of 2,3-dihydrobenzofurans and 3,4-dihydrobenzopyrans, 
mentioned in this study. 
5. Lipophilicity of a-tocopherol 1 could be increased by the introduction of amino 
groups such as L-Dopa. This can be achieved by the bromination of a-tocopherol to 
give the 5a-bromo-a-tocopherol 342, followed by nucleophilic substitution to give the 
antioxidant 343, as outlined in Scheme 81. 
H 
R a R 
342 343 
a) Bf2, in CH2Cl2 b) L-Dopa in EtOAc. 
Scheme 81 
Preliminary synthesis of antioxidant 343 has been carried out by Ismail et al. :'16 
Compound such as 343 could be screened against CNS disorders.:' l7 
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6. The antioxidant activity of all the antioxidants synthesised in this study should be 
conducted as well as X-ray crystallography and molecular modelling of all the 
compounds. 
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5.00 Experiment 
Reagents 
All were purchased from the Aldrich Chemical Co. and Lancaster Synthesis, and were 
used without further purification. 
Purification of Zinc Chloride 
Anhydrous zinc chloride was obtained by sublimation over a slow stream of hydrogen 
chloride gas, followed by heating at 40()OC under nitrogen. 
Solvents 
Solvents were purified according to the methods described by D.O. Perrin & W.L.F. 
Armarego in 'Purification of Laboratory Chemicals', 3rd Edition, Pegamon Press, New 
York, 1988. 
Short-Path High Vacuum Distillation 
All compounds (unless otherwise stated) were purified by short-path vacuum distillation. 
NMR Spectra 
1 Hand l3C NMR spectra were recorded on a BRUKER AC-250 (250 MHz) instrument 
with tetramethylsilane as the internal standard. The spectrometer frequency was 250 
MHz for proton NMR, (equivalent to a field strength of 5.87 TESLA) and 62.896 MHz 
for carbon-13 and DEPT (Distortionless Enhancement by Polarisation Transfer). 
Mass Spectra 
EI mass spectra were recorded on a VO MICROMASS 7070H (70e V) instrument at 
2000C-2500C, with a scan time of 3 seconds/decade from 750 to 20 Daltons (mass 
units). 
For chemical ionisation (CI) experiments, ammonia gas was used, and the spectrometer 
was operated at 50e V. 
Infra-red Spectra 
Infra-red spectra were recorded on a OALAXA yTM, series 5000 Ff-IR spectrometer 
OL-7020. Spectra were plotted using an HP 7440 Colourpro printer. Solid samples 
were lun as their KBr discs; oils as neat liquids. 
Melting Point 
Melting points were recorded on a Oallenkamp apparatus, and are uncOITected. 
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Column chromatography 
Thin layer chromatography (TLC) was carried out on Merck Kieselgel 60 F 254 plates. 
Chromatographic purification was performed on silica gel columns; the silica gel Merck 
Kieselgel 60 of 0.063-0.200mm and using ethyl acetate: petroleum ether 30-400 (10:90) 
as the solvent system under argon, unless otherwise stated. 
Gas Chromatography - Mass Spectrometry 
Gas chromatography was performed on a Varian 3800 GC instrument linked to a Varian 
Saturn 2000 mass spectrometer equipped with an ion trap. Gas chromatograph 
conditions: column used was 30mm DB5, 0.25mm i.d. 0.25 urn film thickness, column 
temp = 2300 C; pressure = 10.0 psi; split ratio = 200; run time = 35.00 mins unless 
otherwise stated. 
Glassware 
Removal of plasticiser contamination (e.g. dioctyl phthalate present in solvents from 
plastic bottles and acetone used for washing), after washing with acetone and distilled 
water ( acid washed if necessary), all the glassware used was annealed at 650°C for 3 
hours, prior to use. 
All reactions were carried out on double vacuum manifold equipped with Teflon taps and 
under an atmosphere of argon (pre-dried using 3A molecular sieves). 
Elemental Analysis 
CHN analysis carried out by MEDAC LTD, BRUNEL SCIENCE CENTRE, 
COOPER'S HILL LANE, ENGLEFIELD GREEN, EGHAM, SURREY. 
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2,2-Dimethyl-3,4-dihydro-6-hydroxy-2,2,5, 7 ,S- pentamethyl benzopyr an 
(S2a) 
Trimethylhydroquinone (2Sa) (6.15g, 0.05mol) and freshly fused zinc chloride (5.24g, 
0.39mol) were dissolved in acetic acid (30 ml) under argon with constant stirring. The 
solution was heated under reflux for 3hrs during which isoprene (SI) (3.43g, 0.05mol) 
was added dropwise. The reaction was monitored by TLC (ethyl acetate: petroleum 
ether 30-40°, 10:90). After completion of the reaction, the solution was poured onto ice, 
neutralised with 5% w/v sodium bicarbonate solution (300ml) and extracted with ethyl 
acetate. The extract was dried with magnesium sulphate. Evaporation of the solvent 
gave a brown oil. To this was added methanol (40ml) and concentrated hydrochloric acid 
(lOml) and the solution was heated under reflux for 1hr. The methanol was removed in 
vacuo, the solution was neutralised with 5% w/v sodium bicarbonate solution and 
extracted with ethyl acetate. The organic layer was washed with water and dried with 
magnesium sulphate. Evaporation of the solvent gave a dark brown oil which was 
crystallised from petroleum ether (b.pt 40-60°) to afford the title compound (4.06g, 37%) 
as a light brown crystalline solid, m.pt. 92-940C.(Lit. m. pt 92-94°C)88,173. TLC (ethyl 
acetate: petroleum ether, 40-60°, 10:90), Rf 0.56. 
IR (KBr) : u 3251 (O-H), 2981-2929 (C-H), 1366 (d, geminal CH3), 1264 (C-O-C), 
1168 (C-O), 850 (C-H) bend em-I. 
1H NMR (CDCI3) : 8 1.28 (6H, s, C-2-2xCH3)' 1.81 (2H, t, J 6.88 Hz, C-3-CH2), 
2.10 (6H, s, C-5,7-2xCH3)' 2.15 (3H, S, C-8-CH3)' 2.61 (2H, t, J 6.80 Hz, C-4-
CH2), 4.22 (lH, s, C-6-0H, exchangeable with 020) ppm. 
13C NMR (CDCI3) : 8 11.30 (C-5-CH3), 11.81 (C-8-CH3) ,12.24 (C-7 -CH3), 21.12 
(C-4-CH2)' 26.70 (C-2-2xCH3)' 33.11 (C-3-CH2). 72.51 (C-2), 117.17 (C-5), 118.60 
(C-6), 121.13 (C-8), 122.62 (C-7), 144.63 (C-9), 145.74 (C-10) ppm. 
MS (EI) : m/z 220 (M+·, 70%),205 (M+' - CH3, 5%), 177 (6%), 165 (95%), 164 
(l00%), 149 (3%), 136 (18%), 121 (12%), 105 (4%), 91 (9%). 
Analysis calcd. for C14H2002 (220) C, 76.33; H, 9.15. Found: C, 76.17; H, 9.21%. 
3,4-Dihydro-2,2,5,7 ,S-pentamethyl benzopyran (S2b) 
2,3,5-Trimethylphenol (2Sb) (8.23g, 0.06mol), and freshly fused zinc chlOlide (8.44g, 
0.06mol) were dissolved in acetic acid (40 ml) under argon with constant stirring. The 
solution was heated under reflux for 3hrs dming which isoprene (SI) (3.42g, 0.05mol) 
was added dropwise. The reaction was monitored by TLC (ethyl acetate: petroleum 
ether 30-400, 10:90). After completion of the reaction, the solution was poured onto ice, 
neutralised with 5% w/v sodium bicarbonate solution (300ml) and extracted with ethyl 
acetate. The organic layer was dried with magnesium sulphate. Evaporation of the 
1 1 6 
Experimental 
solvent afforded a reddish-brown oil. The oil was purified by column chromatography 
(ethyl acetate I petroleum ether 30-400 , 10:90) to afford the title compound (4.65g, 46%) 
as light yellow crystalline solid, m.pt 39-400C (Lit. m.pt 40-41°C), Rf 0.78. Analysis of 
the mother liquor of 28b by mass spectrometry showed the presence of the title 
compound, 3,4-dihydro-6-isopentenyl-2,2,5, 7 ,8-pentamethylbenzopyran (144b), and 
163. 
IR (KBr) : u 2971-2910 (C-H), 1363 (d, geminal CH3), 1219 (C-O-C), 1157 (C-O) cm-
1 
1H NMR (CDCI3) : 8 1.29 (6H, S, C-2-2xCH3)' 1.77 (2H, t, 1 6.48 Hz, C-3-CH2), 
2.07 (3H, s, C-5-CH3), 2.10 (3H, s, C-7-CH3), 2.15 (3H, S, C-8-CH3)' 2.59 (2H, t, 1 
6.87 Hz, C-4-CH2)' 6.54 (lH, s, C-6-H) ppm. 
13C NMR (CDC13) : 8 11.34 (Ar-CH3), 18.82 (Ar-CH3). 19.75 (Ar-CH3), 21.39 
(CH2), 26.88 (2xCH3), 32.73 (CH2), 72.99 (C-2), 116.57 (Ar-C), 121.95 (Ar-C), 
122.25 (C-6-CH), 133.33 (Ar-C), 134.60 (Ar-C), 151.65 (Ar-C) ppm. 
MS (EI): m/z 204 (M+·, C14H200, 40%), 189 (C 14H200 - CH3, 10%), 149 (100%), 
105 (12%), 91 (8%),55 (9%). 
Evidence for the formation of 3 ,4-dihydro-6-isopentenyl-2,2,5, 7,8-
pentamethylbenzopyran (144b) 
MS (EI) : m/z 272 (M+·, C19H280, 8%), 257 (M+·, C19H280 - CH3, 18%). 
MS (CI) : m/z 273 (M+H, C14H200, compound 144b, 8%). 
Evidence for the formation of (163). 
MS (CI) : m/z 407 (M+H), C28H3802, 180/0). 
The following compounds were synthesised using the method outlined 
above. 
3,4-Dihydro-6-chloro-2,2-dimethylbenzopyran (82c) 
p-Chlorophenol (28c) (6.43g, 0.05ml), was reacted with isoprene (81) (3.41g, 
0.05mol) to afford a dark brown oil. Purification by column chromatography (ethyl 
acetate: petroleum ether 40-60°, 15:85) afforded the title compound (82c) (2.7 4g, 
28%) as a light brown oil, (Lit. m. pt 83-85DC)172, Rf 0.68 and 144c «1 %). 
1 H NMR (CDCI3) : 8 1.31 (6H, S, C-2-2xCH3)' 1.76 (2H, t, 1 7.01 Hz. CH2), 2.72 
(2H, t, 1 6.77 Hz. CH2), 6.67-6.71 (1H, m, meta-coupled, 19.41 Hz, 1m 3.67 Hz, Ar-
H), , 6.99-7.03 (2H, m, meta-coupled, 16.77 Hz. 1m 3.20 Hz, Ar-H) ppm. 
I I 7 
Experimental 
13C NMR (CDCh) : 8 22.36 (C-4-CH2), 26.71 (C-2-2xCH3)' 32.39 (C-3-CH2), 74.22 
(C-2), 118.52 (Ar-CH), 122.07 (Ar-C), 124.19 (Ar-C), 127.18 (Ar-CH), 128.92 (Ar-
CH) ppm. 
MS (EI) m/z : 196 (M+., CllH130Cl, 60%), 181 (M+. Cl1H130Cl - CH3,45%), 167 
(35%),155 (32%),141 (100%), 123 (43%),77 (33%), 69 (47%),43 (65%). 
Formation of 3,4-dihydro-6-ch10ro-5-pentenyl-2,2-dimethy lbenzopyran (144c) 
MS : (EI) : m/z 264 (M+',C16H210Cl, 22%), 249 (C16H210Cl - CH3, 10%), 223 
(95%), 209 (58%), 196 (M+., CllH 130Cl, compoumd 82c, 60%), 181 (M+. 
Cl1H130Cl - CH3,45%), 167 (35%), 155 (32%), 141 (100%), 123 (43%), 77 (33%), 
69 (47%), 43 (65%). 
3,4-Dihydro-6-hydroxy-2,2-dimethylbenzopyran (82d) 
Hydroquinone (28d) (3.43g, 0.03mol) was reacted with isoprene (81) (3.44g, 0.05 
mol) to a dark brown oil. The oil was purified by column chromatography (methanol: 
dichloromethane, 5:95) to afford the title compound (82d) as a light brown oil (0.98g. 
11 %), (Lit. m.pt 77-800C)173,174, Rf 0.40. 
IH NMR (Acetone-d6) : 8 1.25 (6H, S, C-2-2xCH3), 1.74 (2H, t, J 6.81 Hz, C-3-CH2), 
2.69 (2H, t, J 6.81 Hz, C-4-CH2), 2.99 (1H, s, C-6-0H), 6.50 (2H, s, 2xAr-H), 7.68 
(1 H,s, Ar-CH) ppm. 
13C NMR (Acetone-d6) : 8 23.21 (CH2), 26.96 (C-2-2xCH3)' 33.70 (CH2), 73.87 (C-
2), 115.11(Ar-CH), 115.90 (Ar-CH), 118.23 (Ar-CH), 122.19 (Ar-C), 147.92 (Ar-C), 
151.15 (Ar-C) ppm. 
3,4-Dihydro-7,8-Dihydroxy-2,2-dimethylbenzopyran (82e) 
Pyrogallol (28e) (2.53g, 0.02mol) was reacted with isoprene (59) (2.75g, 0.02mol) to 
afford the title compound as a red oil (82e) (1.82g, 51 %) and (145e). 
IH NMR (CDCh) : 8 1.34 (6H, S, C-2-2xCH3), 1.75 (2H, t, J 8.10 Hz, CH2), , 2.69 
(2H, t, J 7.23 Hz, CH2), 6.05 (Ar-H), 6.54 (Ar-H) ppm. 
13C NMR (CDCh) : 8 21.58 (CH2)' 26.71 (C-2-2xCH3), 32.87 (CH2), 75.85 (C-2), 
107.27 (Ar-CH), 113.08 (Ar-C), 119.57 (Ar-CH), 131.89 (C-8-C-OH), 141.37 (Ar-C). 
MS (EI) : 194 (M+', CllH1403, 58%),179 (M+', CllH 140 3 - CH3, 12%), 139 
(100%), 138 (95%), 126 (39%), 43 (22%). 
Evidence for the formation of 2,2,8,8-tetramethyl-3,4,6.7 -tetrahydro-2H .6H-
pyranoI3,2-g]chromen-5-ol (145e) 
MS (EI) : m/z 262 (M+·, C16H2203. 109(), 247 (M+·. C16H220 3 - CH3. 89r), 236 
(8%), 207 (18%). 
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3,4-Dihydro-2,2-dimethyl-3H -naphtho-[2, 1-b ]pyran (82f) 
2-Naphthol (28f) (11.63g, 0.08mol) was reacted with isoprene (81) (6.81g, O.lmol) to 
afford a red oil. The oil was purified by column chromatography (ethyl acetate : 
petroleum ether 40-60°, 10:90) to afford the title compound (82f) (11.02g, 52%) as a 
light yellow oil, (Lit. NMR evidence only134), Rf 0.62 and a red oil 3,4-dihydro-2,2-
dimethyl-4-pentenyl-3H-naphtho-[2,I-b]-pyran (144f). 
IR (film) : u 3437 (O-H), 2975-2927 (C-H), 1391 (geminal CH3), 1267 (-C-O-C-), 
1157 (C-O) cm-I. 
1 H NMR (CDCI3) : 8 1.38 (6H, S, C-2-2xCH3), 1.85 (2H, t, 1 6.70 Hz, CH2), 2.82 
(2H, t, 1 6.95 Hz, CH2), 7.10-7.13 (1H, d, J 8.35 Hz, Ar-CH), 7.26-7.29 (1H, d, J 
8.32 Hz, Ar-CH), 7.37-7.41 (2H, m, meta-coupled, 1 8.85 Hz, 1m 3.22 Hz, 2xAr-H), 
7.82-7.88 (1H, d, meta-coupled, J 9.42 Hz, Jm 3.60 Hz, Ar-H), 8.35 (1H, d, meta-
coupled, J 9.75 Hz, Jm 4.30 Hz, Ar-H) ppm. 
13C NMR (CDCh) : 8 22.72 (CH2), 27.60 (C-2-2xCH3)' 32.72 (CH2), 74.37 (C-2), 
114.17 (Ar-C), 118.79 (Ar-CH), 121.58 (Ar-CH), 125.28 (Ar-CH), 125.40 (Ar-H), 
125.42 (Ar-CH), 127.68 (Ar-CH), 133.26 (Ar-C), 148.61 (Ar-C) ppm. 
MS (EI) : m/z 212 (M+·,CIsHI60, 70%), 195 (10%), 181 (8%), 170 (10%), 157 
(100%),156 (57%),141 (7%), 128 (28%),115 (7%). 
Evidence for the formation of 3,4-dihydro-2,2-dimethyl-4-pentenyl-3H-naphtho-[2,l-b]-
pyran (144f). 
MS (EI) : m/z 280 (M+·, C20H240, 40%), 225 (25%). 
3,4-Dihydro-2,2-( 4-isopropyl)-S,6-hydroxy -7,8- pentamethy I benzopyran 
(178) 
Trimethylhydroquinone (28a) (0.02 mol) was reacted with 2,5-dimethyl-hexa-2,4-diene 
(177) (2.21g, 0.02 mol) to afford the title compound (178) (1.36g, 26%) as a red oil. 
IH NMR (CDCh) : 8 0.77-0.80 (3H, d, J 6.67 Hz, C-4'a-CH3)' 0.83-0.86 (3H, d, J 
6.83 Hz, C-4'b-CH3)' 0.89-0.98 (IH, m, J 6.87 Hz, C-4'-H), 1.05 (3H, s, C-2-
CH3ax), 1.48 (3H, s, C-2-CH3eq), 1.59-1.67 (3H, m, J 7.65 Hz, C-3-Hax), 2.00-2.03 
(IH, m, J 6.19 Hz, C-3-Heq), 2.11 (3H, s, Ar-CH3), 2.15 (6H, s, 2xAr-CH3), 2.76-
2.84 (lH, m, J 7.22 Hz, C-4-CH), 4.35 (lH, broad, C-6-0H, D20 exchangeable) ppm. 
13C NMR (CDCh) : 8 11.83 (Ar-CH3), 12.20 (Ar-CH3), 12.48 (Ar-CH3), 18.05 (C-4'-
CH3ax), 21.28 (C-4'-CH3eq), 26.97 (C-2-CH3ax), 30.03 (C-4-CH), 30.84 (C-2-CH3eq), 
36.43 (C-3-CH2), 38.61 (C-4'-CH), 75.37 (C-2), 118.16 (Ar-CH3), 120.12 (Ar-CH3), 
123.92 (Ar-CH3), 126.82 (Ar-CH3), 146.10 (Ar-CH3), 146.34 (Ar-CH3) ppm. 
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3,4-Dihydro-6-hydroxy-2,2,S,7 ,8-pentamethylbenzopyran (82a) - Method 
II 
Trimethylhydroquinone (28a) (l2.61g, 0.11 mol) was dissolved in trifluoroacetic acid 
under reflux in an atmosphere of argon. 3-Methyl-2-buten-1-01 (199) (6.89g, 0.08mol) 
was added slowly over a period of 3hrs. After completion of the reaction, the mixture 
was poured onto ice. The organic layer was extracted with ethyl acetate (2S0ml), 
neutralised with S%w/v sodium bicarbonate solution and washed with water (lOOml x 2). 
The ethyl acetate was removed under reduced pressure. To the organic layer, methanol 
(100ml) and concentrated hydrochloric acid (Sml) were added and the solution was 
heated under reflux for 1hr. The methanol was removed under reduced pressure. The 
solution was neutralised with S%w/v sodium bicarbonate solution, and extracted with 
ethyl acetate (lSOml). The extract was washed with water (lOOml), dried over anhydrous 
magnesium sulphate and the solvent removed in vacuo. On standing the brown oil 
solidified. Crystallisation from petroleum ether (40-60°) afforded the title compound 
(l0.09, S7%) as a light brown solid, m.pt. 88-90°C (Lit. 92-94°C88,173). TLC (ethyl 
acetate: petroleum ether 40-60°, 10:90), Rf 0.34. 
IR (KBr) : 1) 3243 (O-H), 2980-2929 (C-H), 1367 (d, geminal CH3), 1224 (C-O-C), 
1167 (C-O) cm- I . 
IH NMR (COCI3) : (5 1.28 (6H, s, C-2-2xCH3)' 1.80 (2H, t, J 6.87 Hz, C-3-CH2)' 
2.03 (6H, s, C-S,7-2xCH3), 2.07 (3H, s, C-8-CH3)' 2.61 (2H, t, J 6.79 Hz, C-4-
CH2), 4.23 (C-6-0H, 020 exchangeable) ppm. 
l3C NMR (COCI3) : (5 11.69 (C-S-CH3), 11.72 (C-8-CH3)' 12.6S (C-7-CH3), 20.46 
(C-4-CH2), 26.38 (C-2-2xCH3)' 32.46 (C-3-CH2), 71.88 (C-2), 116.36 (C-S), 120.20 
(C-6), 120.77 (C-8), 122.47 (C-7), 144.S3 (C-9), 14S.01 (C-10) ppm. 
MS (EI) : m/z 220 (M+·, 68%), 20S (M+· - CH3, S%), 190 (3%), 16S (93%), 164 
(100%), 149 (3%), 136 (13%), 121 (l2%), lOS (4%),91 (10%). 
The following compounds were synthesised using the above general 
procedure. 
3,4_Dihydro-2,2,S,7,8-pentamethylbenzopyran (82b) 
2,3,S-Trimethylphenol (28b) (6.81g, O.OSmol) was dissolved in trifluoroacetic acid at 
1000C under an atmosphere of argon. 3-Methyl-2-buten-l-ol (199) (4.31g, O.OSmol) 
was added slowly over a peliod of 3hrs. After completion of the reaction, the mixture 
was poured onto ice. The organic layer was extracted with ethyl acetate (200ml), 
neutralised with S%w/v sodium bicarbonate solution, washed with water (7Sml x 2), and 
dried over anhydrous magnesium sulphate. The ethyl acetate was removed in \'OCIIO to 
afford a clude brown oil. 
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TLC (ethyl acetate: petroluem ether 40-600, 15:85) : 2 spots; Rf 0.35, 0.65. Purification 
by column chromatography afforded the title compound as a pale yellow oil (3.01g, 
30%), (Lit m.pt 40-410C). 
IR (film) : u 2980-2928 (C-H), 1367 (d, geminal CH3), 1223 (C-O-C), 1168 (C-O) cm-
1 
1 H NMR (CDCI3) : 3 1.30 (6H, S, C-2-2xCH3)' 1.78 (2H, t, J 6.83 Hz, C-3-CH2), 
2.04 (3H, s, C-5-CH3), 2.09 (3H, s, C-8-CH3), 2.15 (3H, s, C-7-CH3), 2.59 (2H, t, J 
6.86 Hz, C-4-CH2), 6.54 (1H, s, C-6-CH) ppm. 
13C NMR (CDC13) : 3 11.33 (C-5a-CH3), 18.80 (C-8-CH3), 19.74 (C-7-CH3), 20.44 
(C-3-CH2), 26.68 (C-2-2xCH3)' 32.77 (C-4-CH2), 73.03 (C-2), 116.61 (C-5), 121.97 
(C-8), 122.28 (C-6-CH), 133.34 (C-7), 133.34 (C-9), 151.67 (C-I0) ppm. 
MS (EI) : m/z 204 (M+·, 23%), 189 (M+· - CH3, 10%), 174 (4%), 163 (10%), 149 
(1000/0), 133 (70/0), 105 (10%), 91 (5%). 
3,4-Dihydro-2,2,7,S-tetramethylbenzopyran (S2g) 
2,3-dimethylphenol (2Sg) (10.66g, 0.1 mol) was reacted with 3-methyl-2-buten-l-01 
(199) (8.62g, 0.1 mol) to afford a crude yellow oil. Fractional distillation yielded two 
main fractions. 
Fraction 1 (0.99g, 5%) the title compound (S2g). B.pt. 128-132°C I 2 torr, TLC (ethyl 
acetate I 40-60° pet ether,15:85), Rf 0.69. 
1 H NMR (CDCI3) : 3 1.31 (6H, S, C-2-2xCH3)' 1.75 (2H, t, J 6.81 Hz, C-3-CH2), 
2.09 (3H, s, Ar-CH3), 2.21 (3H, s, Ar-CH3), 2.70 (2H, t, J 6.73 Hz, C-4-CH2)' 6.61-
6.64 (lH, d, J 7.66 Hz, Ar-H), 6.78-6.81 (IH, d, J 7.71 Hz, Ar-H) ppm. 
13C NMR (CDC13) : 3 11.60 (Ar-CH3), 19.96 (Ar-CH3), 22.60 (CH2), 26.96 (2xCH3), 
32.90 (CH2), 73.88 (C-2), 117.88 (Ar-C), 120.80 (Ar-H), 124.51 (Ar-C), 126.05 (Ar-
H), 127.48 (Ar-C), 135.33 (Ar-C), 151.85 (Ar-C) ppm. 
MS (EI) : m/z 190 (M+·, C13H 180, 9%), 175 (M+·, C13H 180 - CH3, 38%), 149 
(12%), 135 (100%), 122 (25%), 91 (10%),77 (8%),57 (9%). 
Evidence for the formation of 1,1,4,5,7,7-hexamethyl-l,2,3,7,8,9-hexahydro-6-oxa-
cyclopenta[a]naphthalene (200g) as a yellow oil. Fraction 2 (4.66g, 25%). Bpt 148-
1520 C I 3 torr 
1 H NMR (CDCI3) : 3 1.31 (6H, s, 2 x CH3), 1.33 (6H, s, 2 x CH3), 1.72-1.78 (2H, t, 
J 6.82 Hz, CH2), 1.84-1.88 (2H, t, J 7.13 Hz, CH2), 2.08 (3H, s, Ar-CH3)' 2.12 (Ar-
CH3), 2.70-2.76 (2H, t, J 7.27 Hz, CH2), 2.80-2.85 (2H, t, J 6.79 Hz, CH 2) ppm. 
l3C NMR (CDCI3): 3 11.81 (Ar-CH3), 16.04 (Ar-CH3), 22.08 (CH2), 27.03 (2xCH 3 L 
27.20 (2xCH3), 28.45 (CH2), 32.32 (CH2), 43.31 (CH2), 45.77 (Aliphatic-C), 72.73 
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(Aliphatic-C), 114.17 (Ar-C), 122.89 (Ar-C), 130.05 (Ar-C), 132.64 (Ar-C), 145.43 
(Ar-C), 150.69 (Ar-C) ppm. 
MS (EI) : m/z 258 (M+·, 58%),243 (M+· - CH3, 75%), 229 (19%), 203 (70%), 187 
(58%),175 (100%), 159 (18%),149 (20%),135 (27%),91 (18%). 
3,4-Dihydro-2,2,S,S-tetramethylbenzopyran (S2h) 
2,5-Dimethylphenol (2Sh) (12.21g, 0.1 mol) was reacted with 2-methyl-3-buten-2-01 
(199) (8.64g, 0.1 mol) to afford a pale green oil (S2h) and a green oil (200h). 
Fraction 1 contained the title compound (S2h) (0.72g, 4%) as a pale green oil. B.pt. 
108-112°C I 1 torr. TLC (ethyl acetate: petroleum ether 40-60°, 15:85), Rf 0.67 
t H NMR (CDCI3) : 8 1.30 (6H, S, C-2-2xCH3)' 1.78 (2H, t, J 8.71 Hz, C-3-CH2), 
2.13 (Ar-CH3), 2.18 (Ar-CH3), 2.60 (2H, t, J 6.88 Hz,C-4-CH2), 6.58-6.61 (1H, d, J 
7.48 Hz, Ar-H), 6.85-6.88 (lH, d, J 7.44 Hz, Ar-H) ppm. 
13C NMR (CDCI3) : 8 15.94 (Ar-CH3), 18.95 (Ar-CH3), 20.85 (CH2), 26.77 (C-2-
2xCH3), 32.80 (CH2), 72.99 (C-2), 119.04 (Ar-C), 120.16 (Ar-H), 123.77 (Ar-C), 
127.65 (Ar-CH), 134.32 (Ar-C), 152.01 (Ar-C) ppm. 
Evidence for the formation of 3,3,4,6,6,9-hexamethyl-l ,2,3,6,7 ,8-hexahydro-5-oxa-
cyc1openta[b ] naphthalene (200h) 
Fraction 2 as a green oil (3.01g, 16%). B.pt. 126-132°C I 3 torr. TLC (ethyl acetate: 
petroleum ether 40-60°, 15:85) Rf 0.71. 
tH NMR (CDC13) : 8 1.29 (6H, S, C-2-2xCH3)' 1.39 (6H, S, 2xCH3), 1.73-1.79 (2H, 
t, J 6.86 Hz, CH2), 1.81-1.89 (2H, t, J 8.75 Hz, CH2), 2.05 (3H, S, Ar-CH3), 2.18 
(3H, s, Ar-CH3), 2.58-2.63 (2H, t, J 6.83 Hz, CH2), 2.69-2.75 (3H, t, J 7.27 Hz, 
CH2) ppm. 
13C NMR (CDCI3) : 8 11.07 (Ar-CH3), 15.17 (Ar-CH3), 20.84 (CH2), 26.95 (2xCH3). 
27.74 (2xCH3), 28.16 (CH2), 32.85 (CH2), 42.95 (CH2), 45.59 (Aliphatic-C), 72.68 
(Aliphatic-C), 116.97 (Ar-C), 119.33 (Ar-C), 128.77 (Ar-C), 132.53 (Ar-C), 147.21 
(Ar-C), 150.89 (Ar-C) ppm. 
3,4-Dihydro-2,2,S,7 -tetramethylbenzopyran (S2i) 
3,5-Dimethylphenol (2Si) (12.28g, 0.1 mol) was reacted with 2-methyl-3-buten-2-01 
(199) (8.60g, 0.1 mol) to afford the title compound as a yellow oil (7.14g, 38%). Bpt 
108-1100 C I 1 torr, TLC (ethyl acetate: petroleum ether 40-600, 15:85) Rf 0.66. 
tH NMR (CDCI3) : 8 1.30 (6H, S, C-2-2xCH3)' 1.77-1.82 (2H,t , J 6.85 Hz, CH2)· 
2.17 (Ar-CH3)' 2.22 (Ar-CH3)' 2.54-2.60 (2H, t, J 6.80 Hz, CH2), 6.49 (1H. s, Ar-
H), 6.54 (1 H, s, Ar-H) ppm. 
122 
Experimental 
13C NMR (CDC13) : 8 19.04 (Ar-CH3), 20.02 (CH2), 20.95 (Ar-CH3), 26.68 (C-2-
2xCH3), 32.95 (CH2), 73.24 (C-2), 115.42 (Ar-H), 116.58 (Ar-C). 122.17 (Ar-H), 
136.46 (Ar-C), 136.88 (Ar-C), 153.73 (Ar-C) ppm. 
3,4-Dihydro-6-chloro-2,2,S-trimethylbenzopyran (82j) 
4-Chloro-3-methylphenol (28j) (71.35g, 0.5 mol) was reacted with 2-methyl-3-buten-
2-01 (199) (43.1lg, 0.5 mol) to afford the title compound (76.58g, 73%) as a pale 
yellow solid, m. pt. 54-56°C. 
IR (film) : u 2976-2828 (sat. C-H str.), 1614-1563 (C=C), 1489-1453 (C-H def.) 1376 
(d, geminal CH3), 1157 (C-O), 874 (C-H bend), 776 (C-Cl) em-I. 
IH NMR (CDC13) : 8 1.30 (6H, s, C-2-2xCH3)' 1.73-1.81 (2H, t, J 6.79 Hz, CH2), 
2.26 (Ar-CH3), 2.67-2.72 (2H, t, J 6.77 Hz,CH2), 6.64 (Ar-H), 7.01 (Ar-H) ppm. 
13C NMR (CDC13) : 8 19.71 (Ar-CH3), 21.41 (CH2), 26.75 (C-2-2xCH3)' 32.59 
(CH2), 74.30 (C-2), 119.30 (Ar-H), 119.87 (Ar-C), 124.60 (Ar-C), 129.20 (Ar-H), 
134.69 (Ar-C), 152.43 (Ar-C) ppm. 
MS (EI) : m/z 210 (M+', C12H I5ClO, 39%),195 (M+', C l2Hl5ClO - CH3, 12%), 175 
(16%),155 (100%),149 (6%),135 (15%),91 (19%),77 (7%). 
Analysis ca1cd. for C12H150Cl (210) C, 69.48; H, 7.62. Found: C, 69.32; H, 7.93%. 
Racemic ex-Tocopherol (1) 
Trimethylhydroquinone (28a) (15.30g, 0.1 mol) was reacted with phytol (36) (27.28g, 
0.1 mol) to afford the title compound (35.66g, 83%)34 as a red oil, TLC (100% 
chloroform) : Rf 0.80. 
I H NMR (CDC13) : 8 0.84 (3H, d, J 6.0 Hz, CH3), 0.85 (3H, d, J 6.25 Hz, CH3), 0.87 
(6H, d, J 6.40 Hz, 2xCH3)' 1.08-1.60 (24H, m), 1.78 (2H, m, J 6.68 Hz, C-3-CH2)' 
2.10 (6H, s, C-5,7-2xCH3)' 2.15 (3H, s, C-8-CH3)' 2.60 (2H, t, J 6.83 Hz. C-4-
CH2), 4.18 (1H, S, C-6-0H) ppm. 
13C NMR (CDCI3) : 8 11.27 (C-5-CH3)' 11.78 (C-8-CH3), 12.21 (C-7-CH3)' 19.70 
(C-4'-CH3)' 19.76 (C-8'-CH3)' 20.78 (C-4-CH2), 21.08 (C-2'-CH2)' 22.64 (C-I3'-
CH3), 22.73 (C-12'-CH3)' 23.81 (C-2-CH3)' 24.47 (C-6'-CH2)' 24.83 (C-I0'-CH2)' 
27.99 (C-12'-CH), 31.59 (C-3-CH2)' 32.72 (C-4-CH), 32.81 (C-8'-CH), 37.31 (C-7'-
CH2), 37.42 (C-5'-CH2)' 38.36 (C-9'CH2)' 39.40 (C-3'-CH2)' 39.84 (C-ll'-CH2)· 
39.92 (C-1'-CH2)' 74.53 (C-2), 117.34 (C-5), 118.54 (C-6), 121.09 (C-8). 122.61 (C-
7), 144.56 (C-9), 145.58 (C-10) ppm. 
MS (EI) : m/z 431 (M+l, 33%),430 (M+·, 100o/r), 205 00%). 165 (90%), 149 (l8(lr). 
121 (5%),91 «5%),71 00%),57 (19%),43 (22o/r,). 
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2,3-Dihydro-5-hydroxy-2,2,4,6, 7-pentamethylbenzofuran (124a) 
Trimethylhydroquinone (2Sa) (15.38g, 0.1 mol) was mixed with trifluoroacetic acid (30 
ml) at 100°C under an atmosphere of argon. 2-Methyl-2-propen-101 (207) (7.3lg, 0.1 
mol) was added dropwise over a period of 30 mins and the reaction mixture was heated 
under reflux for 3-4 hrs. The reaction mixture was poured into ice, neutralised with 
10%w/v sodium bicarbonate solution (500 ml), and the organic layer was extracted with 
ethyl acetate (200 mI), washed with water, and dried with anhydrous magnesium 
sulphate. Solvent was evaporated to give a brown oil. To the oil was added methanol 
(100 mI), and concentrated hydrochloric acid (10 ml), and the mixture was heated under 
reflux for 1hr. The resulting solution was poured into ice, extracted with ethyl acetate 
(200 mI), neutralised with 10%w/v sodium bicarbonate solution (300 ml), was treated 
with Claisens alkali, acidified with concentrated hydrochloric acid, washed with water 
(2x100ml), and dried with anhydrous magnesium sulphate. The solvent was removed in 
vacuo to afford a brown oil which solidified on standing. Crystallisation from petroleum 
ether ( b pt 40-600 ) gave the title compound (7.67 g, 37%) as a light brown solid, m.pt. 
118-1200 C (Lit. m.pt. 122-1230 C57,130), TLC (ethyl acetate: petroleum ether 40-600, 
15:85), Rf 0.38. The mother liqour from recrystallisation was analysed by mass 
spectrometry and was shown to contain compounds 224, 225, 226. These were not 
isolated. 
IR (KBr) : u 3446 (O-H), 2967-2852 (sat. C-H str.), 1630 (C=C), 1457-1414 (C-H 
def.), 1368 (d, geminal CH3), 1273-1214 (C-O), 833 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 1.44 (6H, s, C-2-2xCH3)' 2.09 (6H, s, C-4,C-6-CH3)' 2.11 (3H, 
s, C-7-CH3), 2.89 (2H, S, C-3-CH2)' 4.27 (1H, s, C-5-0H) ppm. 
13C NMR (CDCI3) : 8 11.99 (C-4-CH3)' 12.18 (C-7-CH3), 12.81 (C-6-CH3), 28.45 
(C-2-2CH3)' 42.84 (C-3-CH2), 85.08 (C-2), 115.71 (C-4), 117.60 (C-5), 121.60 (C-
7), 123.04 (C-6), 145.29 (C-8), 151.07 (C-9) ppm. 
M.S. (EI) : m/z 206 (M+·, C13H I80 2, 56%),191 (M+·, C13HI80 2 - CH3. 100%), 176 
(16%), 163 (10%), 91 (7%),77 (6%),43 (11 %). 
Analysis ca1cd. for C13H1802 (206) C, 75.69; H, 8.79. Found: C, 75.66; H, 8.89%. 
Evidence for the presence of 2,2,4,6,7-pentamethyl-5-(2,3,5-trimethyl-phenoxy)-2,3-
dihydro-benzofuran (224) in the recrystallisation mother liquor. 
M.S. (CI) : m/z 325 (M+ 1, C22H280 2, 3%). 
Evidence for the presence of 2,4-diisopropyl-6.7 ,8-trimethyl-4H -benzo[ I ,3 ]dioxane 
(225) in the recrystallisation mother liquor. 
M.S. (CI) : m/z 263 (M+ 1, C 17H2602' 2%) 
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Evidence for the presence of (226) in the recrystallisation mother liquor. 
M.S. (CI) : m/z 337 (M+1, C22H3002' 2%). 
2,3-Dihydro-2,2,4,6,7-pentamethylbenzofuran (124b) 
2,3,5-Trimethylphenol (28b) (13.62g, 0.1 mol) was dissolved in trifluoroacetic acid 
(30ml) under an atmosphere of argon at 100°C. 2-Methyl-2-propen-1-01 (207) (7.21g, 
0.1 mol) was added drop wise over a period of 30mins. The solution was heated under 
reflux for 1hr. Formation of the benzofuran was monitored by tIc (ethyl acetate: 
petroleum ether 40-600 , 15:85). The solution was poured into ice, neutralised with 
10%w/v sodium bicarbonate solution, washed with water (2x100ml), extracted with 
ethyl acetate (200 ml) and dried with magnesium sulphate. Evaporation of the solvent 
gave a dark brown oil. Crystallisation from methanol-water (3: 1) afforded the title 
compound (6.72g, 35%) as a pale yellow crystalline solid, m.pt. 43-450 C (Lit. m.pt. 
47°C241) , (ethyl acetate: petroleum ether 40-60°, 15:85), Rf 0.76. Mass spectrometric 
analysis of the mother liquor confirmed the presence of 2,3-dihydro-2,2,4,6,7-
pentamethyl-(2-methyl-1-propenyl)-benzofuran (209b). 
IR (KBr) : u 2979-2864 (sat. C-H str.), 1599 (C=C), 1366 (d,geminal CH3) 1285 (C-
O), 833 (C-H bend) cm-l. 
1 H NMR (CDCI3) : 8 1.41 (6H, S, C-2-CH3)' 2.07 (3H, S, C-4-CH3)' 2.10 (3H, s, C-
6-CH3), 2.14 (3H, s, C-7-CH3), 2.90 (2H, s, C-3-CH2), 6.47 (1H, s, C-5-CH) ppm. 
13C NMR (CDCI3) 8 11.53 (C-4-CH3)' 18.49 (C-7-CH3), 19.30 (C-6-CH3), 28.62 (C-
2-2CH3), 42.83 (C-3-CH2), 85.83 (C-2), 115.29 (C-4), 122.12 ( C-5-CH), 122.68 (C-
7), 131.16 (C-6) 136.38 (C-8), 157.32 (C-9) ppm. 
M.S. (EI) : m/z 190 (M+·, C 13H 1SO, 82%), 175 (M+·, C13H 1SO - CH3, 100%), 160 
(12%), 147 (M+·, C13H 1SO - C3H7, 15%), 115 (16%), 105 (16%),91 (19%),77 
(16%). 
Analysis caIcd. for C13HlSO (190) C, 82.06; H, 9.53. Found: C, 81.14; H, 9.52%. 
Evidence for the presence of 2,3-Dihydro-2,2,4,6,7-pentamethyl-(2-methyl-1-propenyl)-
benzofuran (209b) in the mother liquor. 
M.S. (EI) : m/z 244 (M+·, C17H240, 29%), 229 (M+·, C 17H240 - CH3, 29%), 203 
(52%), 190 (98%), 187 (15%), 175 (100%), 173 ( 19%), 147 (14%), 145 (14%),91 
(17%), 43 (19%). 
The following compounds were prepared using the above method. 
Those compounds which were obtained as oils were purified by short-path high vacuum 
distillation. 
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2,3-Dihydro-S-chloro-2,2-dimethylbenzofuran (124c) 
4-Chlorophenol (28c) (25.76g, 0.20mol) was reacted with 2-methyl-2-propen-l-ol 
(207) (15.16g, 0.21mol) to afford the title compound as a pale yellow oil (2.10g, 6%). 
B.pt. 82-84°C / 0.18mmHg, (Lit. b.pt. 117°C / 12 Torr23S), TLC (ethyl acetate: 
petroleum ether 40-60°, 25:75), Rf 0.80, G.C. Rt 12.29 min. 
IH NMR (CDC13) : 8 1.46 (6H, S, C-2-2xCH3)' 2.98 (2H, s, C-3-CH2), 6.61-6.64 
(IH, d, 1 7.50Hz, C-7-H), 7.02-7.03 (1H, s, 13.0 Hz, C-4-H), 7.05-7.09 (lH, d, m, 1 
7.50 Hz, 1 3.88 Hz, C-6-H) ppm. 
13C NMR (CDC13) : 8 28.07 (C-2-2xCH3)' 42.75 (C-3-CH2), 87.46 (C-2), 110.37 (Ar-
CH), 116.73 (Ar -C), 125.20 (Ar-CH), 127.80 (Ar-CH), 129.00 (Ar-C), 157.53 (Ar-C) 
ppm. 
GC-MS : m/z 184 (M+·, ClOHl10C1, 28%), 182 (M+·, C lOHl1 0C1, 72%), 169 (M+·, 
ClOHllOCl - CH3, 36%), 167 (M+·, ClOHllOCl - CH3, 100%), 147 (18%), 141 (M+·, 
C 13H 1SO - C3H7, 27%), 139 (M+·, C13H 1SO - C3H7, 48%), 132 (18%), 119 (9%), 
103 (28%),91 (18%), 77 (27%). 
2,3-Dihydro-2,2-dimethylnaphtho[2,1-b ]furan (124f). 
I-Napthol (28f) (28.84g, 0.2 mol) was reacted with 2-methyl-2-propen-l-ol (207) 
(14.44g, 0.2 mol) to afford the title compound (2.31g, 6%) as a red oil. B.pt. 58-60°C / 
0.2mmHg, (Lit. Gum240). 
IH NMR (CDCI3) : 8 1.50 (6H, s, C2-2xCH3), 3.08 (2H, s, C3-CH2), 7.21-7.24 (lH, 
d,1 8.0 Hz, Ar-H), 7.29-7.32 (lH, d, 1 8.0Hz,Ar-H), 7.31-7.34 (lH, d, J 8.0Hz, 
meta-coupled, Ar-H), 7.97-8.00 (IH, d, meta-coupled, 18.0 Hz, 1m Hz, Ar-H ) ppm. 
13C NMR (CDCI3) : 8 28.63 (C-2-2xCH3)' 43.86 (C-3-CH2), 87.53 (C-2), 119.69 (Ar-
CH), 120.64 (Ar-C), 121.79 (Ar-CH), 122.87 (Ar-C), 123.39 (Ar-CH), 124.63 (Ar-
CH), 125.13 (Ar-CH), 127.99 (Ar-CH), 134.18 (Ar-C), 154.37 (Ar-C) ppm. 
2,3-Dihydro-2,2,6,7-tetramethylbenzofuran (124g) 
2,3-Dimethylphenol (28g) (28.76g, 0.24 mol) was reacted with 2-methyl-2-propen-l-ol 
(207) (l8.87g, 0.26 mol) to afford (124g) and (210g) which were separated by 
fractional distillation. 
The first fraction was the title compound as a pale yellow oil (11.llg, 26%). B.pt. 82-
860C / O.llmmHg, (Lit. b. pt 450C / 0.05mmHg241) TLC (ethyl acetate: petroleum 
ether 40-600, 25:75), G.C. Rt 12.03 min. 
IR (film) : u 3031 (ar. C-H str.), 2953-2867 (sat. C-H str), 1620 (C=C), 1459 (C-H 
-1 
def.), 1368 (d, geminal CH3), 1081 (C-O) cm . 
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IH NMR (CDC13) : 8 1.46 (6H, S, C-2-2xCH3)' 2.11 (3H, S, C-6-CH3)' 2.22 (3H, s, 
C-7 -CH3), 2.97 (2H, s, C-3-CH2), 6.61-6.64 (lH, d, J 7.44 Hz, C-4-H), 7.24 (lH. d, 
J 7.44 Hz, C-5-H) ppm. 
13C NMR (CDC13) : 8 11.73 (C-6-CH3), 19.43 (C-7-CH3), 28.36 (C-2-2CH3), 43.29 
(C-3-CH2), 85.97 (C-2), 118.26 (C-6), 121.07 (C-4-CH), 121.63 (C-5-CH), 123.73 
(C-7), 136.41 (C-8), 157.66 (C-9) ppm. 
GC-MS : m/z 176 (M+', C12H 160, 58%), 161 (M+', C12H I60 - CH3, 100%), 143 
(12%), 133 (M+', CI2HI60 - C3H7, 39%),115 (7%), 105 (12%),91 (16%),77 (9%). 
The second fraction was a yellow oil, b.pt. 116-120oC I 0.16mmHg, G.C. Rt 16.51 
min, identified as 2,3-dihydro-5-isopropyl-2,2,6,7-tetramethy1benzofuran (210g). 
IR (film) : u 2953-2867 (C-H str), 1620 (C=C), 1468 (C-H), 1367 (d, gemina1 CH3), 
1081 (C-O) em-I. 
IH NMR (CDC13) : 8 0.88-0.92 (6H, d, J 9 Hz, C-2'-2xCH3)' 1.43 (6H, s, C-2-
2xCH3), 1.75-1.78 (1H, m, J 7.5 Hz, C-2'-H), 2.12 (3H, S, C-6-CH3)' 2.13 (3H, S, 
C-7-CH3)' 2.39-2.42 (2H, d, J 7.1 Hz, C-1'-CH2)' 2.94 (2H, S, C-3-CH2)' 6.71 (1H, 
s, C-4-H) ppm. 
13C NMR (CDC13) : 8 12.40 (C-6-CH3), 15.27 (C-7 -CH3), 22.61 (C-2'-2xCH3)' 28.36 
(C-2-2xCH3)' 29.53 (C-2'-CH), 43.28 (C-3-CH2), 85.35 (C-2), 118.04 (C-6), 122.71 
(C-7), 123.97 (C-4-CH), 131.17 (C-5), 134.04 (C-8), 155.90 (C-9) ppm. 
GC-MS : m/z 232 (M+', C16H240, 25%), 189 (M+', C16H240 - C3H7, 100%), 159 
(5%),147 (7%),119 (9%),105 (4%),91 (6%),77 (3%). 
Dihydro-2,2,4,7 -tetramethylbenzofuran (124h) 
2,5-Dimethy1pheno1 (28h) (12.76g, 0.10 mol) was reacted with 2-methyl-2-propen-l-ol 
(207) (l1.24g, 0.16 mol) to afford a mixture of the title compound (124h) and 210h 
which were separated by fractional distillation. 
The first fraction (124h) was a pale yellow oil (1.99g, 11 %), b. pt 92-96°C / 
0.06mmHg (Lit. b. pt 480C I 0.03241 ), GC Rt 12.18 min. 
IR (film) : u 2954-2868 (C-H str.), 1594 (C=C), 1469-1415 (C-H def.), 1368 (d, 
geminal CH3), 1268 (C-O), 879 (C-H bend) em-I. 
1 H NMR (CDC13) : 8 1.47 (6H, S, C-2-2xCH3)' 2.16 (3H, S, C-4-CH3)' 2.17 (3H, S, 
C-7-CH3)' 2.91 (2H, S, C-3-CH2)' 6.53-6.56 (lH, d, J 7.46 Hz, Ar-H), 6.82-6.85 
(lH, d J 7.61 Hz, Ar-H) ppm. 
l3C NMR (CDCI3) : 8 15.10 (Ar-CH3), 18.61 (Ar-CH3), 28.60 (C-2-2xCH3)' 42.27 
(C-3-CH2), 85.76 (C-2), 116.64 (Ar-C), 120.54 (Ar-CH), 125.18 (Ar-C), 129.04 (Ar-
CH), 131.98 (Ar-C), 157.06 (Ar-C) ppm. 
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GC-MS : m/z 176 (M+·, C12HI60, 52%),161 (M+·, Cl6H240 - CH3, 100%), 133 (M+·, 
C l6H240 - C3H7, 38%),105 (17%),91 (22%),77 (18%),39 (32%). 
The second fraction was also a yellow oil, B.pt. l24-l27°C I 0.1mmHg, GC Rt 16.74 
min and was identified as 2,3-dihydro-2,2,4,7 -tetramethyl-5-isopropyl-benzofuran 
(210h) 
IR (film) : u 2953-2867 (sat. C-H str.), 1595 (C=C), 1462-1415 (C-H def.), 1367 (d, 
geminal CH3), 1267 (C-O), 877 (C-H bend) em-I. 
IH NMR (CDC13) : () 0.89-0.92 (6H, d, J 6.61 Hz, C-2'-2xCH3)' 1.46 (6H, s, C-2-2 x 
CH3), 1.73-1.81 (1H, m, J 6.70 Hz, C-2'-H), 2.16 (3H, S, C-4-CH3)' 2.17 (3H, s, C-
7-CH3), 2.35-2.38 (2H, d, J 7.10 Hz, C-l'-CH2)' 2.92 (2H, s, C-3-CH2), 6.67 (1H, 
s, C-6-CH) ppm. 
13C NMR (CDC13) : () 15.09 (C-4-CH3), 15.70 (C-7-CH3), 22.60 (C-2'-2xCH3)' 28.23 
(C-2-2xCH3)' 29.71 (C-2'-H), 41.97 (C-1'-CH2), 42.97 (C-3-CH2), 85.65 (C-2), 
116.56 (Ar-C), 125.17 (Ar-C), 129.92 (Ar-C), 130.94 (C-6-CH), 131.16 (Ar-C), 
155.05 (Ar-C) ppm. 
GC-MS : m/z 232 (M+·, C16H240, 32%), 189 (M+·, Cl6H240 - C3H7, 100%), 147 
(8%),119 (13%),91 (7%),77 (6%),39 (17%). 
2,3-Dihydro-2,2,4,6-tetramethylbenzofuran (124i) 
3,5-Dimethylphenol (2Si) (24.45g, 0.20 mol) was reacted with 2-methyl-2-propen-l-01 
(207) (15.15g, 0.21mol) to afford a mixture of the title compound which was separated 
by vacuum distillation and 210i which was present in the mother liquor and was 
identified by GC/MS). 
The title compound (124i) (9.51g, 27%) was a pale green oil. B.pt 84-86°C I 
O.lmmHg (Lit. b. pt 88-890C I 0.01 mmHg243), TLC (ethyl acetate: pet. ether 40-60°, 
25:75), Rf 0.89, G.C. Rt 9.25 min. 
IR (film) : u 2972-2866 (C-H str.), 1620-1600 (C=C), 1492-1460 (C-H def), 1369 (d, 
geminal CH3), 1284 (C-O), 831 (C-H bend) em-I. 
IH NMR (CDC13) : () 1.49 (6H, S, C-2-2xCH3)' 2.13 (3H, s, C-4-CH3), 2.21 (3H, s, 
C-6-CH3), 2.87 (2H, s, C-3-CH2), 6.40 (1H, s, C-5-H), 7.19 (1H, s, C-7-H) ppm. 
13C NMR (CDC13) : () 18.80 (C-4-CH3)' 21.42 (C-6-CH3), 28.45 (C-2-2xCH3), 41.69 
(C-3-CH2), 86.38 (C-2), 107.56 (C-5-CH), 121.74 (C-7-CH), 122.95 (C-4), 134.44 
(C-6), 137.98 (C-8), 158.85 (C-9) ppm. 
GC-MS : m/z 176 (M+·, C I2H I60, 68%), 161 (M+·, C12H 160 - CH3, 100%). 146 
(8%),133 (M+·, C 12H160 - C3H7, 260/r), 91 (169r)' 71 (1 RO/C). 57 (44%),43 (73%). 
Analysis ca1cd. for C12H160 (176) C, 81.77; H, 9.15. Found: C. 81.49: H, 9.069r. 
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The presence of 2,3-dihydro-5-isopropyl-2,2,4,6-tetramethylbenzofuran (210i) was 
confirmed by GC/MS. 
G.C. Rt 12.51 min, G.C. Rt 12.47 min (M+·, C16H 240 - CH3, 1 %), 189 (M+·, 
C16H240 - C3H7, 100%), 159 (4%), 147 (22%), 119 (8%),91 (8%),77 (3%). 
2,3-Dihydro-5-chloro-2,2,6-trimethylbenzofuran (124j) 
4-Ch1oro-3-methylphenol (28j) (28.52g, 0.20 mol) was reacted with 2-methyl-2-
propen-1-o1 (207) (16.35g, 0.22 mol) to afford a mixture of the title compound and 
209j. The compound (124j) was a yellow oil (12.0g, 31 %) which was separated by 
fractional distillation. TLC (ethyl acetate: petroleum ether 40-60°, 25:75) Rf 0.81, b.pt. 
72-78°C 1 0.12mmHg, G.C. Rt 10.84 min. 
IR (film) : u 2973-2870 (sat. C-H str.), 1620-1583 (C=C), 1486-1458 (C-H def.) 1370 
(d, geminal CH3), 1262 (C-O), 867 (C-H bend), 779 (C-CI) em-I. 
IH NMR (CDCI3) : 8 1.44 (6H, s, C-2-2CH3)' 2.28 (3H, S, C-6-CH3)' 2.93 (2H, s, C-
3-CH2), 6.58 (IH, s, C-4-CH), 7.06 (1H, s, C-7-CH) ppm. 
13C NMR (CDCI3) : 8 20.35 (C-6-CH3), 28.05 (C-2-2CH3)' 42.55 (C-3-CH2), 87.36 
(C-2), 111.58 (C-4-CH), 124.57 (C-5), 125.33 (C-7-CH), 126.27 ( C-6), 135.34 (C-
8), 157.70 (C-9) ppm. 
GC-MS : m/z 198 (M+', CllH13CIO, 37%), 196 (M+', CllH13CIO, 100%), 183 (M+', 
C llH 13CIO - CH3, 32%), 181 (M+', CllH 13CIO - CH3, 90%), 161 (29%), 155 (M+', 
C ll H 13CIO - C3H7 , 28%), 153 (M+', Cll H 13CIO - C3H7, 32%), 146 (25%), 119 
(15%),117 (15%),105 (15%),91 (22%). 
The presence of 2,3-dihydro-5-chloro-2,2,6-trimethyl-7 -(2-methyl-1-propenyl)-
benzofuran (209j) was confirmed by GC/MS. 
G.C. Rt 10.84 min. 
GC-MS : m/z 252/250 (M+', C15H 19CIO, 100%), 237/235 (M+', C15H l9CIO - CH3, 
90%),219 (8%), 207 (7%),193 (15%),179 (6%),141 «5%), 115 (5%),93 «5%). 
Dihydro-2,2,5,6-tetrabenzofuran (1241) 
3,4-Dimethy1pheno1 (281) (24.25g, 0.2 mol) was reacted with 2-methyl-2-propen-1-01 
(207) (15.26, 0.2 mol) to afford a mixture of 2091, which was separated by fraction 
distillation and 2101 which was present in the mother liquor. 
The first fraction was the title compound as a yellow oil (4.51g, 130/<). B.pt. 52-60°C 1 
0.1 mmHg (Lit. b. pt 50-650C 1 1 Ton·244 ), TLC (ethyl acetate: pet. ether 40-60°, 
25:75), Rf 0.95, GC Rt 10.11 min. 
IH NMR (CDC13) : 8 1.44 (6H, s, C-2-2xCH3)' 2.15 ( 3H, s, Ar-CH3), 2.17 (3H, s, 
Ar-CH3)' 2.93 (2H, s, C-3-CH2)' 6.54 (lH, s, Ar-H), 6.89 (lH, s, Ar-H) ppm. 
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13C NMR (CDC13) : 8 19.42 (Ar-CH3), 20.15 (Ar-CH3), 28.25 (C-2-2xCH3). 42.86 
(C-3-CH2), 86.39 (C-2), 110.72 (Ar-CH), 124.21 (Ar-C), 126.16 (Ar-CH), 127.66 
(Ar-C), 136.10 (Ar-C), 157.22 (Ar-C) ppm. 
GC-MS : m/z 176 (M+·, C12H 160, 62%), 161 (M+·, C12H 160 - CH3, 100%), 143 
(15%),133 (M+·, C12H160 - C3H7, 39%),115 (8%),105 (16%),91(17%),77 (11%). 
Analysis calcd. for C12H160 (176) C, 81.77; H, 9.15. Found: C, 80.90; H, 9.49%. 
The presence of 2,3-dihydro-2,2,5,6-tetramethyl-7-(2-methyl-1-propenyl)-benzofuran 
(2091) (2.97 g, 8%) was confirmed by GC/MS. GC Rt 14.30 min. 
GC- MS : m/z 230 (M+·, C16H220, 47%), 215 (M+·, C16H240 - CH3, 100%), 200 
(13%), 187 (7%), 173 (14%), 159 (5%), 145 (5%), 129 (4%), 115 (5%),91 (4%), 77 
(4%). 
The second fraction was a brown oil, B.pt. 72-76°C I 0.13mmHg, GC Rt 13.16 min 
and identified as 2,3-dihydro-2,2,5,6-tetramethyl-7 -isopropyl-benzofuran (2101) 
IH NMR (CDC13) : 8 0.89-0.92 (6H, d, J 7.2 Hz, C-2'-2xCH3)' 1.44 (6H, s, C-2-
2xCH3), 2.08 (3H, s, C-5-CH3), 2.15 (3H, s, C-6-CH3), 2.29-2.42 (lH, m, J 8.9 Hz, 
C-2'-H), 2.12 (3H, S, C-6-CH3)' 2.91 (2H, s, C-3-CH2), 6.69 (lH, s, C-4-H) ppm. 
13C NMR (CDC13) : 8 15.99 (C-5-CH3), 22.52 (C-6-CH3), 28.52 (C-2'-2xCH3)' 28.34 
(C-2-2xCH3)' 29.13 (C-2'-CH), 42.83 (C-3-CH2), 85.53 (C-2), 120.31 (Ar-C), 
124.76 (Ar-C), 127.11 (Ar-C), 130.27 (C-4-CH), 132.31 (Ar-C), 155.27 (Ar-C) ppm. 
GC-MS : m/z 232 (M+·, C16H240, 25%), 217 (M+·, C16H240 - CH3, 1 %), 189 (M+·, 
C 16H240 - C3H7, 100%), 159 (4%), 147 (18%), 119 (8%), 105 (4%),91 (8%),77 
(4%). 
Dihydro-2,2,7 -trimethylbenzofuran (124m) 
2-Methylphenol (28m) (21.65g, 0.20 mol) was reacted with 2-methyl-2-propen-l-ol 
(207) (15.43g, 0.21 mol) to afford the title compound 124m and 210m (11.61g, 36%) 
which were separated by fractional distillation. 
The first fraction was a pale yellow oil (0.82g, 3%), B. pt. 80 - 82°C I 0.25mmHg (Lit. 
b.pt 320C I 0.1 mmHg241), TLC (ethyl acetate: pet. ether 40-60°,25:75), Rf 0.77, Rt 
9.81 min. 
IR (film) : u 3022 ( aromat. C-H str.), 2971-2867 (sat. C-H str), 1598 (C=C), 1468 (C-
H def.), 1368 (d, geminal CH3), 1263 (C-O), 881 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 1.45 (6H, S, C-2-2xCH3)' 2.18 (.3H, s, C-7-CH3), 2.97 (2H, s, 
C-3-CH2), 6.68-6.71 (lH, d, J 7.37 Hz, Ar-H), 6.89-6.95 (2H, m, J 8.02 Hz, Ar-H) 
ppm. 
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13C NMR (CDC13) : () 15.58 (C-7-CH3)' 28.31 (C-2-2xCH3)' 43.29 (C-3-CH2)' 85.80 
(C-2), 119.52 (Ar-C), 119.68 (Ar-CH), 122.41 (Ar-CH), 126.18 (Ar -C), 129.09 (Ar-
CH), 157.43 (Ar-C) ppm. 
GC-MS : m/z 162 (M+·, CllH 140, 59%), 147 (M+', CllH I40 - CH3, 100%), 129 
(8%),119 (M+·, CllH140 - C3H7, 42%),105 (7%),91 (27%),77 (11%), 39 (15%). 
The second fraction was a dark yellow oil (l1.61g, 36%). B.pt. 60-64°C /0.2mmHg, 
G.C. Rt 14.81min and was identified as 2,3-dihydro-2,2,7 -trimethyl-5-isopropyl-
benzofuran (210m). 
IR (film) : u 3022 (arom. C-H str.), 2971-2867 (sat. C-H str), 1598 (C=C), 1466 (C-H 
def.), 1368 (d, geminal CH3), 1263-1135 (C-O), 861 (C-H bend) em-I. 
IH NMR (CDC13) : () 0.86-0.89 (6H, d, 1 7.5Hz, C-2'-2xCH3)' 1.46 (6H, s, C-2-
2xCH3), 2.16 (3H, s, C-7 -CH3), 1.70-1.82 (2H, m, 1 7.5Hz,C-2'-H), 2.33-2.36 (2H, 
d,1 7.5Hz, C-1'-CH2)' 2.96 (2H, s, C-3-CH2), 6.69 (1H, s, Ar-H), 6.73 (1H, s, Ar-
H) ppm. 
13C NMR (CDC13) : () 15.39 (C-7-CH3)' 22.42 (C-2'-2xCH3)' 28.37 (C-2-2xCH3)' 
30.53 (C-2'-H), 43.31 (C-1 '-CH2), 44.97 (C-3-CH2), 85.87 (C-2), 118.75 (Ar-C), 
122.99 (Ar -CH), 125.97 (Ar-C), 129.81 (Ar-CH), 133.09 (Ar-C), 155.55 (Ar-C) ppm. 
GC-MS : m/z 218 (M+', C1sH220, 30%), 175 (M+', C1sH220 - C3H7, 100%), 147 
(5%), 133 (8%), 105 (9%), 91 (5%), 77 (4%),39 (8%). 
2,3-Dihydro-2,2,6-trimethylbeozofurao (1240) 
3-Methylphenol (280) (21.62g, 0.20 mol) was reacted with 2-methyl-2-propen-1-ol 
(207) (l5.20g, 0.21 mol) to afford the title compound 1240 and 210n which were 
separated by fractional distillation. 
The first fraction was a colourless oil (l0.38g, 32%. B.pt. 80-82°C / 0.28mmHg (Lit. 
b. pt 1310C / 50 mmHg133), TLC (ethyl acetate: pet ether 40-60°,25:75), Rf 0.76, G.C. 
Rt 10.56 min. 
IR (film) : u 3049 (ar. C-H str.), 2973-2862 (sat. C-H str.), 1621-1590 (C=C), 1498-
1466 (C-H def.), 1369 (d, geminal, CH3), 1277 (C-O), 798 (C-H bend) em-I. 
IH NMR (CDCI3) : () 1.45 (6H, S, C-2-2xCH3)' 2.28 (3H, S, C-6-CH3)' 2.94 (2H, S, 
C-3-CH2)' 6.55 (lH, s, C-7-H), 6.60-6.63 (lH, d, meta-coupled, 17.5 Hz, 1m 0.65 
Hz, C-5-H), 6.97-7.00 (lH, d, 17.50 Hz, C-4-CH3) ppm. 
13C NMR (CDC13) : () 21.49 (C-6-CH3)' 28.19 (C-2-2xCH3)' 42.61 (C-3-CH2), 86.61 
(C-2), 110.24 (Ar-CH), 120.61 (Ar-CH), 123.98 (Ar-C), 124.70 (Ar-CHL 138.01 (Ar-
C), 159.06 (Ar-C) ppm. 
GC-MS: m/z 162 (M+·, C 11 H 140' 770/c), 147 (M+·, C 11 H 1-+0 - CH3, 1 009r), 129 
(6%),119 (M+·, C
ll
H140 - C3H7, 37CJ,), 105 (8%), 91 (209r), 77 (99r), 39 (l2(lr). 
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Analysis ca1cd. for CllHl40 (162) C, 81.44; H, 8.70. Found: C, 81.29; H, 8.879c 
The second fraction was a yellow oil (0.84g, 3%), b.pt. 64-68°C / 0.25mmHg, G.C. Rt 
15.64 min, G.C. R t 14.46 min was identified as 2,3-dihydro-2,2,6-trimethyl-5-
isopropylbenzofuran (210n). 
IR (film) : u 2954-2867 (C-H str), 1622-1591 (C=C), 1493-1464 (C-H saturated deL), 
1367 (d,geminal CH3), 1271 (C-O), 877 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 0.89-0.92 (6H, d, J 7.50 Hz, C-2'-2xCH3)' 1.44 (6H, s, C-2-
2xCH3)' 1.72-1.83 (1H, m, J 7.50 Hz, C-2'-H), 2.21 (3H, S, C-6-CH3)' 2.36-2.39 
(2H, d, J 7.50 Hz, C-1'-CH2)' 2.94 (2H, S, C-3-CH2)' 6.52 (1H, s, Ar-H), 6.84 (1H, 
s, Ar-H) ppm. 
l3C NMR (CDCI3) : 818.65 (C-6-CH3), 22.57 (C-2'-2xCH3), 28.21 (C-2-2xCH3), 
29.54 (C-2'-CH), 42.20 (C-1'-CH2)' 42.81 (C-3-CH2), 86.35 (C-2), 110.88 (Ar-CH), 
124.51 (Ar -C), 126.28 (Ar-CH), 131.05 (Ar-C), 135.72 (Ar-C), 157.02 (Ar-C) ppm. 
GC-MS : m/z 218 (M+·, CI5H220, 39%), 175 (M+·, Cl5H220 - C3H7, 100%), 157 
(5%), 133 (7%), 105 (8%), 91 (4%),77 (5%),39 (7%). 
2,3-Dihydro-2,2,S-trimethylbenzofuran (1240) 
4-Methylpheno1 (280) (21.62g, 0.20 mol) was reacted with 2-methyl-2-propen-1-o1 
(207) (15.43g, 0.21 mol) to afford the title compound 1240 containing traces 2100. 
The title compound 1240 was a yellow oil (3.24g, 10%), B.pt. 68-72°C / 0.22mmHg 
Lit. b.pt 320C / 0.1 mmHg241), TLC (ethyl acetate: pet ether 40-60°,25:75), Rf 0.77, 
G.C. Rt 10.53 min 
IR (film) : u 2973-2866 (C-H str), 1618 (C=C), 1468 (C-H def.), 1491, 1369 (d, 
geminal, CH3), 1256 (C-O), 809 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 1.44 (6H, S, C-2-2xCH3)' 2.26 (3H, s, Ar-CH3), 2.95 (2H, s, C-
3-CH2), 6.60-6.62 (1H, d, J 8.0 Hz, Ar-H), 6.87-6.90 (1H, d, J 8.0 Hz, Ar-H), 7.00 
(1H, s, C-4-H) ppm. 
l3C NMR (CDCI3) : 8 20.74 (Ar-CH3), 28.16 (C-2-2xCH3)' 42.96 (C-3-CH2), 86.31 
(C-2), 109.03 (Ar-CH), 125.73 (Ar-CH), 127.05 (Ar-C), 128.28 (Ar-CH), 129.09 (Ar-
C), 156.77 (Ar-C) ppm. 
GC-MS : m/z 162 (M+·, C llH I40, 67%), 147 (M+·, CllH 140 - CH3, 100%), 129 
(8%), 119 (M+·, C llHl40 - C3H7, 45%), 105 (10%),91 (29%),77 (1S9c), 39 (l3o/r). 
The presence of 2,3_dihydro-2,2,4-trimethyl-7-isopropyl-benzofuran (2100) was 
confirmed by GC/MS. 
GC Rt 14.33 min. 
1 .3 2 
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GC-MS : m/z 218 (M+·, C15H220, 23%), 175 (M+·, Cll H I40 - C3H7, 100%), 161 
(6%), 147 (4%), 133 (38%), 119 (6%), 105 (8%),91 (6%),77 (5%). 
2,3-Dihydro-5-methoxy-2,2-dimethylbenzofuran (124p) 
4-Methoxyphenol (28p) (24.80g, 0.20mol) was reacted with 2-methylpropen-l-ol 
(207) (l5.62g, 0.21mol) to afford the title compound (1.33g, 4%) as a yellow oil. 
B.pt. 62-66°C I 0.13mmHg ( Lit. nmr evidence245), TLC (ethyl acetate: pet. ether 40-
60°, 25:75), Rf 0.83. 
IR (film) : u 2965 (sat. C-H str), 1512 (C=C), 1488 (C-H def.), 1368 (d,geminal CH3), 
1254 (C-O), 823 (C-H bend) cm-I. 
IH NMR (CDC13) : 8 1.45 (6H, s, C-2-2xCH3)' 2.96 (2H, s, C-3-CH2), 3.71 (3H, s, 
C-5-0CH3), 6.59 (lH, s, Ar-H), 6.60 (lH, s, Ar-H), 7.06-7.09 (lH, s, meta-coupled, 
1 3.04 Hz, C-6-H) ppm. 
13C NMR (CDCI3 ) : 8 28.12 (C-2-2xCH3)' 43.34 (C-3-CH2), 55.99 (C-5-0CH3), 
86.49 (C-2), 109.29 (Ar-CH), 111.58 (Ar-CH), 112.82 (Ar-CH), 128.05 (Ar-C), 
153.07 (Ar-C), 153.80 (Ar-C) ppm. 
Analysis calcd. for C llHI40 2 (l78) C, 74.13; H, 7.79. Found: C, 74.36; H, 9.14%. 
2,3-Dihydro-5-bromo-2,2-dimethylbenzofuran (124q) 
4-Bromophenol (28q) (34.15g, 0.20 mol) was reacted with 2-methyl-2-propen-l-01 
(207) (IS.ISg, 0.21mol) to afford the title compound as a yellow oil (1.48g, 3%) and 
was obtained by fractional distillation, b.pt. 56-60°C / 0.09mmHg (Lit. NMR 
evidence246), TLC (ethyl acetate: pet. ether40-600, 25:75), Rf 0.91, GC Rt 13.76 min. 
IR (film) : u 2961-2871 (C-H saturated str.), 1475 (C-H saturated def.), 1370 (d, 
geminal CH3), 1258 (C-O), 809 (C-H bend), 661 (C-Br) cm -1. 
IH NMR (CDC13) : 81.44 (6H, S, C-2-2xCH3)' 2.96 (2H, s, C-3-CH2), 6.56-6.59 
(lH, d, J 7.50Hz, C-7-H), 7.15-7.14 (lH, s, meta-coupled, 1m 2.95 Hz, C-4-H), 
7.7.17-7.21 (IH, d, meta-coupled, J 6.37 Hz, 1m 2.07 Hz, C-6-H) ppm. 
13C NMR (CDCI3) : 8 27.49 (C-2-2xCH3)' 42.64 (C-3-CH2), 87.35 (C-2), 111.00 (Ar-
CH), 111.53 (Ar-C), 128.03 (Ar-CH), 129.53 (Ar-C), 130.67 (Ar-CH), 158.01 (Ar-C) 
ppm. 
GC-MS : m/z 228 (M+·, ClOHllOBr, 100%), 226 (M+·, CI6H240, 87%), 213 (M+·, 
C 16H240 - CH3, 57%), 211 (M+·, CI6H240 - CH3, 56%), 185 (M+·, C I6H 240-
C
J
H
7
, 12%), 147 (21%),132 (71%),119 (13%),91 (22%),77 (23%). 
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2,3-Dihydro-2,2-dimethylbenzofuran (124r) 
Phenol (28r) (32.92, 0.35 mol) was reacted with 2-methyl-2-propen-1-o1 (207) 
(25.96g, 0.36 mol) to afford the title compound 124r which was separated by fraction 
distillation and 210r which was present in the mother liquor. 
The title compound (124r) was a yellow oil (0.30g, 1 %). B.pt. 52-54°C I 0.17mmHg 
(Lit. b.pt 31°C I 0.1 mmHg241). TLC (ethyl acetate: pet. ether 40-600 ,25:75), Rf 0.87, 
GC Rt 8.33 min. 
IH NMR (CDCI3) : 3 1.49 (6H, S, C-2-2xCH3)' 3.02 (2H, s, C-3-CH2), 6.73-6.76 
(1H, d, 10 7.50 Hz, 1m 0.95 Hz, Ar-H), 7.09-7.12 (1H, d, 17.50 Hz, Ar-H), 7.12-
7.16 (1H, m, Ar-H) ppm. 
13C NMR (CDCI3) : 3 28.23 (C-2-2xCH3)' 42.87 (C-3-CH2), 86.48 (C-2), 109.54 (Ar-
CH), 119.95 (Ar-CH), 125.17 (Ar-CH), 127.09 (Ar-C), 127.98 (Ar-CH), 158.86 (Ar-
C) ppm. 
GC-MS : m/z 148 (M+·, C lOH 120, 67%), 133 (M+·, C16H240 - CH3, 100%), 119 
(7%), 105 (M+·, C16H240 - C3H7, 63%),91 (16%),77 (20%),63 (10%), 50 (13%). 
The presence of 2,3-dihydro-2,2-dimethyl-5-isopropylbenzofuran (210r) was 
confirmed by GC/MS. 
GC Rt 14.18 min. 
GC-MS : m/z 204 (M+·, C 14H200, 33%), 161 (M+·, C14H200 - C3H7, 100%), 143 
(6%),133, (5%),119 (12%),104 (7%),91 (13%),77 (10%),55 (20%). 
2,3-Dihydro-2,2,4,6,7 -pentamethyl benzofuran (124a) 
Trimethylhydroquinone (28a) (45.82g, 0.30 mol) was stirred in toluene (30 ml) at room 
temperature under an atmosphere of argon. Isobutyraldehyde (208) (22.58g, 0.30 mol) 
and concentrated sulphuric acid (1ml) were added over 30mins and the reaction mixture 
was heated under reflux for 4 hrs. The mixture was poured onto ice (200g), neutralised 
with 10%w/v sodium bicarbonate solution (500 m1), extracted with ethyl acetate (200 ml) 
washed with water and dried over anhydrous magnesium sulphate. The solvent was 
removed in vacuo to give a brown oil which was treated with Claisens alkali. acidified 
with concentrated hydrochloric acid washed water (2 x 1ooml), and dried over anhydrous 
magnesium sulphate. Filtration of the drying agent and removal of the solvent il1 vacuo 
afforded a red oil. To this oil was added methanol (100 ml), and concentrated 
hydrochloric acid (10 ml); the mixture was heated under reflux for 1 hr. The resulting 
solution was poured into ice (I OOg), extracted with ethyl acetate (200 ml), neutralised 
with 10%w/v sodium bicarbonate solution, washed with water (2x1CX) ml) and dried with 
anhydrous magnesium sulphate. Filtration of the drying agent and removal of the solvent 
in vacuo afforded the title compoumd as a hrown oil (13.86g, 22£7,). (Lit. m.pt 122-
134 
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123°C130). Analysis of the mother liquor of 124a, by GC/MS showed the presence of 
223. 
GC Rt 18.66 min. 
GC-MS : m/z 206 (M+·, C13H 1S0 2, 100%), 191 (M+·, C13H 1S0 2 - CH3, 73%), 173 
(18%), 163 (M+·, C13H 1S0 2 - C3H7, 19%), 145 (10%) 135 (13%), 121 (8%), 105 
(8%), 91 (9%),77 (8%). 
The presence of 2,2,4,6,7-pentamethyl-5-(2-methy1-propeny10xy)-2,3-
dihydrobenzofuran (223) was identified by GC/MS. 
GC Rt 27.96 min. 
GC-MS : m/z 262 (M+·, C17, H260 2, 28%), 203 (100%),189 (37%),173 (43%),163 
(12%),149 (12%),133 (17%),119 (10%),91 (14%). 
2,3-Dihydro-2,2,4,6, 7 -pentamethyl benzofuran (124b) 
2,3,5-Trimethylphenol (28b) (40.83g, 0.30 mol) was dissolved in toluene (75 ml) 
under an atmosphere of argon. To the solution was added isobutyra1dehyde (208) 
(21.63g, 0.30 mol) and concentrated sulphuric acid (2.0g) and the reaction mixture was 
heated under reflux for 4 hrs in a Dean and Stark apparatus. The solvent was removed in 
vacuo to afford a brown oil. The oil was dissolved in ethyl acetate (200 m1), washed 
with C1aisens alkali solution and acidified with concentrated hydrochloric acid. The 
organic layer was washed with brine (2x200ml) and water (2x200m1) and dried over 
anhydrous magnesium sulphate. After the filtration of the drying agent and removal of 
the solvent in vacuo a dark brown oil was obtained which solidified on standing. 
Crystallisation from aqueous methanol afforded the title compound as a pale yellow solid 
(50.99g, 83%). M.pt 46-47°C (Lit. M.pt 47°C241), G.C. Rt 13.54 min. 
I H NMR (CDC13) : 8 1.45 (6H, s, 2xC-2-CH3)' 2.07 (3H, s, C-4-CH3)' 2.13 (3H, s, 
C-6-CH3), 2.19 (3H, s, C-7-CH3), 2.89 (2H, s, C-3-CH2), 6.47 (1H, s, C-5-CH) 
ppm. 
13C NMR (CDCI3) 8 11.64 (C-4-CH3)' 18.59 (C-7-CH3), 19.41 (C-6-CH3), 28.71 (C-
2-2CH3), 42.37 (C-3-CH2), 85.90 (C-2), 115.37 (C-4), 122.23 ( C-5-CH), 122.75 (C-
7), 131.22 (C-6) 136.45 (C-8), 157.40 (C-9) ppm. 
GC-MS : m/z 190 (M+·, C13H 1SO, 95%), 175 (M+·, C13H I80 - CH3· 100%), 157 
(15%), 147 (M+·, C13H180 - C3H7• 18%), 133 (5%), 119 (9%), 105 (9%),91 (8%). 
Analysis ca1cd. for C13H180 (190) C, 82.06; H, 9.53. Found: C, 81.73; H, 9.40%. 
The following compounds were synthesised using the method outlined as 
above. 
The compounds which were obtained as oils were purified hy high vacuum distillation. 
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2,3-Dihydro-5-chloro-2,2-dimethylbenzofuran (124c) 
4-Chlorophenol (28c) (2.20g, 0.20mol) was reacted with isobutyraldehyde (208) 
(14.55g, 0.21mol) to afford the title compound (2.22g, 6%) as a yellow oil. B.pt 60-
62°C I 0.13mmHg (Lit. b. pt 117°C I 12 Torr), GC Rt 12.68 min. 
IR (film) u 2967-2874 (sat. C-H str), 1756-1717 (C=C), 1475 (C-H deL), 1370 
(d,geminal CH3), 1256 (C-O), 823 (C-H bend) 781 (C-CI) em-I. 
IH NMR (CDCI3) : 8 1.46 (6H, S, C-2-2xCH3)' 2.98 (2H, s, C-3-CH2), 6.61-6.64 
(lH, d, J 8.43 Hz, C-7-H), 7.02-7.03 (1H, s, meta-coupled, Jm 2.30 Hz, C-4-H), 7.05-
7.08 (lH, d, meta-coupled, J 7.89 Hz, Jm 3.79 Hz, C-6-H) ppm. 
l3C NMR (CDCI3) : 8 28.03 (C-2-2xCH3)' 42.74 (C-3-CH2), 87A2 (C-2), 110.35 (Ar-
CH), 124.48 (Ar-C), 125.19 (Ar-CH), 127.77 (Ar-CH), 128.99 (Ar-C), 157.37 (Ar-C) 
ppm. 
GC-MS : m/z 184 (M+·, C lOH130CI, 23%), 182 (M+·, C lOHl3OCI, 70%), 169 (M+·, 
C 10H 130CI - CH3, 33%), 167 (M+·, ClO H 13 0CI - CH3, 100%), 141 (M+', 
C lOH 130CI - C3H7 , 28%), 139 (M+·, ClOH 130CI - C3H7, 47%), 119 (12%),103 
(48%),91 (22%),77 (34%),63 (17%),51 (28%). 
2,3-Dihydro-2,2-dimethylnaphtho[2,1-b]benzofuran (124f) 
I-Naphthol (28f) (28.25g, 0.20 mol) was reacted with isobutyraldehyde (208) 
(14.62g, 0.20 mol) to afford the title compound (9.02g, 23%) as a yellow semi-
crystalline solid. B.pt 64-66°C I 0.22mmHg (Lit. Gum240), GC Rt 17A3 min. 
IR (film) u 3058 (arom. C-H str.), 2972-2854 (C-H saturated str), 1632-1600 (C=C), 
1466 (C-H saturated deL), 1371 (d, geminal CH3), 1261 (C-O), 809 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 1.53 (6H, S, C-2-2xCH3)' 3.23 (2H, s, C-3-CH2), 7.04-7.08 
(1H, d, J 8.0 Hz, Ar-H), 7.23-7.29 (1H, dd, meta-coupled, J 8.18, J 8.12, Jm 1.37 Hz, 
Ar-H), 7.39-7A3 (1H, dd meta-coupled, J 8.28 Hz, J 7.95 Hz, J 1.27 Hz, Ar-H), 7A9-
7.53 (1H, d, meta-coupled, J 8.23 Hz, Jm 0.54 Hz, Ar-H), 7.62-7.66 (1H, d, J 8.74 
Hz, Ar-H), 7.75-7.78 (1H, d, J 8.21 Hz, Ar-H) ppm. 
l3C NMR (CDCI3) : 8 28.52 (C-2-2xCH3)' 41.68 (C-3-CH2), 87 Al (C-2), 112.38 (Ar-
CH), 118.13 (Ar -C), 122.56 (Ar-CH), 126A9 (Ar-CH), 128.68 (Ar-CH), 128.90 (Ar-
CH), 129.00 (Ar-C), 131.13 (Ar-C), 131.13 (Ar-C), 156.21 (Ar-C) ppm. 
GC-MS : m/z 198 (M+·, C I4HI40, 100%),183 (M+·, Cl4Hl40 - CH3, 84%),165 
(M+., C l4Hl40 - C3H7' 38%),153 (19%),139 (11%),128 (13%),91 «5%),77 
(II %). 
Analysis calcd. for C14H140 (198) C, 84.81; H, 7.12. Found: C, 84.51~ H, 7.82%. 
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2,3-Dihydro-2,2,4,7-tetramethylbenzofuran (124h) 
2,5-Dimethylphenol (28h) (36.70g, 0.30 mol) was reacted with isobutyraldehyde 
(208) (21.95g, 0.30 mol) to afford a mixture of 124h, 209h and 210h which were 
separated by fractional distillation. 
The first fraction was the title compound (124h) as a pale yellow oil (7.72g, 15%), b.pt 
58-640C I 0.04mmHg (Lit. b. pt 48°C I 0.03 mmHg24l), G.C. Rt 11.64 min. 
IR (film) u 3051 (arom. C-H), 2972-2923 (sat. C-H str.), 1594 (C=C), 1460 (C-H 
def.), 1368 (d, geminal CH3), 1267 (C-O), 867 (C-H bend) cm-l. 
lH NMR (CDCI3) : 8 1.49 (6H, S, C-2-2xCH3)' 2.18 (3H, S, C-4-CH3)' 2.19 (3H, s, 
C-7-CH3), 2.92 (2H, s, C-3-CH2), 6.53-6.50 (1H, d, J 7.61 Hz, Ar-H), 6.84-6.87 
(1H, d J 7.75 Hz, Ar-H) ppm. 
BC NMR (CDC13) : 8 15.22 (Ar-CH3), 18.72 (Ar-CH3), 28.70 (C-2-2xCH3)' 42.36 
(C-3-CH2), 85.89 (C-2), 116.73 (Ar-C), 120.68 (Ar-CH), 125.26 (Ar-C), 129.17 (Ar-
CH), 132.07 (Ar-C), 157.15 (Ar-C) ppm. 
GC-MS : m/z 176 (M+·, C12H l60, 68%), 161 (M+·, C12H l60 - CH3, 100%), 143 
(14%),133 (M+·, C12Hl60 - C3H7, 35%),115 (9%),105 (12%),91 (15%),77 (9%). 
Analysis calcd. for C12Hl60 (176) C, 81.77; H, 9.15. Found: C, 81.18; H, 9.89%. 
The second fraction was a yellow oil (4.16g, 6.0%) and was identified as 2,3-dihydro-
2,2,4,7-tetramethyl-5-(2-methyl-1-propenyl)benzofuran (209h). 
Compound 124h has 80% of 209h ctH NMR). B.pt 112-116°C I 0.06mm Hg, G.C. 
Rt 16.51 min. 
IR (film) : u 2970-2868 (sat. C-H str.), 1592 (C=C), 1460 (C-H def.), 1366 (d, geminal 
CH3), 1258 (C-O), 878 (C-H bend) cm-l. 
lH NMR (CDCI3) : 8 1.47 (6H, S, C-2-2xCH3)' 1.67 (3H, S, C-2'-CH3)' 1.86 (3H, S, 
C-2'-CH3)' 2.04 (3H, s, Ar-CH3), 2.23 (3H, s, Ar-CH3), 2.92 (2H, s, C-3-CH2), 6.14 
(lH, s, C-l'-H), 6.73 (1H, s, Ar-CH) ppm. 
13C NMR (CDC13) : 8 15.13 (Ar-CH3), 16.58 (Ar-CH3), 19.02 (C-2'-CH3)' 26.03 (C-
2'-CH3)' 28.90 (C-2-2CH3)' 85.94 (C-2), 115.81 (Ar-C), 123.94 (C-1'-CH), 129.58 
(C-2'), 130.25 (Ar-CH), 133.71 (Ar-C), 136.91 (Ar-C), 152.67 (Ar-C), 155.39 (Ar-C) 
ppm. 
GC-MS : m/z 230 (M+·, Cl6H220, 100%),215 (M+·, Cl6H220 - CH3, 54%), 187 
(M+., C l6H220 - C3H7, 16%),173 (41%),159 (24%),145 (l1lk), 131 (8%),91 (9%). 
Analysis calcd. for C16H220 (230) C, 83.436; H, 9.63. Found: C, 80.22; H, 10.4R0(. 
The third fraction was a yellow oil (3.12g, 6o/c), b.pt. 96-1 10°C / 0.06mm Hg, G.C. Rt 
16.19 min and identified as 2J_dihydro-2,2,4,7-tetramcthyl-5-isopropylbenzofuran 
(210h). 
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IR (film) : u 2953-2867 (sat. C-H str.), 1595 (C=C), 1462-1415 (C-H def.), 1367 (d, 
geminal CH3), 1267 (C-O), 877 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 0.89-0.92 (3H, d, J 9.15 Hz, C-2'-2xCH3)' 1.46 (6H, s, C-2-2x 
CH3), 1.73-1.80 (lH, m, J 6.75 Hz, C-2'-H), 2.16 (3H, S, C-4-CH3)' 2.17 (3H, s, C-
7 -CH3), 2.35-2.38 (2H, d, J 7.09 Hz, C-1 '-CH2), 2.91 (2H, s, C-3-CH2), 6.67 (lH, 
s, C-6-CH) ppm. 
l3C NMR (CDCI3) : 8 14.49 (C-4-CH3), 22.63 (C-7 -CH3), 28.30 (C-2'-2xCH3)' 28.67 
(C-2-2xCH3)' 29.54 (C-2'-H), 41.80 (C-1 '-CH2), 43.03 (C-3-CH2), 85.81 (C-2), 
114.54 (Ar-C), 116.74 (C-6-CH), 125.64 (Ar-C), 132.05 (Ar-C), 134.79 (Ar-C), 
151.72 (Ar-C) ppm. 
GC-MS : m/z 232 (M+·, C16H240, 22%), 189 (M+·, CI6H240 - C3H7, 100%), 159 
(5%), 147 (7%), 119 (12%), 105 (3%), 91 (6%), 77 (3%). 
Analysis calcd. for CI5H240 (232) C, 82.70; H, 10.41. Found: C, 81.41; H, 10.19%. 
2,3-Dihydro-2,2,4,6-tetramethylbenzofuran (124i) 
3,5-Dimethylphenol (28i) (36.85g, 0.30 mol) was reacted with isobutyraldehyde (208) 
(l9.08g, 0.26 mol) to afford a mixture of the title compound (124i) which was 
separated by fractional distillation. Compound 209i which was confirmed by NMR. 
The title compound was a pale yellow oil (l9.79g, 38%), b.pt 50-56°C I 0.08mmHg 
(Lit. b. pt 88-890 C I 0.01 mmHg243). TLC (ethyl acetate: pet ether 40-60°, 25:75) Rf 
0.80, G.C. Rt 12.10 min. 
IR (film) : \) 2972 (sat. C-H str.), 1620-1600 (C=C), 1492-1460 (C-H def.), 1368 (d, 
geminal CH3), 1284 (C-O), 872-831 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 1.43 (6H, S, C-2-2xCH3)' 2.15 (3H, s, C-4-CH3), 2.24 (3H, s, 
C-6-CH3), 2.84 (2H, S, C-3-CH2)' 6.38 (lH, s, C-5-H), 6.45 (lH, s, C-7-H) ppm. 
l3C NMR (CDCI3) : 8 18.77 (C-4-CH3), 21.15 (C-6-CH3)' 28.40 (C-2-2xCH3)' 41.69 
(C-3-CH2), 86.25 (C-2), 107.56 (C-5-CH), 121.21 (C-7-CH), 122.90 (C-4), 134.33 
(C-6), 137.86 (C-8), 158.86 (C-9) ppm. 
GC-MS : m/z 176 ( M+·, C12H I60, 100%), 161 (M+·, C12H I60 - CH3, 60%), 143 
(8%),133 (M+·, CI2HI60 - C3H7, 20%),117 (5%), 105 (8%),91 (2%). 
Analysis calcd. for C16H220 (230) C, 81.27; H, 9.15. Found: C, 81.30; H, 9.28%. 
Evidence for the presence of 2,3-dihydro-2,2,4,6-tetramethyl-5-(2-methyl-l-propenyl)-
benzofuran (209i) was confirmed by NMR. 
Compound 124i contains 18% pure of (209i) ct H NMR), G.C. Rt 17.31 min. 
IH NMR (CDCI3) : 8 1.45 (6H, S, C-2-2xCH3)' 1.56 (3H, S, C-2'-CH3)' 1.89 (3H, S, 
C-2'-CH3)' 2.10 (3H, s, Ar-CH3) 2.24 (3H, s, Ar-CH3)' 2.92 (2H, S, C-3-CH2), 5.95 
(1 H, s, broad, C-l '-H), 6.72 (1 H, s, Ar-H) ppm. 
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GC-MS : m/z 230 (M+·, C16H220, 48%), 215 (M+·, C16H220 - CH3, 100%), 200 
(8%),185 (9%),173 (12%),159 (9%),142 (8%),128 (5%),115 «5%),91 (10%),77 
(5%). 
2,3-Dihydro-S-chloro-2,2,6-trimethylbenzofuran (124j) 
4-Chloro-3-methylphenol (2Sj) (42.90g, 0.30 mol) was reacted with isobutyraldehyde 
(20S) (121.96g, 0.30 mol) to afford a mixture of the title compound 124j which was 
separated by fractional distillation, 209j and 210j which were present in the mother 
liquor of 124j and were identified by GC/MS. 
The title compound was a yellow oil (7.01g, 12%), TLC (ethyl acetate: pet. ether 40-
600, 25:75) Rf 0.79, b.pt 62-66°C I 0.09mmHg, G.C. Rt 13.88 min. 
IR (film) : u 2976-2855 (sat. C-H str.), 1619-1583 (C=C), 1485-1460 (C-H def.) 1370 
(d, gemina1 CH3), 1285 (C-O), 867 (C-H bend), 778 (C-C1) em-I. 
1 H NMR (CDCI3) : 8 1.44 (6H, s, C-2-2xCH3)' 2.28 (3H, S, C-6-CH3)' 2.94 (2H, s, 
C-3-CH2), 6.58 (1H, s, C-4-H), 7.06 (1H, s, C-7-H) ppm. 
13C NMR (CDC13) : 8 20.33 (C-6-CH3), 28.03 (C-2-2CH3)' 42.54 (C-3-CH2)' 87.36 
(C-2), 111.60 (C-4-CH), 124.63 (C-5), 125.35 (C-7-CH), 126.26 (C-6), 135.34 (C-
8), 157.63 (C-9) ppm. 
GC-MS : m/z 198 (M+·, CllH130CI, 32%), 196 (M+·, C llH130CI, 91 %), 183 (M+·, 
C 13H I80 - CH3, 33%),181 (M+·, C13H I80 - CH3, 100%), 161 (31%), 155 (M+·, 
C13H I80 - C3H7, 33%), 153 (M+·, C13H I80 - C3H7, 38%), 146 (28%), 117 (16%), 
115 (18%), 105 (12%), 91 (30%). 
Analysis calcd. for C13H180 (198) C, 67.18; H, 6.66. Found: C, 69.58; H, 7.78%. 
Evidence for the presence of 2,3-dihydro-5-chloro-2,2-6-trimethyl-7-isopropenyl-
benzofuran (209j) in the mother liquor. 
G.C. Rt 18.12 min 
GC-MS : m/z 252 (M+', CI5HI90CI, 32%), 250 (M+·, CI5HI90CI, 27%), 237 (M+·, 
C I5H I90CI - CH3, 33%),235 (M+', CI5H2lOCI - CH3, 100%), 220 (9%), 193 (22%) 
179 (11%),141 (5%), 128 (4%),115 (5%),91 (17%),77 (6%). 
Evidence for the presence of 2,3-dihydro-5-chloro-2,2-6-trimethyl-7 -isopropyl-
benzofuran (210j) in the mother liquor. 
G.C. Rt 17.86 min. 
GC-MS : m/z 254 (M+·, C15H21 0Cl, 9%),252 (M+', C 15H21 0Cl, 2991), 211 (M+, 
C 15 H21 0Cl, 29%), 209 (M+', C 15H21 OCl, 100%), 174 (27%), 169 (%) 167 (24%), 
145 (17%),115 (11%),91 (17%), 77 (l~%). 
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2,3-Dihydro-2,2,5,6-tetramethylbenzofuran (1241) 
3,4-Dimethylphenol (281) (40.93g, 0.34 mol)was reacted with isobutyraldehyde (208) 
(40.93g, 0.30 mol) to afford a mixture of the title compound 1241 which was separated 
by fractional distillation, 2091 which was confirmed by NMR and 2101 which was 
present in the mother liquor of 1241 and was identified by GC/MS. 
The title compound was a pale yellow oil (46%), b.pt 64-66°C I 0.12mmHg (Lit. b. pt 
50-650C I 1 Torr244), G.C. Rt 12.65 min. 
IR (film) : u 3017 (arom. C-H str.), 2972-2861 (sat. C-H str.), 1623-1592 (C=C), 1495 
(C-H def.), 1368 (g, geminal CH3), 1267 (C-O), 880 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 1.43 (6H, s, C-2-2xCH3)' 2.16 (3H, s, Ar-CH3), 2.18 (3H, s, 
Ar-CH3), 2.92 (2H, s, C-3-CH2), 6.53 (1H, s, Ar-H), 6.88 (1H, s, Ar-H) ppm. 
13C NMR (CDCI3) : 8 19.15 (C-6-CH3), 20.04 (C-5-CH3), 28.16 (C-2-2xCH3)' 42.82 
(C-3-CH2), 86.21 (C-2), 110.67 (C-7-CH), 124.13 (Ar-C), 126.22 (C-4-CH), 127.50 
(Ar-C), 135.96 (Ar-C), 157.24 (Ar-C) ppm. 
GC-MS : m/z 176 (M+·, C12H160, 88%), 161 (M+·, C12H I60 - CH3, 100%), 143 
(11%),133 (M+·, C12H I60 - C3H7, 21%),115 (7%),105 (15%),91 (15%),39 (14%). 
Analysis ca1cd. for C12HI60 (176) C, 81.77; H, 9.15. Found: C, 81.30; H, 9.282%. 
Evidence for the presence of 2,3-Dihydro-2,2,5,6-tetramethyl-7 -(2-methy1-1-propenyl)-
benzofuran (2091) by NMR. 
Compound (1241) contains 18% purity of (2091) by ctH NMR), G.C. Rt 17.24 min. 
IH NMR (CDCI3) : 8 1.46 (6H, S, C-2-2xCH3)' 1.69 (3H, S, C-2'-CH3)' 1.90 (3H, S, 
C-2'-CH3)' 2.04 (3H, s, Ar-CH3), 2.31 (3H, s, Ar-CH3), 2.92 (2H, S, C-3-CH2), 5.98 
(1H, s, C-1'-H), 6.80 (1H, s, Ar-H) ppm. 
GC-MS : m/z 230 (M+·, C16H220, 23%), 215 (M+·, CI6H220 - CH3, 100%), 200 
(9%),173 (15%),159 (9%),145 (8%),91 «5%). 
Evidence for the presence of 2,3-dihydro-2,2,5,6-tetramethyl-7 -isopropylbenzofuran 
(2101) was identified by GC/MS. 
G.C. Rt 15.90 min. 
GC-MS : m/z 232 (M+', C16H240, 32%), 189 (M+·, CI6H240 - C3H7, 100%), 147 
(22%),119, (6%),105 (3%),91 (7%),39 (8%). 
2,3_Dihydro_2,2,7-trimethylbenzofuran (124m) 
2-Methylphenol (28m) (32.48g, 0.30 mol) was reacted with isobutyraldehyde (208) 
(21.83g, 0.31 mol) to afford a mixture of the title compound (3.99g, 8%), 210m which 
were separated by fractional distillation, and 56m was present in the mother liquor of 
124m. 
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The first fraction was the title compound as a colourless oil (3.99g, 8%), b.pt 42-480C I 
0.15mmHg (Lit b. pt. 320C I 0.1 mmHg24I), TLC (ethyl acetate: pet. ether 40-600, 
25:75), Rf 0.77, O.C. Rt 9.86 min. 
IR (film) : u 3025 ( arom. C-H str.), 2973-2926 (sat. C-H str), 1598 (C=C), 1466 (C-H 
def.), 1369 (d, geminal CH3), 1263 (C-O), 881 (C-H bend) em-I. 
1 H NMR (CDCI3) : 8 1.44 (6H, s, C-2-2xCH3), 2.18 (3H, s, C-7-CH3), 2.95 (2H, s. 
C-3-CH2), 6.66-6.72 (1H, t, 1 7.40 Hz, Ar-H), 6.91-6.94 (2H,t , 1 7.68 Hz, Ar-H) 
ppm. 
13C NMR (CDCI3) : 8 15.30 (C-7-CH3), 28.30 (C-2-2xCH3), 43.19 (C-3-CH2), 85.76 
(C-2), 119.52 (Ar-C), 119.50 (Ar-CH), 122.41 (Ar-CH), 126.16 (Ar -C), 129.08 (Ar-
CH), 157.44 (Ar-C). 
GC-MS : m/z 162 (M+·, Cll H 140, 92%), 147 (M+·, Cll H 140 - CH3, 100%) 129 
(7%), 119 (M+·, C llH 140 - C3H7, 42%), 105 (10%),91 (17%),77 (4%), 39 01 %). 
Analysis calcd. for CU Hl40 (162) C, 81.44; H, 8.70. Found: C, 81.15; H, 8.58%. 
Evidence for the presence of 2,3-dihydro-2,2,7-trimethyl-5-(2-methyl-l-propenyl)-
benzofuran (209m) confirmed by GC/MS. 
G.C. Rt 15.25 min. 
GC-MS : m/z 216 (M+·, C15H200, 57%), 201 (M+·, C15H220 - CH3, 100%), 186 
(8%),173 00%),159(14%),145 (9%),131 (8%),115 (8%),91 «5%),77«5%). 
The second fraction was a dark yellow oil (0.75g, 2%), b.pt 60-640C I 0.22mmHg, 
G.C. Rt 14.86min and was identified as 2,3-dihydro-2,2,7-trimethyl-5-isopropyl-
benzofuran (210m). 
IR (film) : u 2971-2867 (sat. C-H str), 1598 (C=C), 1466 (C-H def.), 1366 (d, geminal 
CH3), 1262-1130 (C-O), 861 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 0.86-0.90 (6H, d, 1=7.5 Hz, C-2'-2xCH3), 1.46 (6H, d, 1=2.21 
Hz, C-2-2xCH3)' 2.16 (3H, s, C-7-CH3), 1.70-1.82 (2H, m, 1 7.15 Hz, C-2'-H), 
2.33-2.37 (2H, d, 1 7.5Hz, C-l'-CH2), 2.96-2.99 (2H, d, 1 7.04, C-3-CH2), 6.68-
6.69 (lH, s meta-coupled, 1 1.73 Hz, Ar-H), 6.73-6.74 OH, s, meta-coupled, 1 2.37 
Hz, Ar-H) ppm. 
13C NMR (CDC13) : 8 15.38 (C-7-CH3), 22.43 (C-2'-2xCH3), 28.32 (C-2-2xCH3), 
30.52 (C-2'-CH), 43.32 (C-l'-CH2), 44.97 (C-3-CH2)' 85.78 (C-2), 118.74 (Ar-C). 
122.99 (Ar-CH), 125.94 (Ar-C), 129.82 (Ar-CH), 133.08 (Ar-C), 155.54 (Ar-C) ppm. 
GC-MS : m/z 218 (M+', C 15H220, 55%),175 (M+', C15H22 0 - C3H7, \O()\7r). 147 
(5%), 133 (8%),115 «5%),105 (9%),91 (5<7r), 77 (4<7r,), 39 (R<7r). 
Analysis calcd. for C15H220 (218) C. 82.52; H. 10.16. Found: C. 81.47; H, 10.24<7r. 
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2,3-Dihydro-2,2,6-trimethylbeozofurao (1240) 
3-Methylphenol (280) (43.25g, 0.4 mol) was reacted with isobutyra1dehyde (208) 
(29.02g, 0.4 mol) to afford a mixture of the title compound 2090, 2100 were separated 
by fractional distillation. The presence of compounds 2470, 2490, 2500 and 2510 
were identified by GC/MS. 
The first fraction was the title compound as a colourless oil (20.88g, 32%), b.pt 42-440C 
I 0.16mmHg (Lit. m. pt. 131°CI33), (ethyl acetate: pet ether 40-600,25:75), Rf 0.76, 
G.C. Rt 10.58 min. 
IR (film) : u 3049 (arom. C-H str.), 2973-2862 (sat. C-H str.), 1621-1590 (C=C), 
1498-1466 (C-H def.), 1369 (d,geminal CH3), 1277 (C-O), 798 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 1.45 (6H,s,C-2-2xCH3), 2.28 (3H,s,C-6-CH3), 2.94 (2H,s,C-3-
CH2), 6.55 (lH,s,C-7-H), 6.61-6.64 (IH,d, J 7.45 Hz, C-5-H), 6.98-7.01 (lH,d, J 
7.45 Hz, C-4-CH3) ppm. 
13C NMR (CDCI3) : 8 21.49 (C-6-CH3), 28.20 (C-2-2xCH3)' 42.64 (C-3-CH2), 86.61 
(C-2), 110.25 (Ar-H), 120.62 (Ar-CH), 123.99 (Ar-C), 124.70 (Ar-CH), 138.02 (Ar-
C), 159.09 (Ar-C) ppm. 
GC-MS : m/z 162 ( M+·, C llH 140, 58%), 147 (M+·, Cll H l40 - CH3, 100%), 129 
(6%), 119 (M+·, C llH l40 - C3H7, 37%), 105 (9%),91 (21 %),77 (12%),40 (13%). 
Analysis calcd. for CllH140 (162) C, 81.44; H, 8.70. Found: C, 81.10; H, 9.39%. 
Presence of 2,3-dihydro-2,2-6-trimethyl-5-(2-methyl-l-propeny1)benzofuran (1690) 
detected by GC/MS. 
G.C. R t 15.94 min. 
GC-MS : m/z 216 (M+', C15H200, 100%),201 ( M+·, C15H 200 - CH3, 400/0), 173 
(22%),159 (31%),145 (20%),131 (9%), 115 (11%),91 (12%). 
The second fraction was a yellow oil (7.11g, 11%), b.pt 116-l200C I 0.43mmHg, G.C. 
Rt 15.44 min and identified as 2,3-dihydro-2,2,6-trimethyl-5-isopropy1benzofuran 
(210n). 
IR (film) : u 2954-2867 (C-H str), 1622-1591 (C=C), 1493-1464 (C-H saturated def.), 
1367 (d,geminal CH3), 1271 (C-O), 877 (C-H bend) em-I. 
lH NMR (CDCI3) : 8 0.89-0.92 (6H,d J 6.46 Hz, C-2'-2xCH3)' 1.44 (6H,s,C-2-
2xCH3), 1.72-1.83 (lH,m,J 7.50 Hz,C-2'-H), 2.21 (3H,s,C-6-CH3), 2.36-2.39 
(2H,d,J 7.50 Hz,C-l '-CH2), 2.94 (2H,s,C-3-CH2), 6.52 (1 H,s,Ar-H), 6.84 (1 H,s,Ar-
H) ppm. 
l3C NMR (CDCl3) : 8 18.59 (C-6-CH_~), 22.43 (C-2'-2CH3)' 28.19 (C-2-2CH3)' 29.26 
(C-2'-CH), 42.27 (C-I '-CH2), 42.83 (C-3-CH2), 86.70 (C-2), 110.97 (Ar-CH), 
124.50 (Ar-C), 125.80 (Ar-CH), 132.18 (Ar-C), 136.27 (Ar-C), 154.83 (Ar-C). 
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GC-MS : m/z 218 (M+·, C15H220, 29%), 175 (M+·, C15H220 - C3H7. 100%), 160 
(8%),147 (160/0),133 (20%),121 (9%), 105 (13%),91 (8%),77 (5%), 39 (10%). 
The presence of 2,2,6-trimethyl-5-{2-methyl-1-[3-methylphenoxyl]propyl }-2,3-
dihydrobenzofuran (2470) or 2,2,6-trimethyl-7-{2-methyl-1-[3-
methylphenoxyl]propyl}-2,3-dihydrobenzofuran (2490) detected by GC/MS 
GC Rt 27.59 min. 
GC-MS : m/z 324 (M+·, C22H2502' 3%), 281 (M+·, C22H2502 - CH3, 100%), 263 
(5%),210 «5%),178 «5%),144 «5%),121 «5%),91 «5%). 
GC Rt 27.84 min. 
GC-MS : m/z 324 (M+·, C22H2502' 38%), 281 (M+·, C22H2502 - CH3, 100%), 263 
(5%),238 «5%),223 «5%),207 «5%), 180 «5%), 159 «5%), 144 «5%), 120 
«5%), 91 «5%). 
The presence of 2,2,6-trimethyl-5-(2-methylpropenyl)-7 -{2-methy1-1-[3-methy1methyl-
phenoxyl]-propyl} 2,3-dihydrobenzofuran (2500) or 2,2,6-trimethyl-5-{2-methyl-l-[3-
methyl-phenoxylpropyl]-(2-methylpropenyl) }-2,3-dihydrobenzofuran (2510) detected 
by GC/MS 
GC Rt 20.06 min. 
GC-MS : m/z 378 (M+·, C26H3402' 38%), 335 (M+·, C22H2502 - C3H7, 100%), 320 
(5%),274 «5%),239 «5%),223 «5%),201 «5%), 175 «5%), 145 «5%), 115 
«5%),91 «5%). 
GC Rt 29.01 min. 
GC-MS : m/z 378 (M+·, C26H3402' 4%), 335 (M+·, C22H2502 - C3H7, 100%), 317 
(5%), 281 «5%),223 «5%),223 «5%), 174 «5%), 133 «5%), 105 «5%),91 
«5%). 
2,3-Dihydro-2,2,5-trimethylbeozofurao (1240) 
4-Methylphenol (280) (32.43g,0.30 mol) was reacted with isobutyraldehyde (208) 
(21.71g, 0.30 mol) to afford a mixture of the title compound 1240 which was separated 
by fractional distillation, 2090 «5%), 2100, 2500 and 2540 were present in the 
mother liquor and were detected by GC/MS. 
The title compound was a yellow oil (4.86g, 10%). B.pt 48-50oC I 0.15mmHg (Lit. b. 
pt 320C 10.1 mmHg241), G.C. Rt 10.58 min. 
IR (film) : u 2973-2867 (C-H str), 1617 (C=C), 1491 (C-H deL). 1369 (d,geminal 
CH3), 1257 (C-O), 809 (C-H bend) em-I. 
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IH NMR (CDCI3) : 8 1.44 (6H, S, C-2-2CH3)' 2.25 (3H, s, Ar-CH3), 2.94 (2H, s, C-
3-CH2), 6.59-6.63 (1H, d, 1 8.0 Hz, Ar-H), 6.87-6.90 (1H, d, meta-coupled, 1 8.0 Hz, 
1m 0.82 Hz, Ar-H), 6.93 (1H,s, meta-coupled 1m 0.63 Hz,C-4-H) ppm. 
13C NMR (CDCI3) : 8 20.71 (Ar-CH3), 28.13 (C-2-2xCH3), 42.96 (C-3-CH2), 86.21 
(C-2), 109.02 (Ar-CH), 125.72 (Ar-CH), 127.00 (Ar-C), 128.27 (Ar-CH), 128.99 (Ar-
C), 156.81 (Ar-C) ppm. 
GC-MS : m/z 162 (M+·, C l1H 140, 78%), 147 (M+·, CllH 140 - CH3, 100%), 129 
(5%), 119 (M+·, C1sH220 - C3H7, 39%), 105 (8%),91 (20%), 77 00%), 39 03%). 
Analysis calcd. for CllH140 (162) C, 81.44; H, 8.70. Found: C, 81.04; H, 8.97%. 
The presence of 2,3-dihydro-2,2-5-trimethyl-7-(2-methyl-1-propenyl)benzofuran 
(2090) was detected by GC/MS. 
G.C Rt 25.53 min. 
GC-MS : m/z 216 (M+·, C1sH200, 32%), 201(M+·, C1sH 200 - CH3, 100%), 186 
(4%),159 (19%),145 (5%),131 (5%), 115 (4%),91 (3%). 
The presence of 2,3-dihydro-2,2,5-trimethyl-7 -isopropylbenzofuran (2100) was 
detected by GC/MS. 
G.C. Rt 15.24 min. 
GC-MS : m/z 218 (M+·, C1sH220, 40%), 175 (M+·, C1sH220 - C3H7, 100%), 147 
(19%), 133 (30%), 121 (15%), 105 (18%), 91 00%),44 (19%). 
Analysis calcd. for ClsH220 (218) C, 82.52; H, 10.16. Found: C, 81.16; H, 9.32%. 
The presence of 2,2,5-trimethyl-7 -(2-methyl-1-p-tolyloxypropyl)-2,3-dihydrobenzofuran 
(2520) was detected by GC/MS. 
GC Rt 25.53 min 
GC-MS : m/z 324 ( M+·, C22H280 2, 18%),281 (M+·, C22H2802 - C3H7, 100%), 263 
«5%), 239 «5%),225 «5%), 195 «5%), 172 «5%), 145 «5%), 121 (7%),91 
(5%). 
The presence of 2,2,5-trimethyl-7-{ 2-methyl-1-[ 4-methyl-2-(2-methylpropenyl)-
phenoxyl]propyl}-2,3-dihydrobenzofuran (2540) was detected by GC/MS. 
GC Rt 27.39 min 
GC-MS : m/z 378 ( M+·, C26H3402' 8%), 335 (M+·, C26H3402 - C3H7 , 1 009c L 317 
«5%),281 «5%),248 «5%), 217 «5%), 175 «59(,), 133 «59(,),91 (5%), 
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2,3-dihydro-S-bromo-2,2-dimethylbenzofuran (124q) 
4-Bromophenol (28q) (26.31g, 0.15 mol) was reacted with isobutyraldehyde (208) 
(15.15g, 0.21mol) to afford the title compound which was separated by fractional 
distillation. 
The title compound was a yellow oil (0.73g, 2%), b.pt 62-64°C I 0.07mmHg (Lit. NMR 
evidence246), GC Rt 14.11 min. 
IR (film) : u 2970-2873 (C-H saturated str.), 1475 (C-H saturated def.), 1370 (d, 
geminal CH3), 1258 (C-O), 809 (C-H bend), 662 (C-Br) em-I. 
IH NMR (CDCI3) : 8 1.46 (6H, s, C-2-2xCH3), 2.97 (2H, s, C-3-CH2), 6.58-6.61 
(1H, d, 1 8.33Hz, C-7-H), 7.16-7.17 (1H, s, meta-coupled, 1m 2.15 Hz, C-4-CH). 
7.20-7.23 (1H, d, meta-coupled, 16.87 Hz, 1m 3.73 Hz, C-6-H) ppm. 
13C NMR (CDCI3) : 8 28.06 (C-2-2xCH3)' 42.71 (C-3-CH2), 87.44 (C-2), 111.04 (Ar-
CH), 111.58 (Ar-C), 128.07 (Ar-CH), 129.59 (Ar-C), 130.73 (Ar-CH), 158.05 (Ar-C) 
ppm. 
GC-MS : m/z 228 (M+', C lOH130Br, 81%),226 (M+', C lOH130Br, 73%), 213 (M+', 
C lOH 130Br - CH3, 74%), 211 (M+', C lOH 130Br - CH3, 68%), 185 (10%), 147 
(20%),132 (100%),107 (13%),91 (28%),77 (29%),63 (22%),51 (31%). 
2,3-Dihydro-2,2-dimethylbenzofuran (124r) 
Phenol (28r) (28.88g, 0.30 mol) was reacted with isobutyraldehyde (208) (21.74g, 
0.30 mol) to afford a mixture of the title compound, which was separated by fractional 
distillation 209r and 210r were detected by GC/MS. 
The title compound was a yellow oil (1.33g, 3%), b.pt 56-62°C I 0.19mmHg (Lit. 31°C 
I 0.1 mmHg24I), GC Rt 8.29 min. 
IR (film) : u 2974-2855 (C-H saturated str.), 1481 (C-H saturated def.), 1369 (d, 
geminal CH3), 1260 (C-O), 882 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 1.45 (6H, s, C-2-2xCH3)' 2.97 (2H, s, C-3-CH2), 6.70-6.82 
(2H, m, Ar-H), 7.04-7.12 (2H, m, Ar-H) ppm. 
l3C NMR (CDCI3) : 8 28.78 (C-2-2xCH3)' 42.93 (C-3-CH2), 86.48 (C-2), 109.58 (Ar-
CH), 120.05 (Ar-CH), 125.71 (Ar-CH), 127.13 (Ar-C), 128.04 (Ar-CH), 158.93 (Ar-
C) ppm. 
GC-MS : m/z 148 (M+', C lOH I20, 63%), 133 (M+', C lOH120 - CH3. 100%), 119 
(6%),105 (M+', C lOH 120 - C3H7' 48%), 91 (12%),77 (18%),63 (9%).50 (12O/C). 
Analysis calcd. for ClOH120 (148) C, 81.04; H, 8.16. Found: C, 80.35; H. 8.19o/c. 
The presence of 2,3_dihydro-2,2-dimethyl-5-(2-methyl-l-propenyl)benzofuran (209r) 
was detected by GC/MS. 
GC Rt 15.25 min 
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GC-MS : mlz 202 (M+·, C I4HI80, 15%), 187 (M+', C lOH120 - CH3, 100%), 159 
(8%), 145 (43%), 128 (7%), 115 (6%), 105 (55), 91 (6%), 77 (5%). 
The presence of 2,3-dihydro-2,2-dimethyl-5-isopropylbenzofuran (210r) was detected 
by GC/MS 
GC Rt 14.09 min 
GC-MS : m/z 204 (M+·, C14H200, 37%), 161 (M+·, C14H200 - C3H7, 100%), 159 
(8%),145 (43%),128 (7%),115 (6%),105 (5%),91 (6%),77 (5%). 
4.Amino-2,3,S-trimethylphenol (269) 
4-Amino-2,3,5-trimethy1pheno1 (269) was prepared by the method of Smith268 from 
2,3,5-trimethy1phenol (28b). M. pt. 150-1520 C (Lit. 268) 
IR (KBr) : u 3391-3327 (N-H str., d, sharp), 3095 (O-H str., broad), 2973 (C-H str.), 
1596 (N-H bend or C=C), 1469-1422 (C-H def.), 1244 (O-H bend), 1089 (C-O str.), 
867 (C-H bend) cm-I. 
IH NMR (OMSO-d) : 8 1.96 (3H, s, Ar-CH3), 1.99 (6H, s, 2xAr-CH3), 3.44 (H20), 
3.83 (2H, broad, 0 20 exchangeable, NH2), 6.34 (1H, s, Ar-H), 8.11 (1H, S, °2° 
exchangeable, Ar-OH) ppm. 
13C NMR (OMSO-d) : 8 12.04 (Ar-CH3), 13.46 (Ar-CH3), 17.76 (Ar-CH3), 114.15 
(Ar-CH), 118.81 (Ar-C), 119.66 (Ar-C), 120.92 (Ar-C), 136.06 (Ar-C), 145.97 (Ar-C) 
ppm. 
MS (EI) : m/z 151 (M+', C9H13NO, 100%), 149 (M+' - 1, C9H12NO, 10%), 136 
(M+·, C8HlONO - CH3, 37%), 121 (M+', C18H lONO - C2H6, 19%), 106 (17%),91 
(7%), 77 (8%), 53 (8%), 39 (11 %). 
4-(Formylamino )-2,3,S-trimethyl phenol (270) 
4-Amino-2,3,5-trimethylphenol (28b) (8.96g) was dissolved in anhydrous formic acid 
(60 ml) and heated under reflux for 1 hour. The solution was poured onto ice (100g) and 
allowed to stand for 15 min. A pale grey solid precipitated (7.47g). The solid was dried 
under an atmosphere of argon. Crystallisation from petroleum ether 40-60° afforded the 
title compound as a white solid (7.32g, 92%), m.pt 206-208°C. 
1 H NMR (OMSO-d) : 8 2.00 (3H, s, Ar-CH3), 2.02 (6H, s, 2xAr-CH3)' 3.83 (lH, 
broad, O2° exchangeable, NH), 6.57 (1H, s, Ar-H), 8.19 (lH, S, 020 exchangeable, 
Ar-OH), 9.14-9.18 (lH, d, J 8.91 Hz, -CHO) ppm. 
BC NMR (OM SO-d) : 8 11.87 (Ar-CH3)' 14.76 (Ar-CH3)' 18.15 (Ar-CH3), 1 Lt39 
(Ar-CH), 119.89 (Ar-C), 125.09 (Ar-C), 132.05 (Ar-C), 134.35 (Ar-C), 153.33 (Ar-
C), 159.68 (-CHO) ppm. 
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MS (EI) : m/z 179 (M+·, C lOH13N02, 73%), 162 (M+·, C lOH 13N02 - OH, 27%), 150 
(C lOH13N02 - CHO, 68%), 136 (17%), 121 (12%), 107 (13%), 91 (11 %), 77 (11Ck), 
65 (10%), 53 (12%),44 (27%), 40 (100%). 
5-(Formylamino )-3,4-dihydro-2,2,4,6, 7 -pentamethyl benzofuran (271) -
(Method A) 
4-(Formylamino)-2,3,5-trimethylphenol (270) (2.31g, 0.013 mol) was stirred in toluene 
(30 ml) at room temperature under an atmosphere of argon. Isobutyraldehyde (208) 
(0.93g, 0.13 mol) and concentrated sulphuric acid (ml) were added over a period 30 mins 
and the reaction mixture was heated under reflux for 4 hrs. The reaction the mixture was 
poured onto ice (100g), neutralised with 10%w/v sodium bicarbonate (400 ml) solution, 
extracted with ethyl acetate (150 ml), washed with water, and dried over anhydrous 
magnesium sulphate. Filtration of the drying agent and removal of the solvent in vacuo 
afford a lime green oil (2.93g). Crystallisation (MeOH) afforded the title compound as a 
light brown solid (1.60g, 53%). TLC (ethyl acetate: pet ether 40-600 ,25:75), Rf 0.20, 
GC Rt 22.43 min. 
*GC/MS conditions: Oven temp. 600 C, rate (OOC I min, held for 5 min, then oven 
temperature increased to 2200C, rate 16.67°C I mins, held for 10.50 min. 
1 H NMR (DMSO-d) : 8 1.46-1.48 (6H, d, J 5.28 Hz, 2 x CH3), 2.09 (3H, s, Ar-CH3), 
2.11 (3H, s, Ar-CH3), 2.16 (1.5H, s, Ar-CH3), 2.17 (1.5H, s, Ar-CH3)' 2.93-2.94 
(2H, d, J 3.44 Hz, CH2), 6.89 (0.5H, b, D20 exchangeable, NH), 7.07-7.12 (0.5H, d, 
D20 exchangeable, J 11.62 Hz, N-H), 7.94-7.98 (0.5H, d, J 12.05 Hz, CHO), 8.38 
(0.5H, s, CHO) ppm. 
13C NMR (DMSO-d) : 8 12.31 (2xAr-CH3), 14.76 (Ar-CH3), 15.03 (Ar-CH3), 15.30 
(Ar-CH3), 15.48 (Ar-CH3), 28.52 (2xCH3), 28.62 (2xCH3), 85.99 (Aliphatic-C), 
86.30 (Aliphatic-C), 116.10 (Ar-C), 116.36 (Ar-C), 123.33 (Ar-C), 123.58 (Ar-C), 
124.11 (Ar-C), 124.93 (Ar-C), 129.10 (Ar-C), 129.77 (Ar-C), 133.86 (Ar-C), 134.75 
(Ar-C), 156.69 (Ar-C), 160.29 (Ar-NH-CHO), 165.98 (Ar-NH-CHO) ppm. 
GC-MS : m/z 233 (M+·, C14H19N02' 100%),204 (M+', C14H1902 - CHO), 30%), 188 
(31%),173 (24%),159 (8%),146 (5%),131 (5%), 105 (4%), 91 (5%),39 (8%). 
*The GC/MS conditions outlined above were used for all the compounds in this section, 
unless othetwise stated. 
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5-(Formylamino )-2,3-dihydro-2,2,4,6, 7 -pentamethyl benzofuran (271) -
(Method B) 
4-(Formylamino)-2,3,5-trimethylphenol (270) (3.60g, 0.02 mol) was dissolved in 
formic acid (30 ml) and conc. sulphuric acid (S drops) at 100°C under an atmosphere of 
argon. 2-Methyl-2-propen-1-01 (207) (1.4Sg, 0.02 mol) was added over a period of 30 
mins and the reaction mixture was heated under reflux for 4 hrs. The mixture was 
poured into ice, neutralised with 10%w/v sodium bicarbonate (2x200 ml), extracted with 
ethyl acetate (150 ml) washed with water, and dried over anhydrous magnesium 
sulphate. Filtration of the drying agent and removal of the solvent in vacuo afforded the 
title compound as a white solid (4.07g, 87%), m.pt 17S-177°C. TLC (ethyl acetate: pet 
ether 40-60°, 25:7S); Rf 0.20. 
5-(Formylamino )-2,3-dihydro-2,2,4,6, 7 -pentamethyl benzofuran (271) -
(Method C) 
4-(Formylamino)-2,3,5-trimethylphenol (270) (4.S9g, 0.026 mol) was dissolved in 
trifluoroacetic acid (30 ml). To this was added 2-methyl-2-propen-1-01 (207) (5.0lg, 
0.07 mol) over a period of 20 min. The reaction mixture was heated under reflux for 4 
hours. After cooling the residue was worked up as usual to afford the title compound as 
a brown solid (4.43g, 73%), m.pt 176-178°C, GC Rt 22.91 min 
IH NMR (COClrd) : 8 1.46 (6H, s, 2 x CH3), 1.48 (6H, s, 2 x CH3), 2.08-2.16 (I8H, 
m, 6 x Ar-CH3), 2.93 (2H, s, CH2), 2.94 (2H, s, CH2), 6.82 (O.SH, S, 0 20 
exchangeable, NH), 6.99-7.03 (O.SH, d, 0 20 exchangeable, NH). 7.94 (O.SH. d. 
CHO), 8.40 (0.5H, s, CHO) ppm. 
GC-MS : m/z 233 (M+', C14H19N02' 100%),218 (M+', C14H1902 - CH3, 15%), 204 
(M+', C14H19N02 - CHO, 52%), 188 (57%), 173 (59%), 159 (17%), 105 (8%).91 
(10%),77 (12%),39 (17%). 
Analysis calcd. for C14H19N02 (233) C, 72.07; H, 8.21; N, 6.00. Found: C, 72.3S; H, 
8.44; N, 5.23%. 
5- A mi no-2,3-dihydro-2,2,4,6, 7 -pen tamethy I benzo-5-furanami ne 
hydrochloride (260)265 
S-(Formylamino )-2,3-dihydro-2,2,4,6, 7 -pentamethylbenzofuran (271) (4.l2g) was 
dissolved in methanol (100 mI). To it was added 3S% hydrochloric acid (60 ml) with 
ice-water bath cooling. The mixture was heated under reflux in an atmosphere of argon 
for 2 hours. After cooling, the reaction mixture was neutralised with aqueous sodium 
hydrogen carbonate solution and extracted with ethyl acetate. The ~xtract was washed 
with brine, and dlied with anhydrous magnesium sulphate. Filtration of the drying agent 
and removal of the solvent in \'{/Cuo. a residue which was treated with hydrochlOlic acid 
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4M and ethanol (6 ml) to afford the title compound as a brown oil (3.98g, 979c). GC: 
Rt 19.28 min 
GC-MS : m/z 205 (M+·, C13H19NO, 95%), 190 (M+', C13H 19NO - CH3, 99c), 162 
(69%),147 (60%),111 (42%),97 (61%),91 (22%),83 (62%),69 (85%), 63 (44lJC), 
57 (100%),41 (96%). 
6-(Formylamino)-3,4-dihydro-2,2,5, 7 ,8-pentamethylbenzopyran (274) -
(Method D) 
4-(Formy1amino)-2,3,5-trimethy1phenol (270) (3.19g, 0.018 mol) was dissolved in 
glacial acetic acid (30 ml) and zinc chloride (2.84g, 0.021 mol). To the mixture was 
added isoprene (81) (1.25g, 0.018 mol) over a period of 30 min and the reaction mixture 
was heated under reflux for 4 hours. The standard work-up produced an orange oil. 
Recrystallisation from pet. ether (40-600 ) afforded a mixture of the title compound as a 
white solid (3.34g, 74%), m.pt 206-208°, GC Rt 26.04 min and 3 as an oil (0.76g, 
17%). 
1 H NMR (COC1r d) : 8 1.29 (6H, s, 2 x CH3), 1.31 (6H, s, 2 x CH3), 1.75 -1.81 (2H, 
t, J 6.90 Hz, CH2), 2.10-2.18 (l8H, m, 6 x Ar-CH3), 2.59-2.66 (4H, m, J 6.71 Hz, 2 
x CH2), 6.86 (0.5H, broad, 0 20 exchangeable, NH), 6.96 (0.5H, d, broad, 0 20 
exchangeable, NH), 7.92-7.97 (0.5H, d, J 12.06 Hz, CHO), 8.36 (0.5H, d, J 1.61 Hz, 
CHOppm. 
GC-MS : mlz 247 (M+', C15H21 N02, 100%),232 (M+', C15H21N02 - CH3, <5%), 218 
(M+', C15H21N02 - CHO, 5%), 202 (23%), 192 (35%), 174 (7%), 162 (15%), 147 
(19%), 135 (14%),91 (7%). 
6-Amino-3,4-dihydro-2,2,5,7 ,8-pentamethyl benzopyran (259) 
IH NMR (COClrd) 1.28 (6H, s, 2 x CH3), 1.75-1.81 (2H, t, J 6.92 Hz, CH2), 2.05-
2.16 (9H,m, 3 x Ar-CH3), 2.58-2.67 (2H, t, J 7.15 Hz, CH2), 3.28 (2H, broad, °2° 
exchangeable, NH2) ppm. GC-MS: mlz 219 (M+', C14H21 NO, 100%),203 (M+', 
C 14H 21 NO, <5%), 189 «5%),163 (42%),135 (21%),120 (15%),106 «5%),91 
«5%). 
6-(Formylamino )-3,4-dihydro-2,2,5, 7 ,8-pentamethyl benzopyran (274)-
(Method E) 
4-(Formylamino)-2,3,5-trimethylphenol (270) (3.20g, 0.018 mol) was dissolved in 
formic acid (30 ml) and concentrated sulphuric acid (5 drops). To this was added 2-
methyl-3-buten-2-o1 (273) (4.43g, 0.05 mol) over a period of 30 min at room 
temperature. The reaction mixture was heated under reflux for 44 hours. After cooling, 
the residue was extracted with ethyl acetate (100 ml), washed with brine, dried \\'ith 
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magnesium sulphate, and concentrated to afford the title compound as a brown residue. 
This residue, was purified on an alumina gel column, eluting the column with i) 
methanol I diethyl ether (1 :9), and ii) methanol (l 00%) to afford a mixture of the title 
compound as an oil (2.63g, 63%) ) and 6-amino-3,4-2,2,5,7,8-dihydrobenzopyran as an 
oil (259) (1.48g, 35%). 
IH NMR (CDClrd) : 8 1.30 (6H, s, 2 x CH3), 1.32 (6H, s, 2 x CH3), 1.75 -1.79 (2H, 
t, J 6.90 Hz, CH2), 1.81-1.85 (2H, t, J 6.84 Hz, CH2), 2.10-2.18 (l8H, m, 6 x Ar-
CH3), 2.59-2.66 ( 4H, m, J 6.71 Hz, 2 x CH2), 6.84 (0.5H, broad, D20 exchangeable, 
NH), 6.91-6.96 (0.5H, d, broad, D20 exchangeable, NH), 7.93-7.98 (0.5H, d, J 12.11 
Hz, CHO), 8.40 (0.5H, d, J 1.47 Hz, CHO) ppm. 
GC-MS : mlz 247 (M+·, C15H21N02, 100%),218 (M+·, C15H21N02 - CHO, 8%),202 
(23%),192 (35%),174 (8%),162 (17%),147 (19%),135 (16%),119 (12%), 91(8%). 
Analysis calcd. for C15H21N02 (247) C, 72.84; H, 8.56; N, 5.66. Found: C, 66.25; H, 
7.20; N, 7.33%. 
Evidence for the presence of 6-amino-3,4-2,2,5,7 ,8-dihydrobenzopyran (259) 
Brown oil, GC R t 21.16 min. 
IH NMR (CDClrd) : 8 1.27 (6H, s, 2 x CH3), 1.74-1.79 (2H, t, J 6.75 Hz, CH2), 
2.04 (3H, s, Ar-CH3), 2.09 (3H, s, Ar-CH3), 2.12 (3H, s, Ar-CH3), 2.57-2.66 (2H, t, 
J 6.84 Hz, CH2), 3.23 (2H, broad, D20 exchangeable, NH2) ppm. 
13C NMR (CDClrd) : 8 12.52 (Ar-CH3), 13.52 (Ar-CH3), 14.16 (Ar-CH3), 21.44 
(CH2), 26.76 (2xCH3), 33.40 (CH2) 72.20 (C-2), 116.86 (Ar-C), 117.63 (Ar-C), 
120.43 (Ar-C), 122.29 (Ar-C), 134.97 (Ar-C), 144.98 (Ar-C) ppm. 
GC-MS : mlz 219 (M+·, C14H21 NO, 100%), 164 (M+·, C 14H21 NO - C4H7, 23%),163 
(C 14H21 NO - C4H8, 69%), 135 (28%), 120 (20%), 91 (6%),77 (5%), 65 «5%),51 
(5%), 39 (9%). 
6-(Formylamino )-3,4-dihydro-2,2,5, 7 ,8-pentamethyl benzopyran (274) -
(Method F) 
4-(Formylamino)-2,3,5-trimethylphenol (270) (1.69g, 0.01 mol) was dissolved in 
trifluoroacetic acid (40 ml). To the reaction mixture was added 2-methyl-3-buten-2-01 
(199) (2.98g, 0.03 mol) over a period of 30 min and the reaction mixture was heated 
under reflux for 4 hours. The cooled solution was worked up to afford the title 
compound (1.68g, 69%)as a brown oil (purity 87% by NMR), GC Rt 2l.08 min. 
1 H NMR (CDClrd) : 8 1.29 (6H, s, 2 x CH3), 1.32 (6H. s. 2 x CH3), 1.75-1.82 (4H. 
m, J 6,82 Hz, 2 x CH2), 2.04-2.17 (I8H. m, 6 x Ar-CH3)· 2.59-2.66 (.+H. m. J 6.71 
Hz, 2 x CH
2
), 6.89 (0.5H, s, broad, D20 exchangeable, NH). 6.98-7.02 (0.51 H, d, 
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broad, 0 20 exchangeable, NH), 7.92-1.97 (0.5H, d, J 12.06 Hz, 0 20 exchangeable 
CHO), 8.38-8.39 (0.5H, d, J 1.54 Hz, CHO) ppm. 
GC-MS : 247 (M+·, CIsH2IN02' 62%), 218 (M+', C1sH21 N02 - CHO, 7%), 202 
(34%),192 (43%),174 (9%),162 (18%),147 (32%),135 (27%),119 (14%),104 
(12%), 91 (16%), 44 (100%). 
Analysis ca1cd. for CIsH2lN02 (247) C, 72.84; H, 8.56; N, 5.66. Found: C, 74.16; H, 
9.49; N, 4.72%. 
3,4-Dihydro-6-hydroxy-2,2,4,S, 7 ,8-hexamethylbenzopyran (309a) 
Trimethylhydroquinone (28a) (7.67 g, 0.05 mol) was dissolved in glacial acetic acid. To 
this was added 2-methyl-2,4-pentanediol (314) (8.97g, 0.076 mol) followed by a mixed 
solution of glacial acetic acid (76.16g, 1.26 mol) and concentrated sulphuric acid 
(25.62g, 0.26 mol) added dropwise over a period of lhr. After completion of the 
addition, the temperature was gradually raised to 30°C over a period of 30 min and 
stirring was continued for 5 hrs at 30°C. The mixture was poured onto ice, neutralised 
with 10%w/v sodium bicarbonate solution, and extracted with ethyl acetate (200 ml). 
Removal of the solvent afforded a red oil. To the oil was added methanol (100 ml) and 
concentrated hydrochloric acid (10 ml) when the mixture was heated under reflux for 1hr. 
The resulting solution was poured onto ice, extracted with ethyl acetate (200 ml), 
neutralised with 10%w/v sodium bicarbonate, was treated with Claisens alkali, acidified 
with concentrated hydrochloric acid, washed with water (2x 100 ml), and dried 
(anhydrous magnesium sulphate). Filtration of the drying agent and removal of the 
solvent in vacuo afford a red oil. Crystallisation from petroleum ether (b. pt.40-600) 
afforded the title compound as a white solid (2.78g, 23%), m.pt 72-74°C. TLC (ethyl 
acetate: petroleum ether 40-60°, 15:85 ) Rf 0.41. 
lR (KBr) : u 3457-3289 (O-H str.), 2975-2867 (sat. C-H str.), 1613 (C=C), 1449 (C-H 
def), 1366 (d, geminal CH3), 1246 (O-H bend), 1228 (C-O), 1144-1082 (C-OH str.), 
912 (C-H bend) cm-l. 
I H NMR (COCI3) : 8 1.15 (3H, s, C-2a-CH3), 1.24-1.27 (3H, d, J 6.89 Hz, C-4-
CH 3), 1.41 (3H, s, C-2b-CH3), 1.67-1.73 (1H, q, J 6.89 Hz, C-3-Hax), 1.92-2.03 
(lH, q, J 7.65 Hz, C-3-Heq), 2.11 (3H, s, Ar-CH3), 2.14 (3H, s, Ar-CH3) 2.18 (3H, s, 
Ar-CH3), 2.97-3.11 (lH, m, J 6.98 Hz,C-4-H), 4.28 (1H. s, C-6-0H) ppm. 
13C NMR (COCI3) : 8 11.90 (Ar-CH3), 12.20 (Ar-CH3), 12.62 (Ar-CH3), 22.10 (C-4-
CH3), 26.10 (C-2-CH3ax), 26.70 (C-4-CH), 29.73 (C-2-CH3eq). 43.76 (C-3-CH2)· 
73.72 (C2), 118.40 (Ar-C), 120.80 (Ar-C), 123.45 (C-6-CH). 124.74 (Ar-C), 145.39 
(Ar-C), 145.69 (Ar-C-OH) ppm. 
M.S. (El) : m/z 234 (M+" C 15H2202' 759('), 219 (M+·. C l'iH 22 0 2 - CH3, 11 (;r). 191 
(9%), 179 (80%),178 (100%),161 (5!1r), 135 (~(~). 91 (Y~). 
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Analysis ca1cd. for CIsH2202 (234) C, 76.88; H, 9.46. Found: C, 76.21; H, 9.46CK. 
3,4-Dihydro-2,2,4,S,7 ,8-hexamethyl benzopyran (309b) 
Trimethylphenol (28b) (13.60g, 0.1 mol) was dissolved in glacial acetic acid (51g). To 
this was added 2-methyl-2,4-pentanediol (314) (17.82g, 0.1 mol) followed by a mixed 
solution of glacial acetic acid (1OOg) and concentrated sulphuric acid (49g) which was 
added dropwise over a peliod of 1hr. After completion of the addition, the temperature 
was gradually raised to 300C over a period of 30 min and stirring continued for 5 hrs at 
300C. The mixture was poured onto ice, neutralised with 10%w/v sodium bicarbonate 
solution, and extracted with ethyl acetate (200 ml). Removal of the solvent afforded a 
yellowish-brown oil. The resulting oil was poured into ice, extracted with ethyl acetate 
(200 ml), neutralised with 10%w/v sodium bicarbonate solution, treated with Claisens 
alkali, acidified with concentrated hydrochloric acid, washed with water (2x 100 ml), and 
dried over anhydrous magnesium sulphate. Filtration of the drying agent and removal of 
the solvent in vacuo afforded the title compound as a pale yellow oil which was distilled 
under high vacuum. 
Pale yellow oil309b (6.82g, 31%). B.pt 100-102°C / 1Torr, TLC (ethyl acetate: pet. 
ether 40-600 , 20:80), Rf 0.70. 
IR (KBr) : u 2973-2870 (sat. C-H str.), 1611-1570 (C=C), 1459 (C-H def.), 1381 (d, 
geminal CH3), 1219 (C-O), 846 (C-H bend) em-I. 
IH NMR (CDCI3) : 8 1.19 (3H, s, C-2a-CH3), 1.27-1.30 (3H, d, J 6.91 Hz, C-4-
CH3), 1.42 (3H, s, C-2b-CH3), 1.63-1.71 (lH, q, J 6.69 Hz, C-3-Hax), 1.94-2.02 
(1H, q, J 7.47 Hz, C-3-Heq), 2.07 (3H, s, Ar-CH3), 2.19 (3H, s, Ar-CH3) 2.32 (3H, s, 
Ar-CH3), 2.95-3.09 (1H, m, J 6.96 Hz, C-4-H), 6.55 (1H, s, C-6-H) ppm. 
13C NMR (CDCI3) : 8 11.50 (Ar-CH3), 19.67 (Ar-CH3), 19.71 (Ar-CH3), 21.71 (C-4-
CH3), 26.33 (C-4-CH), 26.73 (C-2-CH3ax), 29.57 (C-2-CH3eq), 43.43 (C-3-CH2), 
73.95 (C2), 122.64 (Ar-C), 123.71 (Ar-C), 123.87 (C-6-CH), 133.04 (Ar-C), 134.60 
(Ar-C), 151.55 (Ar-C) ppm. 
M.S. (EI) : m/z 218 (M+·, CIsH220, 48%), 203 (M+·, CIsH220 - CH3, 40%), 175 
(M+ - CO-CH3' 18%), 163 (100%),147 (18%),119 (16%),105 (10%),91 (17%). 
Analysis ca1cd. for ClsH220 (218) C, 82.52; H, 10.16. Found: C, 82.39; H, 10.36%. 
The following compounds were synthesised using the method outlined as 
above. 
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3,4-Dihydro-2,2,4,6,7 -pentamethylbenzopyran (309c) 
3,4-Dimethylphenol (28c) (24.43g, 0.2 mol) was reacted with 2-methyl-2,4-pentandiol 
(314) (23.76g, 0.2 mol) to afford the title compound (15.72g, 39%) as a red oil. B.pt 
86-88°C I ltorr, TLC (ethyl acetate: petroleum ether (40-60°), 15:85) Rf 0.76 
IR (film) : u 2975-2879 (sat. C-H str.), 1624-1570 (C=C), 1455 (C-H deL), 1382 
(d,geminal CH3), 1212 (C-O), 886 (C-H bend) em-I. 
1 H NMR (CDC13) : B 1.22 (3H, s, C-2a-CH3ax), 1.28-1.31 (3H, d, J 6.03 Hz, C-4-
CH3), 1.38 (3H, S, C-2b-CH3eq), 1.47-1.56 (1H, t, J 7.91 Hz, C-3-Hax), 1.76-1.84 
(1H, q, J 5.95 Hz, C-3-Heq), 2.16 (Ar-CH3), 2.17 (Ar-CH3), 2.80-2.95 (1H, m, J 6.28 
Hz, C-4-H), 6.58 (1H, s, Ar-H), 6.97 (1H, s, Ar-H) ppm. 
13C NMR (CDCI3) : B = 18.92 (Ar-CH3), 19.40 (Ar-CH3), 20.38 (C-4-CH3), 24.37 
(C-2-CH3ax), 25.97 (C-4-CH), 30.07 (C-2-CH3eq), 42.96 (C-3-CH2), 73.93 (C-2), 
118.09 (Ar-CH), 123.35 (Ar-C), 127.60 (Ar-C), 127.93 (Ar-CH), 135.58 (Ar-C), 
151.29 (Ar-C) ppm. 
Analysis calcd. for C14H200 (204) C, 82.30; H, 9.87. Found: C, 82.31; H, 10.03%. 
3,4-Dihydro-2,2,4,5,8-pentamethylbenzopyran (309d) 
2,5-Dimethylphenol (28d) (12.22g, 0.1 mol) was reacted with 2-methyl-2,4-
pentanediol (314) (17.95g, 0.15 mol) to afford a mixture the title compound which was 
separated by fractional distillation. 
The first fraction was a green oil, b.pt 158-1600C I 2 torr, TLC (ethyl acetate: pet. ether 
40-60°, 15:85) Rf 0.75. 
I H NMR (CDCI3) : B 1.22-1.25, (3H, d, J 7.02 Hz, C-4-CH3)' 1.33 (3H, s, C-2a-
CH3ax), 1.42 (3H, S, C-2b-CH3eq), 1.58-1.65 (1H, m, J 9.32, C-3-Hax), 1.90-2.00 
(1H, m, C-3-Heq), 2.17 (3H, s, Ar-CH3), 2.24 (3H, s, Ar-CH3), 3.16-3.20 (1H, m, J 
7.06 Hz, C-4-H), 6.41 (1H, s, Ar-H), 6.64 (1H, s, Ar-H) ppm. 
13C NMR (CDCI3) : B 10.94 (C-4-CH3)' 18.77 (Ar-CH3), 201.93 (Ar-CH3), 29.34 (C-
2-CH3ax), 29.81 (C-2-CH3eq), 35.41 (C-4-CH), 51.82 (C-3-CH2)' 73.68 (C2), 115.29 
(Ar-CH), 121.58 (Ar-CH), 131.73 (Ar-C), 138.71 (Ar-C), 150.10 (Ar-C), 152.93 (Ar-
C) ppm. 
MS (EI) : m/z 204 (M+·, C14H200, 25%), 189 (M+·, C14H200 - CH3, 100%), 174 
(12%),159 (10%),145 (5%),128 (11%),115 (9%),91 (10%). 
The second fraction was a pale green oil, b.pt 160-162°C I 2 torr and identified as 
1,1 J,4,6,6,8,9-octamethyl-l ,2,),6,7 ,8-hexahydro-5-oxa-cyclopenta[b ]naphthalene 
(225d) 
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MS (EI) : m/z 286 (M+·, C2oH300, 60%), 271 (M+·, C2oH300 - CH3, 100%),231 
(300/0),215 (41%),204 (18%),189 (53%),173 (11%),159 (7%),141 (5%), 128 (99c). 
115 (10%), 91 (10%). 
3,4-Dihydro-2,2,4,S,7-pentamethylbenzopyran (30ge) 
3,5-Dimethy1pheno1 (28e) (24.45g, 0.2 mol) was reacted with 2-methyl-2A-pentandiol 
(314) (28.92g, 0.2 mol) to afford the title compound as a pale blue oil (13.61g, 39%). 
B.pt 82-88°C I 1 torr, TLC (ethyl acetate: petroleum ether 40-60°,15:85) Rf =, GC Rt 
14.81 min. 
IR (film) : u 2974 (sat. C-H str.), 1618 (C=C), 1458 (C-H def.), 1375 (d, geminal 
CH3), 1250 (C-O), 898 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 1.22 (3H, s, C-2a-CH3ax), 1.29-1.31 (3H, d, J 6.84 Hz, C-4-
CH3), 1.39 (3H, S, C-2b-CH3eq), 1.67-1.75 (1H, q, J 6.75 Hz, C-3-Hax), 1.92-2.04 
(1H, q, J 8.68 Hz, C-3-Heq), 2.21 (Ar-CH3), 2.28 (Ar-CH3), 2.92-3.06 (1H, m, J 6.98 
Hz, C-4-H), 6.45 (1H, s, Ar-H), 6.49 (1H, s, Ar-H) ppm. 
13C NMR (CDCI3) : 8 18.39 (Ar-CH3), 20.15 (Ar-CH3), 20.81 (C-4-CH3), 25.97 (C-
4-CH), 26.34 (C-2-CH3ax), 29.05 (C-2-CH3eq), 43.54 (C-3-CH2), 73.68 (C2), 116.05 
(Ar-CH), 122.92 (Ar-C), 123.74 (Ar-CH), 136.33 (Ar-C), 136.91 (Ar-C), 153.58 (Ar-
C) ppm. 
GC-MS : m/z 204 (M+·, CI4H200, 65%), 189 (M+·, C2oH300 - CH3, 58%), 174 
(7%),161 (22%),149 (100%),133 (25%),119 (18%),91 (27%),77 (27%). 
Synthesis of 3,4-dihydro-6-chloro-2,2,4,6,7-pentamethylbenzopyran 
(309f) 
4-chloro-3-methylphenol (28f) (28.50g, 0.2 mol) was reacted with 2-methyl-2,4-
pentanediol (314) (23.76g, 0.2 mol) to afford the title compound as a yellow solid, 
which was reaction mixture from aqueous methanol (17.97g, 40%). M.pt 31-330 C. 
TLC (ethyl acetate I 40-60° petroleum ether, Rf 0.75. 
IR (KBr) : u 2978-2871 (sat. C-H str.), 1614-1556 (C=C), 1491 (C-H def.). 1381 (d, 
geminal CH3), 1209 (C-O), 880 (C-H bend), 679 (C-Cl) em-I. 
I H NMR (CDCI3) : 8 1.21 (3H, s, C-2a-CH3ax), 1.28-1.30 (3H, d, J 6.73 Hz, C-4-
CH3), 1.~9 (3H, S, C-2b-CH3eq), 1.43-1.53 (1H, t, J 13.27 Hz, C-~-Hax), 1.77-1.85 
(lH, q, J 5.96 Hz, C-3-Heq), 2.26 (C-7-CH3), 2.80-2.93 (C-4-H 
),6.64 (lH, s, Ar-H), 7.17 (lH, s, Ar-H) ppm. 
l3C NMR (CDCI3) : 8 19.65 (CT CH3), 20.21 (C-4-CH3)' 24.~7 (C-2-CH3ax ), 26.08 
(C-4-CH), 29.94 (C-2-CH3eq), 42.~8 (C-3-CH2)' 74.55 (C2), 119.29 (Ar-CH). l24.l)3 
CAr-C), 125.43 (Ar-C), l27.22 (Ar-CH), 1 ~4. 79 (Ar-C), 151.95 (Ar-C) ppm. 
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3,4-Dihydro-2,2,4,6,S-pentamethylbenzopyran (309g) 
2,3-Dimethylphenol (2Sg) (24.51g, 0.2 mol) was reacted with 2-methyl-2,4-pentandiol 
(314) (23.47 g, 0.2 mol) to afford the title compound (16.95g, 42%) as a brown oil. 
B.pt 82-86°C I 1 torr, TLC (ethyl acetate: petroleum ether 40-60°, 15:85) Rf 0.75. 
lH NMR (CDCI3) : 8 1.22 (3H, S, C-2-CH3ax), 1.28-1.31 (3H, d, J 6.89 Hz, C-4-
CH3), 1.38 (3H, S, C-2-CH3eq), 1.47-1.56 (1H, dd, J 15.01, J 7.96 Hz, C-3-Hax). 
1.95-2.04 (1H, dd, J 13.4, J 7.42 Hz, C-3-Heq), 2.20 (Ar-CH3), 2.27 (Ar-CH3), 2.92-
3.06 (1H, m, J 6.97 Hz, C-4-H) 2.80, 6.49 (lH, s, Ar-H), 6.54 (1H, s, Ar-H) ppm. 
13C NMR (CDCI3) : 8 20.13 (Ar-CH3), 20.81 (Ar-CH3), 21.65 (C-4-CH3), 25.87 (C-
4-CH), 26.36(C-2-CH3ax), 29.05 (C-2-CH3eq), 43.56 (C-3-CH2), 73.66 (C-2), 116.07 
(Ar-CH), 122.92 (Ar-C), 123.74 (Ar-CH), 136.32 (Ar-C), 136.87 (Ar-C), 153.60 (Ar-
C) ppm. 
3,4-Dihydro-2,2,4,S-tetramethylbenzopyran (309h) 
2-Methylphenol (2Sh) (5.2g, 0.05 mol) was reacted with 2-methyl-2,4-pentanediol 
(314) (7.10g, 0.06 mol) to afford a mixture of the title compound (detected by GC/MS) 
and 315h (4.72g, 50%). 
GC-MS : m/z 190 (M+', C13H I80, 30%), 175 (M+', C13H I80 - CH3%), 160 (12%), 
147 (14%), 115 (8%),91 (7%),77 (5%), 39 (6%). 
The presence of 1,1 ,3,4,6,6,8-Heptamethyl-1,2,3 ,6,7 ,8-hexahydro-5-oxa-
cyc1openta[b ]naphthlene (315h) was confirmed by GC/MS. 
GC Rt 18.89 min. 
I H NMR (CDCI3) : 8 1.23 (3H, s, CH3), 1.27 (3H, s, CH3), 1.31-1.35 (3H, d, J 9.36 
Hz, CH3), 1.39 (3H, s, CH3), 1.41 (3H, s, CH3), 1.43 (3H, s, CH3), 1.46-1.49 IH, 
d, J 7.96 Hz, C-H), 1.75-1.78 (1H, ddt, J 1.98 Hz, Jm 1.89 Hz, C-H), 2.00-2.07 (1H, 
m, J 7.16 Hz, C-H), 2.19 (3H, s, Ar-CH3), 2.21-2.28 (1H, m, J 5.29 Hz, C-H), 2.85-
2.95 (1H, m, J 6.41 Hz, C-H), 3.01-3.11 (1H, m, J 6.97 Hz, C-H), 6.85 (Ar-H) ppm. 
13C NMR (CDCI3) : 8 11.47 (CH3), 19.83 (CH3), 19.96 (CH3), 25.07 (CH3), 26.65 
(C-H), 29.14 (CH3), 30.28 (CH3), 35.06 (C-H), 42.83 (CH2), 43.90 (CH3), 53.23 
(CH2), 73.76 (Aliphatic-C), 73.83 (Aliphatic-C), 118.06 (Ar-H), 121.56 (Ar-C), 
123.91 (Ar-C), 138.41 (Ar-C), 147.64 (Ar-C), 150.38 (Ar-C) ppm. 
GC-MS : m/z 272 (M+', C I9H280, 70%). 257 (M+·. C 19H280 - CH3· 100%),217 
(95%),201 (63%), 187 (9%),173 (15%).159 (89(,),115 (59(). 91 ('+9(). 77 ('+9r). 
Analysis ca1cd. for CI9H280 (272) C. 83.77; H. 10.36. Found: C. 82.92: H. lO.3Y7r. 
---------
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3,4-Dihydro-2,2,4,7 -tetramethylbenzopyran (309i) 
3-Methylphenol (28i) (10.89, O.lmol) was reacted with 2-methyl-2,4-pentandiol (314) 
(12.10g, O.lmol) to afford the title compound (1.66g, 9%) as a pale yellow oil and 315i 
as a contaminant (detected by GCIMS). 
Pale yellow oil. B.pt 84-90OC I 1 ton, GC Rt 15.23 min. 
1 H NMR (CDCI3) : 8 1.24 (3H, S, C-2-CH3ax), 1.29-1.32 (3H, d, 1 6.72 Hz, C-4-
CH3), 1.39 (3H, S, C-2-CH3eq), 1.46-1.56 (1H, t, 1 6.96 Hz, C-Hax), 1.78-1.86 OH, 
m, 15.91 Hz, C-Heq), 2.25 (3H, S, C-7-CH3)' 2.83-2.98 OH, m, 1 6.53 Hz, C-4-CH), 
6.61 (1H, s, C-8-CH), 6.66-6.70 (1H, d, meta-coupled, 17.79 Hz, 1m 1.17 Hz, C-6-
CH), 7.10-7.13 (1H, d, 17.80 Hz, C-5-CH) ppm. 
13C NMR (CDCI3) : 8 19.17 (C-4-CH3)' 24.55 (C-7-CH3), 26.06 (C-4-CH), 29.74 (C-
2-CH3ax), 30.11 (C-2-CH3eq), 42.89 (C-3-CH2)' 74.32 (C-2), 117.65 (Ar-CH), 120.86 
(Ar-CH), 123.37 (Ar-C), 126.94 (Ar-H), 137.22 (Ar-C), 153.30 (Ar-C) ppm. 
GC-MS : m/z 190 (M+·, C13H I80, 74%), 175 (M+·, C13H I80 - CH3, 55%), 160 
(7%), 147 (15%), 135 (100%), 105 (14%), 91 (26%),77 (12%). 
The presence of 1,3,3,4,7,7 ,9-heptamethyl-l ,2,3,7 ,8,9-hexahydro-6-oxa-
cyclopenta[a]naphthalene (315i) was detected by GC/MS. 
GC Rt 18.83 min 
GC-MS : m/z 272 (M+·, C19H280, 30%), 257 (M+·, C13H 180 - CH3, 100%),217 
(27%),201 (32%), 187 (6%),173 (11%),159 (5%),128 «5%),91 «5%). 
Analysis calcd. for CI9H280 (272) C, 82.06; H, 9.53. Found: C, 82.60; H, 10.21 %. 
3,4-Dihydro-2,2,4,6-tetramethylbenzopyran (309j) 
4-Methylphenol (28j) (10.31g, O.lmol)) was reacted with 2-methyl-2,4-pentanediol 
(314) (11.59g, O.lmol) to afford the title compound (0.97g, 5%) as a pale yellow oil, 
B.pt 88-95 °C I 2 torr. 
I H NMR (CDC13) : 8 1.23 (3H, S, C-2-CH3ax), 1.30-1.33 (3H, d, 1 6.73 Hz, C-4-
CH3), 1.39 (3H, S, C-2-CH3eq), 1.47-1.57 (lH, t, 1 12.4 Hz, C-3-Hax), 1.78-1.86 
(1 H, q, 1 5.95 Hz, C-3-Heq), 2.26 (C-6-CH3)' 2.88-2.93 (1H, m, 16.15 Hz, C-4-H), 
6.65-6.69 (lH, d, 1 8.22 Hz, Ar-H), 6.87-6.90 (1H, d, meta-coupled, 1 6.08 Hz, 1m 
2.15 Hz, Ar-H), 7.03 (lH, s, meta-coupled, 10.61 Hz, Ar-H) ppm. 
13C NMR (CDCI3) : 8 20.31 (C-4-CH3)' 20.67 (C-6-CH3)' 24.40 (C-2-CH3ax), 26.29 
(C-4-CH), 30.05 (C-2-CH3eq), 42.83 (C-2), 116.97 (Ar-CH), 125.96 (Ar-C), 127.-+5 
(Ar-CH), 127.95 (Ar-CH), 128.81 (Ar-C), 151.20 (Ar-C) ppm. 
---------------- -------
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3,4-Dihydro-4-methoxy-2,2,4,-trimethylbenzopyran (309k) 
4-Methoxyphenol (28k) (l2.48g, 0.1 mol) was reacted with 2-methyl-2,4-pentanediol 
(314) (l7.82g, 0.15 mol) to afford a mixture of the title compound (3.65g, 18%) and 
315k (4.35g, 21 %) which were separated by fractional distillation. 
The first fraction was the title compound as a yellow oil, B pt 128-1300C /3 torr, TLC 
(ethyl acetate: pet. ether 40-60°, 15:85) Rf 0.74. 
IR (film) : u 2955-2866 (sat. C-H str.), 1609 (C=C), 1482-1454 (C-H deL), 1380-1366 
(d, geminal CH3), 1208 (C-O), 838 (C-H bend) em-I. 
I H NMR (CDCI3) : 8 1.22 (3H, S, C-2-CH3ax), 1.27-1.31 (3H, d, J 6.72 Hz, C-4-
CH3), 1.38 (3H, S, C-2-CH3eq), 1.45-1.52 (lH, t, J 13.03 Hz, C-3-Hax), 1.77-1.84 
(lH, q, J 6.04 Hz, C-3-Heq), 2.82-2.97 (lH, m, J 6.64 Hz, C-4-H), 3.78 (3H, s, C-6-
CH3), 6.78 (lH, s, meta-coupled J 2.62 Hz, Ar-H), 6.81-6.84 (lH, d, J 8.13 Hz, Ar-
H), 6.96-6.70 (lH, d, J 9.13 Hz, Ar-H) ppm. 
13C NMR (CDCI3) : 8 20.41 (C-4-CH3)' 24.32 (C-6-CH3), 26.70 (C-4-CH), 30.05 (C-
2-CH3ax), 30.05 (C-2-CH3eq), 42.76 (C-3-CH2), 55.68 (C-6-0CH3), 73.92 (C-2), 
112.45 (Ar-CH), 112.95 (Ar-CH), 117.67 (Ar-CH), 127.09 (Ar-C), 147.56 (Ar-C), 
153.19 (Ar-C). 
The second fraction was a yellow oil, B.pt 152-156°C / 2 torr. and identified as 
2,3,3,5,5,7 -hexamethyl-9-methoxy-1 ,2,3,3,5,5,7 -heptahydro-4-oxa-
cyclopenta[ c ] naphthalene (315k). 
I H NMR (CDC13) : 8 1.22 (3H, s, C-CH3ax), 1.27-1.30 (3H, d, J 6.30 Hz, CH3), 
1.29-1.31 (3H, d, J 5.88 Hz, CH3), 1.33-1.34 (3H, d, J 2.32 Hz, CH3), 1.36-1.39 
(3H, d, J 6.04 Hz, CH3), 1.41 (3H, S, C-CH3eq), 1.50 (2H, m, J 5.03 Hz, C-Hax, C-
Hax), 1.76-1.84 (lH, m, J 5.95 Hz, C-Heq), 2.08-2.17 (lH, m, J 6.54 Hz, C-Heq), 
2.83-2.96 (lH, m, J 6.63 Hz, C-H), 3.20-3.31 (lH, m, J 6.52 Hz, C-H), 3.75 (3H, S, 
C-6-0CH3)' 6.57 (lH, s, Ar-H) ppm. 
13C NMR (CDCI3) : 8 20.41 (CH3), 21.20 (CH3), 24.15 (CH3), 25.22 (CH3), 26.70 
(CH), 28.15 (CH3), 30.05 (CH3), 36.20 (CH), 42.76 (CH2), 44.24 (CH3)· 51.15 
(CH
2
), 55.23 (O-CH3), 73.18 (Ar-C), 73.92 (Ar-C), 108.06 (Ar-H), 124.43 (Ar-C), 
135.90 (Ar-C), 138.18 (Ar-C), 144.37 (Ar-C), 149.65 (Ar-C) ppm. 
MS (EI) : m/z 288 (M+', C12H 160, 90%), 273 (M+·, C13H 180 - CH3, 43%), 2~3 
(100%),217 (70%),203 (10%),189 (9%),129 (6%),91 (6%).55 (5%). 
3,4_Dihydro_6_Bromo-2,2,4,-tetramethylbenzopy ran (3091) 
4-Bromophenol (281) (17.~5g, 0.1 mol) was reacted with 2-methyl-2,4-pentanediol 
(314) (17.73g, 0.15 mol) to afford the title compound (1.84g, 79c) as an orange oil. 
IS7 
Expelimental 
IR (film) : u 2956 (sat. C-H str.), 1764 (C=C), 1479 (C-H def.), 1383 (d, geminal 
CH3), 1212 (C-O), 898 (C-H bend), 662 (C-Br) cm- l . 
IH NMR (CDCI3) : 8 1.22 (3H, s, C-2-CH3ax), 1.29-1.32 (3H, d, J 6.75 Hz, C-4-
CH3), 1.39 (3H, s, C-2-CH3eq), 1.50-1.56 (lH, t, J 12.4 Hz, C-3-Hax), 1.77-1.87 
(1H, q, J 5.94 Hz, C-3-Heq), 2.26 (C-6-CH3), 2.83-2.99 (lH, m, J 6.73 Hz, C-4-H), 
6.63-6.65 (lH, d, J 5.96 Hz, Ar-H), 7.13-7.18 (lH, d, meta-coupled, J 8.75 Hz, 1m 
1.60 Hz, Ar-H), 7.45 (lH, s, meta-coupled, J 2.19 Hz, Ar-H) ppm. 
l3C NMR (CDCI3) : 8 18.46 (C-4-CH3)' 24.40 (C-2-CH3ax), 26.35 (C-4-CH), 29.87 
(C-2-CH3eq), 42.20 (C-3-CH2), 74.65 (C-2), 111.93 (Ar-C), 119.05 (Ar-CH), 128.05 
(Ar-C), 129.85 (Ar-CH), 130.15 (Ar-CH), 152.65 (Ar-C) ppm. 
2,2,4,6,8,8-Hexamethyl-3,4,6,7 -tetrahydro-2H,6H -pyrano[3,2-
g]chromen-S-ol (309m) 
Pyrogallol (28m) (l2.68g, 0.1 mol) was reacted with 2-methyl-2,4-pentanediol (314) 
(18.20g, 0.2 mol) to afford the title compound as light brown solid (1.19g, 4%), b.pt 
102-1060C I 2 torr, TLC (ethyl acetate: pet ether 40-60°, 15:85) Rf 0.29. 
IH NMR (CDCI3) : 8 1.26-1.32 (l2H, m, 4 x CH3), 1.45 (6H, s, 2 x CH3), 1.48 1.59 
(2H, t, J 13.04 Hz, 2 x C-Hax), 1.78-1.86 (2H, m, J 5.73 Hz, 2 x C-Heq), 2.81-2.98 
(2H, m, J 6.50 Hz, 2 xC-H), 5.35 (lH, s, broad, C-5-0H), 6.36 (lH, s, C-8-H) ppm. 
13C NMR (CDCI3) : 8 20.36 (CH3), 20.42 (CH3), 24.57 (CH3), 24.69 (CH3), 25.91 
(C-H), 25.97 (C-H), 30.04 (CH3), 30.07 (CH3), 43.07 (CH2), 43.11 (CH2), 75.01 
(Aliphatic-C), 75.09 (Aliphatic-C), 113.81 (Ar-H), 118.39 (Ar-C), 118.41 (Ar-C), 
132.84 (Ar-C), 139.25 (Ar-C), 139.34 (Ar-C) ppm. 
MS (EI) : mlz 290 (M+·, C18H2603, 55%), 275 (M+·, Cl8H2603 - CH3, 30%), 235 
(100%),219 (29%), 201 (l0%), 191 (25%), 165 (5%),179 (60%),91 (9%),83 (8%), 
77 (9%). 
3,4-Dihydro-2,2,S-7,8-pentamethyl-6-nitro-benzopyran (309n) 
3,4-Dihydro-2,2,5,7,8-pentamethylbenzopyran (28n) (l0.93g, 0.05mol) was dissolved 
in a cooled solution of conc. sulphuric acid (lOml) at OOC. A mixture of conc. sulphuric 
acid and conc. nitric acid (5ml) at OOC was added dropwise over a period 10 mins with 
constant stirring. The reaction mixture was allowed to stand with constant stining at 
room temperature for a fmther 15 mins. The resultant solution was poured onto ice (50g) 
with stining. On standing an orange oil formed which was taken up in ethyl acetate (50 
mI). The organic layer was washed with water (2x lOOml) and dIied over anhydrous 
magnesium sulphate. Filtration of the drying agent and removal of the solvent in \'OCliO 
afforded the title compound as a light orange oil. 
158 
Experimental 
1 H NMR (CDCI3) : 8 1.18 (3H, S, C-2a-CH3), 1.26-1.29 (3H, d, J 8.70 Hz, C-4-
CH3), 1.43 (3H, S, C-2b-CH3), 1.70-1.78 (1H, q, J 6.96 Hz, C-3-Hax), 1.96-2.01 
(lH, q, J 6.32 Hz, C-3-Heq), 2.10 (6H, S, 2xAr-CH3)' 2.18 (3H, S, Ar-CH3), 2.99-
3.12 (1H, m, J 6.94 Hz, C-4-H) ppm. 
13C NMR (CDCI3) : 8 11.42 (Ar-CH3), 14.49 (Ar-CH3), 14.54 (Ar-CH3), 2l.69 (C-4-
CH3), 26.53 (C-2-CH3ax), 26.58 (C-4-CH), 29.34 (C-2-CH3eq), 43.19 (C-3-CH2), 
73.37 (C2), 124.35 (Ar-C), 124.50 (2xAr-C), 126.84 (Ar-C), 147.46 (Ar-C), 152.46 
(Ar-C) ppm. 
M.S. (EI) : m/z 263 (M+·, ClsH21N03' 67%), 243 (M+·, ClsH21N03 - CH3, 25%), 
233 (8%),217 (M+· - N02, 18%),208 (100%), 190 (34%), 174 (22%), 161 (14%), 
149 (14%),128 (10%),115 (15%),105 (17%),91 (30%),77 (23%). 
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